0000701221 2011-01-01 2011-12-31 0000701221 2010-01-01 2010-12-31 0000701221 2009-01-01 2009-12-31 0000701221 2011-12-31 0000701221 2010-12-31 0000701221 2008-12-31 0000701221 2009-12-31 0000701221 us-gaap:CommonStockMember 2010-12-31 0000701221 us-gaap:CommonStockMember 2009-12-31 0000701221 us-gaap:CommonStockMember 2008-12-31 0000701221 us-gaap:AdditionalPaidInCapitalMember 2010-12-31 0000701221 us-gaap:AdditionalPaidInCapitalMember 2009-12-31 0000701221 us-gaap:AdditionalPaidInCapitalMember 2008-12-31 0000701221 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2010-12-31 0000701221 us-gaap:RetainedEarningsMember 2010-12-31 0000701221 us-gaap:TreasuryStockMember 2010-12-31 0000701221 us-gaap:TreasuryStockMember 2009-12-31 0000701221 us-gaap:TreasuryStockMember 2008-12-31 0000701221 us-gaap:NoncontrollingInterestMember 2010-12-31 0000701221 us-gaap:NoncontrollingInterestMember 2009-12-31 0000701221 us-gaap:NoncontrollingInterestMember 2008-12-31 0000701221 us-gaap:AdditionalPaidInCapitalMember 2011-01-01 2011-12-31 0000701221 us-gaap:AdditionalPaidInCapitalMember 2010-01-01 2010-12-31 0000701221 us-gaap:AdditionalPaidInCapitalMember 2009-01-01 2009-12-31 0000701221 us-gaap:ComprehensiveIncomeMember 2011-01-01 2011-12-31 0000701221 us-gaap:ComprehensiveIncomeMember 2010-01-01 2010-12-31 0000701221 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2011-01-01 2011-12-31 0000701221 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2010-01-01 2010-12-31 0000701221 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2009-01-01 2009-12-31 0000701221 us-gaap:TreasuryStockMember 2011-01-01 2011-12-31 0000701221 us-gaap:TreasuryStockMember 2010-01-01 2010-12-31 0000701221 us-gaap:TreasuryStockMember 2009-01-01 2009-12-31 0000701221 us-gaap:NoncontrollingInterestMember 2011-01-01 2011-12-31 0000701221 us-gaap:NoncontrollingInterestMember 2010-01-01 2010-12-31 0000701221 us-gaap:NoncontrollingInterestMember 2009-01-01 2009-12-31 0000701221 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2009-12-31 0000701221 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2008-12-31 0000701221 us-gaap:RetainedEarningsMember 2009-12-31 0000701221 us-gaap:RetainedEarningsMember 2008-12-31 0000701221 us-gaap:CommonStockMember 2011-12-31 0000701221 us-gaap:AdditionalPaidInCapitalMember 2011-12-31 0000701221 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2011-12-31 0000701221 us-gaap:RetainedEarningsMember 2011-12-31 0000701221 us-gaap:TreasuryStockMember 2011-12-31 0000701221 ci:ShareholderComprehensiveIncomeLossAndShareholdersEquityMember 2011-12-31 0000701221 ci:ShareholderComprehensiveIncomeLossAndShareholdersEquityMember 2010-12-31 0000701221 ci:ShareholderComprehensiveIncomeLossAndShareholdersEquityMember 2009-12-31 0000701221 us-gaap:NoncontrollingInterestMember 2011-12-31 0000701221 2012-01-31 0000701221 us-gaap:RetainedEarningsMember 2009-01-01 2009-12-31 0000701221 ci:HealthCareSegmentMember 2010-01-01 2010-12-31 0000701221 us-gaap:FairValueInputsLevel1Member us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2011-12-31 0000701221 us-gaap:FairValueInputsLevel2Member us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2011-12-31 0000701221 us-gaap:FairValueInputsLevel3Member us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2011-12-31 0000701221 us-gaap:FairValueInputsLevel1Member us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2010-12-31 0000701221 us-gaap:FairValueInputsLevel2Member us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2010-12-31 0000701221 us-gaap:FairValueInputsLevel3Member us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2010-12-31 0000701221 2011-01-01 2011-03-31 0000701221 2011-04-01 2011-06-30 0000701221 2011-07-01 2011-09-30 0000701221 2011-10-01 2011-12-31 0000701221 2010-01-01 2010-03-31 0000701221 2010-04-01 2010-06-30 0000701221 2010-07-01 2010-09-30 0000701221 2010-10-01 2010-12-31 0000701221 us-gaap:EarningsPerShareBasicMember 2011-01-01 2011-12-31 0000701221 us-gaap:EarningsPerShareDilutedMember 2011-01-01 2011-12-31 0000701221 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2009-01-01 2009-12-31 0000701221 us-gaap:DefinedBenefitPensionMember 2011-01-01 2011-12-31 0000701221 us-gaap:OtherMember 2010-12-31 0000701221 us-gaap:CustomerRelationshipsMember 2010-12-31 0000701221 ci:TotalReportedInOtherAssetsMember 2010-12-31 0000701221 us-gaap:SoftwareMember 2010-12-31 0000701221 ci:TotalIntangibleAssetsMember 2010-12-31 0000701221 ci:TotalReportedInOtherAssetsMember 2011-12-31 0000701221 ci:GuaranteedDepositAccountContractMember 2011-01-01 2011-12-31 0000701221 ci:AssetsDisposedOfByMethodOtherThanSaleInPeriodOfDispositionRunOffWorkersCompensationAndPersonalAccidentBusinessMember 2010-12-30 2010-12-31 0000701221 ci:SaleOfWorkersCompensationAndCaseManagementBusinessMember 2010-11-30 2010-12-01 0000701221 ci:VanbredaMember 2010-08-31 0000701221 us-gaap:EarningsPerShareBasicMember 2010-01-01 2010-12-31 0000701221 us-gaap:EarningsPerShareBasicMember 2009-01-01 2009-12-31 0000701221 us-gaap:EarningsPerShareDilutedMember 2010-01-01 2010-12-31 0000701221 us-gaap:EarningsPerShareDilutedMember 2009-01-01 2009-12-31 0000701221 ci:EffectOfDilutionMember 2009-01-01 2009-12-31 0000701221 ci:EffectOfDilutionMember 2010-01-01 2010-12-31 0000701221 ci:EffectOfDilutionMember 2011-01-01 2011-12-31 0000701221 2008-01-01 2008-12-31 0000701221 ci:AnniversaryValueResetMember 2010-12-31 0000701221 us-gaap:OtherMember 2010-12-31 0000701221 ci:TotalMember 2010-12-31 0000701221 ci:AnniversaryValueResetMember 2011-12-31 0000701221 us-gaap:OtherMember 2011-12-31 0000701221 ci:TotalMember 2011-12-31 0000701221 ci:TotalIntangibleAssetsMember 2011-12-31 0000701221 us-gaap:CustomerRelationshipsMember 2011-12-31 0000701221 us-gaap:OtherMember 2011-12-31 0000701221 us-gaap:SoftwareMember 2011-12-31 0000701221 us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember 2011-12-31 0000701221 us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember 2010-12-31 0000701221 ci:TotalPropertyAndEquipmentMember 2011-12-31 0000701221 ci:TotalPropertyAndEquipmentMember 2010-12-31 0000701221 us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember 2009-01-01 2009-12-31 0000701221 us-gaap:SoftwareMember 2011-01-01 2011-12-31 0000701221 us-gaap:SoftwareMember 2010-01-01 2010-12-31 0000701221 us-gaap:SoftwareMember 2009-01-01 2009-12-31 0000701221 us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember 2011-01-01 2011-12-31 0000701221 us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember 2010-01-01 2010-12-31 0000701221 ci:TotalPropertyAndEquipmentMember 2011-01-01 2011-12-31 0000701221 us-gaap:OtherMember 2011-01-01 2011-12-31 0000701221 us-gaap:OtherMember 2010-01-01 2010-12-31 0000701221 us-gaap:OtherMember 2009-01-01 2009-12-31 0000701221 ci:TotalPropertyAndEquipmentMember 2009-01-01 2009-12-31 0000701221 ci:TotalPropertyAndEquipmentMember 2010-01-01 2010-12-31 0000701221 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2011-01-01 2011-12-31 0000701221 us-gaap:DefinedBenefitPensionMember 2011-12-31 0000701221 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2011-12-31 0000701221 us-gaap:DefinedBenefitPensionMember 2010-01-01 2010-12-31 0000701221 us-gaap:DefinedBenefitPensionMember 2010-12-31 0000701221 us-gaap:DefinedBenefitPensionMember 2009-12-31 0000701221 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2010-01-01 2010-12-31 0000701221 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2010-12-31 0000701221 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2009-12-31 0000701221 us-gaap:DefinedBenefitPensionMember 2009-01-01 2009-12-31 0000701221 ci:NotesDue20175375InterestMember 2011-12-31 0000701221 ci:NotesDue2018635InterestMember 2011-12-31 0000701221 ci:NotesDue201985InterestMember 2011-12-31 0000701221 ci:NotesDue20204375InterestMember 2011-12-31 0000701221 ci:NotesDue20205125InterestMember 2011-12-31 0000701221 ci:NotesDue2021637InterestMember 2011-12-31 0000701221 ci:NotesDue2023765InterestMember 2011-12-31 0000701221 ci:NotesDue202383InterestMember 2011-12-31 0000701221 ci:DebenturesDue20277875InterestMember 2011-12-31 0000701221 ci:StepDownNotesDue203383InterestMember 2011-12-31 0000701221 ci:NotesDue2036615InterestMember 2011-12-31 0000701221 ci:OtherLongTermDebtMember 2011-12-31 0000701221 ci:NotesDue20175375InterestMember 2010-12-31 0000701221 ci:DisabilityAndLifeSegmentMember 2011-01-01 2011-12-31 0000701221 ci:NotesDue2018635InterestMember 2010-12-31 0000701221 ci:NotesDue201985InterestMember 2010-12-31 0000701221 ci:NotesDue20204375InterestMember 2010-12-31 0000701221 ci:NotesDue20205125InterestMember 2010-12-31 0000701221 ci:NotesDue2021637InterestMember 2010-12-31 0000701221 ci:NotesDue2023765InterestMember 2010-12-31 0000701221 ci:NotesDue202383InterestMember 2010-12-31 0000701221 ci:DebenturesDue20277875InterestMember 2010-12-31 0000701221 ci:StepDownNotesDue203383InterestMember 2010-12-31 0000701221 ci:NotesDue2036615InterestMember 2010-12-31 0000701221 ci:OtherLongTermDebtMember 2010-12-31 0000701221 ci:DisabilityAndLifeSegmentMember 2010-01-01 2010-12-31 0000701221 ci:DisabilityAndLifeSegmentMember 2009-01-01 2009-12-31 0000701221 ci:InternationalSegmentMember 2011-01-01 2011-12-31 0000701221 ci:InternationalSegmentMember 2010-01-01 2010-12-31 0000701221 ci:InternationalSegmentMember 2009-01-01 2009-12-31 0000701221 ci:RunOffReinsuranceSegmentMember 2011-01-01 2011-12-31 0000701221 ci:RunOffReinsuranceSegmentMember 2010-01-01 2010-12-31 0000701221 ci:RunOffReinsuranceSegmentMember 2009-01-01 2009-12-31 0000701221 ci:OtherOperationsSegmentMember 2011-01-01 2011-12-31 0000701221 ci:OtherOperationsSegmentMember 2010-01-01 2010-12-31 0000701221 ci:OtherOperationsSegmentMember 2009-01-01 2009-12-31 0000701221 ci:CorporateSegmentMember 2011-01-01 2011-12-31 0000701221 ci:CorporateSegmentMember 2010-01-01 2010-12-31 0000701221 ci:CorporateSegmentMember 2009-01-01 2009-12-31 0000701221 ci:HealthCareSegmentMember 2011-01-01 2011-12-31 0000701221 ci:HealthCareSegmentMember 2011-12-31 0000701221 ci:HealthCareSegmentMember 2010-12-31 0000701221 ci:HealthCareSegmentMember 2009-01-01 2009-12-31 0000701221 ci:HealthCareSegmentMember 2009-12-31 0000701221 ci:HealthCareSegmentMember 2011-12-31 0000701221 ci:InternationalSegmentMember 2011-12-31 0000701221 us-gaap:NondesignatedMember ci:NotionalMember ci:WrittenOptionsGmibLiabilityMember 2011-12-31 0000701221 us-gaap:NondesignatedMember ci:NotionalMember ci:WrittenOptionsGmibLiabilityMember 2010-12-31 0000701221 us-gaap:NondesignatedMember ci:NotionalMember ci:PurchasedOptionsGmibAssetMember 2011-12-31 0000701221 us-gaap:NondesignatedMember ci:NotionalMember ci:PurchasedOptionsGmibAssetMember 2010-12-31 0000701221 ci:NotesDue2016275InterestMember 2011-12-31 0000701221 ci:NotesDue2016275InterestMember 2010-12-31 0000701221 ci:NotesDue20224InterestMember 2011-12-31 0000701221 ci:NotesDue20224InterestMember 2010-12-31 0000701221 ci:NotesDue20425375InterestMember 2011-12-31 0000701221 ci:NotesDue20425375InterestMember 2010-12-31 0000701221 us-gaap:FixedMaturitiesMember 2011-01-01 2011-12-31 0000701221 us-gaap:FixedMaturitiesMember 2010-01-01 2010-12-31 0000701221 us-gaap:FixedMaturitiesMember 2009-01-01 2009-12-31 0000701221 us-gaap:EquitySecuritiesMember 2011-01-01 2011-12-31 0000701221 us-gaap:EquitySecuritiesMember 2010-01-01 2010-12-31 0000701221 us-gaap:EquitySecuritiesMember 2009-01-01 2009-12-31 0000701221 us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember 2009-01-01 2009-12-31 0000701221 us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember 2010-01-01 2010-12-31 0000701221 us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember 2011-01-01 2011-12-31 0000701221 us-gaap:RealEstateMember 2011-01-01 2011-12-31 0000701221 us-gaap:RealEstateMember 2010-01-01 2010-12-31 0000701221 us-gaap:RealEstateMember 2009-01-01 2009-12-31 0000701221 us-gaap:OtherLongTermInvestmentsMember 2009-01-01 2009-12-31 0000701221 us-gaap:OtherLongTermInvestmentsMember 2010-01-01 2010-12-31 0000701221 us-gaap:OtherLongTermInvestmentsMember 2011-01-01 2011-12-31 0000701221 ci:SouthKoreaMember 2011-01-01 2011-12-31 0000701221 ci:HongKongMember 2011-01-01 2011-12-31 0000701221 ci:SouthKoreaMember 2010-01-01 2010-12-31 0000701221 ci:HongKongMember 2010-01-01 2010-12-31 0000701221 ci:SouthKoreaMember 2009-01-01 2009-12-31 0000701221 ci:NotesDue2016275InterestMember 2011-01-01 2011-12-31 0000701221 ci:NotesDue20224InterestMember 2011-01-01 2011-12-31 0000701221 ci:NotesDue20425375InterestMember 2011-01-01 2011-12-31 0000701221 ci:NotesDue201985InterestMember 2010-01-01 2010-12-31 0000701221 ci:NotesDue2018635InterestMember 2010-01-01 2010-12-31 0000701221 ci:NotesDue20204375InterestMember 2010-01-01 2010-12-31 0000701221 ci:NotesDue20205125InterestMember 2010-01-01 2010-12-31 0000701221 us-gaap:OneYearFromBalanceSheetDateMember 2011-12-31 0000701221 us-gaap:MoreThanTwoAndWithinThreeYearsFromBalanceSheetDateMember 2011-12-31 0000701221 us-gaap:MoreThanThreeAndWithinFourYearsFromBalanceSheetDateMember 2011-12-31 0000701221 us-gaap:MoreThanFourAndWithinFiveYearsFromBalanceSheetDateMember 2011-12-31 0000701221 us-gaap:MoreThanFiveYearsFromBalanceSheetDateAndThereafterMember 2011-12-31 0000701221 ci:PortionAtAmortizedCostDisclosureMember 2011-12-31 0000701221 ci:UnrealizedGainMember 2011-12-31 0000701221 ci:UnrealizedLossOrWriteDownMember 2011-12-31 0000701221 us-gaap:PortionAtFairValueFairValueDisclosureMember 2011-12-31 0000701221 ci:PortionAtAmortizedCostDisclosureMember 2010-12-31 0000701221 ci:UnrealizedGainMember 2010-12-31 0000701221 ci:UnrealizedLossOrWriteDownMember 2010-12-31 0000701221 us-gaap:PortionAtFairValueFairValueDisclosureMember 2010-12-31 0000701221 ci:OfficeBuildingsMember 2011-12-31 0000701221 ci:ApartmentBuildingMember 2011-12-31 0000701221 ci:IndustrialMember 2011-12-31 0000701221 ci:HotelsMember 2011-12-31 0000701221 ci:RetailFacilitiesMember 2011-12-31 0000701221 ci:OtherPropertyMember 2011-12-31 0000701221 ci:PacificRegionMember 2011-12-31 0000701221 ci:SouthAtlanticRegionMember 2011-12-31 0000701221 ci:NewEnglandRegionMember 2011-12-31 0000701221 ci:CentralRegionMember 2011-12-31 0000701221 ci:MiddleAtlanticMember 2011-12-31 0000701221 ci:MountainMember 2011-12-31 0000701221 ci:OfficeBuildingsMember 2010-12-31 0000701221 ci:ApartmentBuildingMember 2010-12-31 0000701221 ci:IndustrialMember 2010-12-31 0000701221 ci:HotelsMember 2010-12-31 0000701221 ci:RetailFacilitiesMember 2010-12-31 0000701221 ci:OtherPropertyMember 2010-12-31 0000701221 ci:PacificRegionMember 2010-12-31 0000701221 ci:SouthAtlanticRegionMember 2010-12-31 0000701221 ci:NewEnglandRegionMember 2010-12-31 0000701221 ci:CentralRegionMember 2010-12-31 0000701221 ci:MiddleAtlanticMember 2010-12-31 0000701221 ci:MountainMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio130xOrGreaterMember ci:LoanToValueRatioBelow50PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio130xOrGreaterMember ci:LoanToValueRatio50PercentTo59PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio130xOrGreaterMember ci:LoanToValueRatio60PercentTo69PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio130xOrGreaterMember ci:LoanToValueRatio70PercentTo79PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio130xOrGreaterMember ci:LoanToValueRatio80PercentTo89PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio130xOrGreaterMember ci:LoanToValueRatio90PercentTo99PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio130xOrGreaterMember ci:LoanToValueRatio100PercentOrAboveMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio120xTo129xMember ci:LoanToValueRatioBelow50PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio120xTo129xMember ci:LoanToValueRatio50PercentTo59PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio120xTo129xMember ci:LoanToValueRatio60PercentTo69PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio120xTo129xMember ci:LoanToValueRatio70PercentTo79PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio120xTo129xMember ci:LoanToValueRatio80PercentTo89PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio120xTo129xMember ci:LoanToValueRatio90PercentTo99PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio120xTo129xMember ci:LoanToValueRatio100PercentOrAboveMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio110xTo119xMember ci:LoanToValueRatioBelow50PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio110xTo119xMember ci:LoanToValueRatio50PercentTo59PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio110xTo119xMember ci:LoanToValueRatio60PercentTo69PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio110xTo119xMember ci:LoanToValueRatio70PercentTo79PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio110xTo119xMember ci:LoanToValueRatio80PercentTo89PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio110xTo119xMember ci:LoanToValueRatio90PercentTo99PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio110xTo119xMember ci:LoanToValueRatio100PercentOrAboveMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio100xTo109xMember ci:LoanToValueRatioBelow50PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio100xTo109xMember ci:LoanToValueRatio60PercentTo69PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio100xTo109xMember ci:LoanToValueRatio50PercentTo59PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio100xTo109xMember ci:LoanToValueRatio70PercentTo79PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio100xTo109xMember ci:LoanToValueRatio80PercentTo89PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio100xTo109xMember ci:LoanToValueRatio90PercentTo99PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatio100xTo109xMember ci:LoanToValueRatio100PercentOrAboveMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatioLessThan100xMember ci:LoanToValueRatioBelow50PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatioLessThan100xMember ci:LoanToValueRatio50PercentTo59PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatioLessThan100xMember ci:LoanToValueRatio60PercentTo69PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatioLessThan100xMember ci:LoanToValueRatio70PercentTo79PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatioLessThan100xMember ci:LoanToValueRatio80PercentTo89PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatioLessThan100xMember ci:LoanToValueRatio90PercentTo99PercentMember 2011-12-31 0000701221 ci:DebtServiceCoverageRatioLessThan100xMember ci:LoanToValueRatio100PercentOrAboveMember 2011-12-31 0000701221 ci:CommercialMortgageLoansFinancingReceivableWithRelatedAllowanceMember ci:ImpairedCommercialMortgageLoansGrossMember 2011-12-31 0000701221 ci:CommercialMortgageLoansFinancingReceivableWithNoRelatedAllowanceMember ci:ImpairedCommercialMortgageLoansGrossMember 2011-12-31 0000701221 ci:CommercialMortgageLoansFinancingReceivableWithRelatedAllowanceMember ci:ImpairedCommercialMortgageLoansReservesMember 2011-12-31 0000701221 ci:CommercialMortgageLoansFinancingReceivableWithNoRelatedAllowanceMember ci:ImpairedCommercialMortgageLoansReservesMember 2011-12-31 0000701221 ci:CommercialMortgageLoansFinancingReceivableWithRelatedAllowanceMember ci:ImpairedCommercialMortgageLoansNetMember 2011-12-31 0000701221 ci:CommercialMortgageLoansFinancingReceivableWithNoRelatedAllowanceMember ci:ImpairedCommercialMortgageLoansNetMember 2011-12-31 0000701221 ci:CommercialMortgageLoansFinancingReceivableWithRelatedAllowanceMember ci:ImpairedCommercialMortgageLoansGrossMember 2010-12-31 0000701221 ci:CommercialMortgageLoansFinancingReceivableWithNoRelatedAllowanceMember ci:ImpairedCommercialMortgageLoansGrossMember 2010-12-31 0000701221 ci:CommercialMortgageLoansFinancingReceivableWithRelatedAllowanceMember ci:ImpairedCommercialMortgageLoansReservesMember 2010-12-31 0000701221 ci:CommercialMortgageLoansFinancingReceivableWithNoRelatedAllowanceMember ci:ImpairedCommercialMortgageLoansReservesMember 2010-12-31 0000701221 ci:CommercialMortgageLoansFinancingReceivableWithRelatedAllowanceMember ci:ImpairedCommercialMortgageLoansNetMember 2010-12-31 0000701221 ci:CommercialMortgageLoansFinancingReceivableWithNoRelatedAllowanceMember ci:ImpairedCommercialMortgageLoansNetMember 2010-12-31 0000701221 us-gaap:RealEstateInvestmentMember 2011-12-31 0000701221 ci:SecurityPartnershipsMember 2011-12-31 0000701221 ci:InterestRateAndForeignCurrencySwapsMember 2011-12-31 0000701221 ci:MezzanineLoansMember 2011-12-31 0000701221 us-gaap:OtherLongTermInvestmentsMember 2011-12-31 0000701221 us-gaap:RealEstateInvestmentMember 2010-12-31 0000701221 ci:SecurityPartnershipsMember 2010-12-31 0000701221 ci:InterestRateAndForeignCurrencySwapsMember 2010-12-31 0000701221 ci:MezzanineLoansMember 2010-12-31 0000701221 us-gaap:OtherLongTermInvestmentsMember 2010-12-31 0000701221 us-gaap:FairValueInputsLevel2Member 2011-12-31 0000701221 us-gaap:FairValueInputsLevel3Member 2011-12-31 0000701221 us-gaap:FairValueInputsLevel1Member 2011-12-31 0000701221 us-gaap:FairValueInputsLevel2Member 2010-12-31 0000701221 us-gaap:FairValueInputsLevel3Member 2010-12-31 0000701221 us-gaap:FairValueInputsLevel1Member 2010-12-31 0000701221 ci:FixedMaturitiesAndEquitySecuritiesMember 2011-01-01 2011-12-31 0000701221 ci:GuaranteedMinimumIncomeBenefitsAssetsMember 2011-01-01 2011-12-31 0000701221 ci:GuaranteedMinimumIncomeBenefitsLiabilitiesMember 2011-01-01 2011-12-31 0000701221 ci:GuaranteedMinimumIncomeBenefitsNetMember 2011-01-01 2011-12-31 0000701221 ci:FixedMaturitiesAndEquitySecuritiesMember 2009-01-01 2009-12-31 0000701221 ci:GuaranteedMinimumIncomeBenefitsAssetsMember 2009-01-01 2009-12-31 0000701221 ci:GuaranteedMinimumIncomeBenefitsLiabilitiesMember 2009-01-01 2009-12-31 0000701221 ci:GuaranteedMinimumIncomeBenefitsNetMember 2009-01-01 2009-12-31 0000701221 ci:FixedMaturitiesAndEquitySecuritiesMember 2010-01-01 2010-12-31 0000701221 ci:GuaranteedMinimumIncomeBenefitsAssetsMember 2010-01-01 2010-12-31 0000701221 ci:GuaranteedMinimumIncomeBenefitsLiabilitiesMember 2010-01-01 2010-12-31 0000701221 ci:GuaranteedMinimumIncomeBenefitsNetMember 2010-01-01 2010-12-31 0000701221 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2011-12-31 0000701221 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2011-12-31 0000701221 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2011-01-01 2011-12-31 0000701221 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2011-01-01 2011-12-31 0000701221 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2010-12-31 0000701221 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2010-12-31 0000701221 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2010-01-01 2010-12-31 0000701221 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2010-01-01 2010-12-31 0000701221 us-gaap:FixedMaturitiesMember 2011-01-01 2011-12-31 0000701221 us-gaap:EquitySecuritiesMember 2011-01-01 2011-12-31 0000701221 us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember 2011-01-01 2011-12-31 0000701221 us-gaap:PolicyLoansMember 2011-01-01 2011-12-31 0000701221 us-gaap:RealEstateMember 2011-01-01 2011-12-31 0000701221 us-gaap:OtherLongTermInvestmentsMember 2011-01-01 2011-12-31 0000701221 us-gaap:CashAndCashEquivalentsMember 2011-01-01 2011-12-31 0000701221 us-gaap:NoninterestExpenseInvestmentAdvisoryFeesMember 2011-01-01 2011-12-31 0000701221 us-gaap:FixedMaturitiesMember 2010-01-01 2010-12-31 0000701221 us-gaap:EquitySecuritiesMember 2010-01-01 2010-12-31 0000701221 us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember 2010-01-01 2010-12-31 0000701221 us-gaap:PolicyLoansMember 2010-01-01 2010-12-31 0000701221 us-gaap:RealEstateMember 2010-01-01 2010-12-31 0000701221 us-gaap:OtherLongTermInvestmentsMember 2010-01-01 2010-12-31 0000701221 us-gaap:CashAndCashEquivalentsMember 2010-01-01 2010-12-31 0000701221 us-gaap:NoninterestExpenseInvestmentAdvisoryFeesMember 2010-01-01 2010-12-31 0000701221 us-gaap:FixedMaturitiesMember 2009-01-01 2009-12-31 0000701221 us-gaap:EquitySecuritiesMember 2009-01-01 2009-12-31 0000701221 us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember 2009-01-01 2009-12-31 0000701221 us-gaap:PolicyLoansMember 2009-01-01 2009-12-31 0000701221 us-gaap:RealEstateMember 2009-01-01 2009-12-31 0000701221 us-gaap:OtherLongTermInvestmentsMember 2009-01-01 2009-12-31 0000701221 us-gaap:CashAndCashEquivalentsMember 2009-01-01 2009-12-31 0000701221 us-gaap:NoninterestExpenseInvestmentAdvisoryFeesMember 2009-01-01 2009-12-31 0000701221 us-gaap:NondesignatedMember us-gaap:OtherAssetsMember ci:PurchasedOptionsGmibAssetMember 2011-12-31 0000701221 ci:AccountsPayableAccruedExpensesAndOtherLiabilitiesMember us-gaap:NondesignatedMember ci:WrittenOptionsGmibLiabilityMember 2011-12-31 0000701221 us-gaap:NondesignatedMember us-gaap:OtherAssetsMember ci:PurchasedOptionsGmibAssetMember 2010-12-31 0000701221 ci:AccountsPayableAccruedExpensesAndOtherLiabilitiesMember us-gaap:NondesignatedMember ci:WrittenOptionsGmibLiabilityMember 2010-12-31 0000701221 ci:GuaranteedMinimumIncomeBenefitsFairValueGainLossMember us-gaap:NondesignatedMember ci:WrittenOptionsGmibLiabilityMember 2011-01-01 2011-12-31 0000701221 ci:GuaranteedMinimumIncomeBenefitsFairValueGainLossMember us-gaap:NondesignatedMember ci:PurchasedOptionsGmibAssetMember 2011-01-01 2011-12-31 0000701221 ci:GuaranteedMinimumIncomeBenefitsFairValueGainLossMember us-gaap:NondesignatedMember ci:WrittenOptionsGmibLiabilityMember 2010-01-01 2010-12-31 0000701221 ci:GuaranteedMinimumIncomeBenefitsFairValueGainLossMember us-gaap:NondesignatedMember ci:PurchasedOptionsGmibAssetMember 2010-01-01 2010-12-31 0000701221 ci:GuaranteedMinimumDeathBenefitsEquityFuturesMember us-gaap:NondesignatedMember ci:OtherRevenueMember 2011-01-01 2011-12-31 0000701221 ci:GuaranteedMinimumIncomeBenefitsEquityFuturesMember us-gaap:NondesignatedMember ci:OtherRevenueMember 2011-01-01 2011-12-31 0000701221 ci:GuaranteedMinimumDeathBenefitsEquityFuturesMember us-gaap:NondesignatedMember ci:OtherRevenueMember 2010-01-01 2010-12-31 0000701221 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember us-gaap:OtherAssetsMember 2011-12-31 0000701221 ci:InterestRateSwapGrowthInterestMember us-gaap:NondesignatedMember ci:OtherRevenueMember 2011-01-01 2011-12-31 0000701221 ci:InterestRateFuturesGrowthInterestMember us-gaap:NondesignatedMember ci:OtherRevenueMember 2011-01-01 2011-12-31 0000701221 ci:GuaranteedMinimumDeathBenefitsMember us-gaap:NondesignatedMember ci:OtherRevenueMember 2011-01-01 2011-12-31 0000701221 ci:GuaranteedMinimumIncomeBenefitsMember us-gaap:NondesignatedMember ci:OtherRevenueMember 2011-01-01 2011-12-31 0000701221 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember ci:OtherLongTermInvestmentsDesignatedAsAccountingHedgesMember 2011-12-31 0000701221 us-gaap:DesignatedAsHedgingInstrumentMember ci:ForeignCurrencySwapMember ci:OtherLongTermInvestmentsDesignatedAsAccountingHedgesMember 2011-12-31 0000701221 us-gaap:DesignatedAsHedgingInstrumentMember ci:InterestAndForeignCurrencySwapsMember ci:OtherLongTermInvestmentsDesignatedAsAccountingHedgesMember 2011-12-31 0000701221 ci:AccountsPayableAccruedExpensesAndOtherLiabilitiesDesignatedAsAccountingHedgeMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember 2011-12-31 0000701221 ci:AccountsPayableAccruedExpensesAndOtherLiabilitiesDesignatedAsAccountingHedgeMember us-gaap:DesignatedAsHedgingInstrumentMember ci:ForeignCurrencySwapMember 2011-12-31 0000701221 ci:AccountsPayableAccruedExpensesAndOtherLiabilitiesDesignatedAsAccountingHedgeMember us-gaap:DesignatedAsHedgingInstrumentMember ci:InterestAndForeignCurrencySwapsMember 2011-12-31 0000701221 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember us-gaap:OtherComprehensiveIncomeMember 2011-01-01 2011-12-31 0000701221 us-gaap:DesignatedAsHedgingInstrumentMember ci:ForeignCurrencySwapMember us-gaap:OtherComprehensiveIncomeMember 2011-01-01 2011-12-31 0000701221 us-gaap:DesignatedAsHedgingInstrumentMember ci:InterestAndForeignCurrencySwapsMember us-gaap:OtherComprehensiveIncomeMember 2011-01-01 2011-12-31 0000701221 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember us-gaap:OtherComprehensiveIncomeMember 2010-01-01 2010-12-31 0000701221 us-gaap:DesignatedAsHedgingInstrumentMember ci:ForeignCurrencySwapMember us-gaap:OtherComprehensiveIncomeMember 2010-01-01 2010-12-31 0000701221 us-gaap:DesignatedAsHedgingInstrumentMember ci:InterestAndForeignCurrencySwapsMember us-gaap:OtherComprehensiveIncomeMember 2010-01-01 2010-12-31 0000701221 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember ci:OtherLongTermInvestmentsDesignatedAsAccountingHedgesMember 2010-12-31 0000701221 us-gaap:DesignatedAsHedgingInstrumentMember ci:ForeignCurrencySwapMember ci:OtherLongTermInvestmentsDesignatedAsAccountingHedgesMember 2010-12-31 0000701221 us-gaap:DesignatedAsHedgingInstrumentMember ci:InterestAndForeignCurrencySwapsMember ci:OtherLongTermInvestmentsDesignatedAsAccountingHedgesMember 2010-12-31 0000701221 ci:AccountsPayableAccruedExpensesAndOtherLiabilitiesDesignatedAsAccountingHedgeMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember 2010-12-31 0000701221 ci:AccountsPayableAccruedExpensesAndOtherLiabilitiesDesignatedAsAccountingHedgeMember us-gaap:DesignatedAsHedgingInstrumentMember ci:ForeignCurrencySwapMember 2010-12-31 0000701221 ci:AccountsPayableAccruedExpensesAndOtherLiabilitiesDesignatedAsAccountingHedgeMember us-gaap:DesignatedAsHedgingInstrumentMember ci:InterestAndForeignCurrencySwapsMember 2010-12-31 0000701221 ci:EquityFuturesContractMember us-gaap:NondesignatedMember ci:NotionalMember 2011-12-31 0000701221 ci:EquityFuturesContractMember us-gaap:NondesignatedMember ci:NotionalMember 2010-12-31 0000701221 ci:InterestRateSwapGrowthInterestMember us-gaap:NondesignatedMember ci:NotionalMember 2011-12-31 0000701221 ci:EurodollarInterestRateFuturesGrowthInterestMember us-gaap:NondesignatedMember ci:NotionalMember 2011-12-31 0000701221 ci:HealthspringMember 2012-01-01 2012-01-31 0000701221 ci:FirstassistMember 2011-12-30 2011-12-31 0000701221 ci:AssetsDisposedOfByMethodOtherThanSaleInPeriodOfDispositionRunOffWorkersCompensationAndPersonalAccidentBusinessMember 2010-12-31 0000701221 ci:SaleOfWorkersCompensationAndCaseManagementBusinessMember 2010-12-01 0000701221 ci:VanbredaMember 2010-08-01 2010-08-31 0000701221 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember ci:NotionalHedgedMember 2011-12-31 0000701221 us-gaap:DesignatedAsHedgingInstrumentMember ci:ForeignCurrencySwapMember ci:NotionalHedgedMember 2011-12-31 0000701221 us-gaap:DesignatedAsHedgingInstrumentMember ci:InterestAndForeignCurrencySwapsMember ci:NotionalHedgedMember 2011-12-31 0000701221 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember ci:NotionalHedgedMember 2010-12-31 0000701221 us-gaap:DesignatedAsHedgingInstrumentMember ci:ForeignCurrencySwapMember ci:NotionalHedgedMember 2010-12-31 0000701221 us-gaap:DesignatedAsHedgingInstrumentMember ci:InterestAndForeignCurrencySwapsMember ci:NotionalHedgedMember 2010-12-31 0000701221 ci:NotesDue202145InterestMember 2011-12-31 0000701221 ci:NotesDue202145InterestMember 2010-12-31 0000701221 ci:NotesDue20415875InterestMember 2010-12-31 0000701221 ci:NotesDue20415875InterestMember 2011-12-31 0000701221 ci:NotesDue202145InterestMember 2011-01-01 2011-12-31 0000701221 ci:NotesDue20415875InterestMember 2011-01-01 2011-12-31 0000701221 ci:HighestAnniversaryAnnuityValueMember 2010-12-31 0000701221 ci:HighestAnniversaryAnnuityValueMember 2011-12-31 0000701221 us-gaap:ComprehensiveIncomeMember 2009-01-01 2009-12-31 0000701221 ci:HealthspringMember 2012-01-31 0000701221 ci:FirstassistMember 2011-12-31 0000701221 us-gaap:SoftwareMember 2010-12-31 0000701221 us-gaap:SoftwareMember 2011-12-31 0000701221 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2010-12-31 0000701221 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2011-12-31 0000701221 ci:FixedMaturitiesAndEquitySecuritiesMember 2011-01-01 2011-12-31 0000701221 ci:RealEstateAndMortgageLoansMember 2011-01-01 2011-12-31 0000701221 ci:SecuritiesPartnershipsMember 2011-01-01 2011-12-31 0000701221 us-gaap:HedgeFundsMember 2011-01-01 2011-12-31 0000701221 ci:FixedMaturitiesAndEquitySecuritiesMember 2010-01-01 2010-12-31 0000701221 ci:FixedMaturitiesAndEquitySecuritiesMember 2010-12-31 0000701221 ci:FixedMaturitiesAndEquitySecuritiesMember 2009-12-31 0000701221 ci:RealEstateAndMortgageLoansMember 2010-01-01 2010-12-31 0000701221 ci:RealEstateAndMortgageLoansMember 2010-12-31 0000701221 ci:RealEstateAndMortgageLoansMember 2009-12-31 0000701221 ci:SecuritiesPartnershipsMember 2010-01-01 2010-12-31 0000701221 ci:SecuritiesPartnershipsMember 2009-12-31 0000701221 ci:SecuritiesPartnershipsMember 2010-12-31 0000701221 ci:GuaranteedDepositAccountContractMember 2010-01-01 2010-12-31 0000701221 ci:GuaranteedDepositAccountContractMember 2010-12-31 0000701221 ci:GuaranteedDepositAccountContractMember 2009-12-31 0000701221 ci:GuaranteedDepositAccountContractMember 2011-12-31 0000701221 us-gaap:HedgeFundsMember 2011-12-31 0000701221 ci:SecuritiesPartnershipsMember 2011-12-31 0000701221 ci:RealEstateAndMortgageLoansMember 2011-12-31 0000701221 ci:FixedMaturitiesAndEquitySecuritiesMember 2011-12-31 0000701221 ci:OtherPostretirementBenefitPlansDefinedBenefitNetOfMedicarePartDSubsidyMember 2011-12-31 0000701221 ci:MedicalMember 2010-01-01 2010-12-31 0000701221 ci:MedicalMember 2009-01-01 2009-12-31 0000701221 ci:MedicalMember 2011-01-01 2011-12-31 0000701221 ci:DisabilityMember 2009-01-01 2009-12-31 0000701221 ci:DisabilityMember 2011-01-01 2011-12-31 0000701221 ci:DisabilityMember 2010-01-01 2010-12-31 0000701221 ci:LifeAccidentAndHealthMember 2011-01-01 2011-12-31 0000701221 ci:LifeAccidentAndHealthMember 2009-01-01 2009-12-31 0000701221 ci:LifeAccidentAndHealthMember 2010-01-01 2010-12-31 0000701221 ci:MailOrderPharmacyMember 2010-01-01 2010-12-31 0000701221 ci:MailOrderPharmacyMember 2011-01-01 2011-12-31 0000701221 ci:MailOrderPharmacyMember 2009-01-01 2009-12-31 0000701221 ci:OtherProductsMember 2010-01-01 2010-12-31 0000701221 ci:OtherProductsMember 2009-01-01 2009-12-31 0000701221 ci:OtherProductsMember 2011-01-01 2011-12-31 0000701221 ci:FirstassistMember 2010-01-01 2010-12-31 0000701221 ci:DebtServiceCoverageRatio130xOrGreaterMember ci:LoanToValueRatioBelow50PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio130xOrGreaterMember ci:LoanToValueRatio50PercentTo59PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio130xOrGreaterMember ci:LoanToValueRatio60PercentTo69PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio130xOrGreaterMember ci:LoanToValueRatio70PercentTo79PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio130xOrGreaterMember ci:LoanToValueRatio80PercentTo89PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio130xOrGreaterMember ci:LoanToValueRatio90PercentTo99PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio130xOrGreaterMember ci:LoanToValueRatio100PercentOrAboveMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio120xTo129xMember ci:LoanToValueRatioBelow50PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio120xTo129xMember ci:LoanToValueRatio50PercentTo59PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio120xTo129xMember ci:LoanToValueRatio60PercentTo69PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio120xTo129xMember ci:LoanToValueRatio70PercentTo79PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio120xTo129xMember ci:LoanToValueRatio80PercentTo89PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio120xTo129xMember ci:LoanToValueRatio90PercentTo99PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio120xTo129xMember ci:LoanToValueRatio100PercentOrAboveMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio110xTo119xMember ci:LoanToValueRatioBelow50PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio110xTo119xMember ci:LoanToValueRatio50PercentTo59PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio110xTo119xMember ci:LoanToValueRatio60PercentTo69PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio110xTo119xMember ci:LoanToValueRatio70PercentTo79PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio110xTo119xMember ci:LoanToValueRatio80PercentTo89PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio110xTo119xMember ci:LoanToValueRatio90PercentTo99PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio110xTo119xMember ci:LoanToValueRatio100PercentOrAboveMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio100xTo109xMember ci:LoanToValueRatioBelow50PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio100xTo109xMember ci:LoanToValueRatio50PercentTo59PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio100xTo109xMember ci:LoanToValueRatio60PercentTo69PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio100xTo109xMember ci:LoanToValueRatio70PercentTo79PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio100xTo109xMember ci:LoanToValueRatio80PercentTo89PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio100xTo109xMember ci:LoanToValueRatio90PercentTo99PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatio100xTo109xMember ci:LoanToValueRatio100PercentOrAboveMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatioLessThan100xMember ci:LoanToValueRatioBelow50PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatioLessThan100xMember ci:LoanToValueRatio50PercentTo59PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatioLessThan100xMember ci:LoanToValueRatio60PercentTo69PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatioLessThan100xMember ci:LoanToValueRatio70PercentTo79PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatioLessThan100xMember ci:LoanToValueRatio80PercentTo89PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatioLessThan100xMember ci:LoanToValueRatio90PercentTo99PercentMember 2010-12-31 0000701221 ci:DebtServiceCoverageRatioLessThan100xMember ci:LoanToValueRatio100PercentOrAboveMember 2010-12-31 0000701221 2012-02-22 2012-02-23 0000701221 ci:StrategicPerformanceUnitsMember 2011-12-31 0000701221 ci:StrategicPerformanceUnitsMember 2011-01-01 2011-12-31 0000701221 ci:RestrictedStockGrantsAndUnitsMember 2011-01-01 2011-12-31 0000701221 ci:RestrictedStockGrantsAndUnitsMember 2011-12-31 0000701221 us-gaap:StockOptionsMember 2011-01-01 2011-12-31 0000701221 us-gaap:StockOptionsMember 2011-12-31 0000701221 us-gaap:USGovernmentAndGovernmentAgenciesAndAuthoritiesMember 2011-12-31 0000701221 ci:HealthCareSegmentMember 2009-12-31 0000701221 ci:HealthCareSegmentMember 2010-12-31 0000701221 ci:DisabilityAndLifeSegmentMember 2010-12-31 0000701221 ci:DisabilityAndLifeSegmentMember 2009-12-31 0000701221 ci:DisabilityAndLifeSegmentMember 2011-12-31 0000701221 ci:InternationalSegmentMember 2009-12-31 0000701221 ci:InternationalSegmentMember 2010-12-31 0000701221 ci:RunOffReinsuranceSegmentMember 2011-12-31 0000701221 ci:RunOffReinsuranceSegmentMember 2009-12-31 0000701221 ci:RunOffReinsuranceSegmentMember 2010-12-31 0000701221 ci:OtherOperationsSegmentMember 2010-12-31 0000701221 ci:OtherOperationsSegmentMember 2009-12-31 0000701221 ci:OtherOperationsSegmentMember 2011-12-31 0000701221 ci:CorporateSegmentMember 2010-12-31 0000701221 ci:CorporateSegmentMember 2011-12-31 0000701221 ci:CorporateSegmentMember 2009-12-31 0000701221 ci:HealthCareSegmentMember 2009-01-01 2009-12-31 0000701221 ci:HealthCareSegmentMember 2011-01-01 2011-12-31 0000701221 ci:HealthCareSegmentMember 2010-01-01 2010-12-31 0000701221 ci:DisabilityAndLifeSegmentMember 2010-01-01 2010-12-31 0000701221 ci:DisabilityAndLifeSegmentMember 2009-01-01 2009-12-31 0000701221 ci:DisabilityAndLifeSegmentMember 2011-01-01 2011-12-31 0000701221 ci:InternationalSegmentMember 2009-01-01 2009-12-31 0000701221 ci:InternationalSegmentMember 2010-01-01 2010-12-31 0000701221 ci:InternationalSegmentMember 2011-01-01 2011-12-31 0000701221 ci:RunOffReinsuranceSegmentMember 2011-01-01 2011-12-31 0000701221 ci:RunOffReinsuranceSegmentMember 2009-01-01 2009-12-31 0000701221 ci:RunOffReinsuranceSegmentMember 2010-01-01 2010-12-31 0000701221 ci:OtherOperationsSegmentMember 2009-01-01 2009-12-31 0000701221 ci:OtherOperationsSegmentMember 2010-01-01 2010-12-31 0000701221 ci:OtherOperationsSegmentMember 2011-01-01 2011-12-31 0000701221 ci:CorporateSegmentMember 2009-01-01 2009-12-31 0000701221 ci:CorporateSegmentMember 2010-01-01 2010-12-31 0000701221 ci:CorporateSegmentMember 2011-01-01 2011-12-31 0000701221 us-gaap:LifeInsuranceInForceMember 2011-01-01 2011-12-31 0000701221 us-gaap:LifeInsuranceInForceMember 2010-01-01 2010-12-31 0000701221 us-gaap:LifeInsuranceInForceMember 2009-01-01 2009-12-31 0000701221 us-gaap:LifeInsuranceSegmentMember 2010-01-01 2010-12-31 0000701221 us-gaap:LifeInsuranceSegmentMember 2009-01-01 2009-12-31 0000701221 us-gaap:LifeInsuranceSegmentMember 2011-01-01 2011-12-31 0000701221 us-gaap:AccidentAndHealthInsuranceSegmentMember 2011-01-01 2011-12-31 0000701221 us-gaap:AccidentAndHealthInsuranceSegmentMember 2010-01-01 2010-12-31 0000701221 us-gaap:AccidentAndHealthInsuranceSegmentMember 2009-01-01 2009-12-31 0000701221 us-gaap:AllowanceForLoansAndLeasesReceivableMember 2010-01-01 2010-12-31 0000701221 us-gaap:AllowanceForLoansAndLeasesReceivableMember 2009-01-01 2009-12-31 0000701221 us-gaap:AllowanceForLoansAndLeasesReceivableMember 2010-12-31 0000701221 us-gaap:AllowanceForLoansAndLeasesReceivableMember 2011-01-01 2011-12-31 0000701221 us-gaap:AllowanceForLoansAndLeasesReceivableMember 2011-12-31 0000701221 us-gaap:AllowanceForLoansAndLeasesReceivableMember 2009-12-31 0000701221 us-gaap:AllowanceForLoansAndLeasesReceivableMember 2008-12-31 0000701221 us-gaap:AllowanceForDoubtfulAccountsMember 2011-01-01 2011-12-31 0000701221 us-gaap:AllowanceForDoubtfulAccountsMember 2011-12-31 0000701221 us-gaap:AllowanceForDoubtfulAccountsMember 2010-01-01 2010-12-31 0000701221 us-gaap:AllowanceForDoubtfulAccountsMember 2010-12-31 0000701221 us-gaap:AllowanceForDoubtfulAccountsMember 2008-12-31 0000701221 us-gaap:AllowanceForDoubtfulAccountsMember 2009-01-01 2009-12-31 0000701221 us-gaap:AllowanceForDoubtfulAccountsMember 2009-12-31 0000701221 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2011-12-31 0000701221 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2009-01-01 2009-12-31 0000701221 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2010-01-01 2010-12-31 0000701221 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2009-12-31 0000701221 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2010-12-31 0000701221 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2011-01-01 2011-12-31 0000701221 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2008-12-31 0000701221 us-gaap:AllowanceForReinsuranceRecoverableMember 2009-01-01 2009-12-31 0000701221 us-gaap:AllowanceForReinsuranceRecoverableMember 2010-01-01 2010-12-31 0000701221 us-gaap:AllowanceForReinsuranceRecoverableMember 2011-01-01 2011-12-31 0000701221 us-gaap:AllowanceForReinsuranceRecoverableMember 2009-12-31 0000701221 us-gaap:AllowanceForReinsuranceRecoverableMember 2011-12-31 0000701221 us-gaap:AllowanceForReinsuranceRecoverableMember 2010-12-31 0000701221 us-gaap:AllowanceForReinsuranceRecoverableMember 2008-12-31 0000701221 us-gaap:USStatesAndPoliticalSubdivisionsMember 2011-12-31 0000701221 us-gaap:ForeignGovernmentDebtMember 2011-12-31 0000701221 us-gaap:PublicUtilityBondsMember 2011-12-31 0000701221 us-gaap:AllOtherCorporateBondsMember 2011-12-31 0000701221 us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2011-12-31 0000701221 us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember 2011-12-31 0000701221 us-gaap:AssetBackedSecuritiesMember 2011-12-31 0000701221 us-gaap:MandatorilyRedeemablePreferredStockMember 2011-12-31 0000701221 us-gaap:FixedMaturitiesMember 2011-12-31 0000701221 us-gaap:EquitySecuritiesInvestmentSummaryMember 2011-12-31 0000701221 us-gaap:NonredeemablePreferredStockMember 2011-12-31 0000701221 us-gaap:IndustrialMiscellaneousAndAllOthersMember 2011-12-31 0000701221 us-gaap:MortgageLoansOnRealEstateMember 2011-12-31 0000701221 us-gaap:PolicyLoansMember 2011-12-31 0000701221 us-gaap:OtherLongTermInvestmentsMember 2011-12-31 0000701221 us-gaap:ShortTermInvestmentsMember 2011-12-31 0000701221 us-gaap:NondesignatedMember ci:NotionalMember ci:TreasuryInterestRateFuturesGrowthInterestMember 2011-12-31 0000701221 us-gaap:RealEstateInvestmentMember 2011-12-31 0000701221 us-gaap:CommonStockMember 2011-01-01 2011-12-31 0000701221 us-gaap:ParentCompanyMember 2011-01-01 2011-12-31 0000701221 us-gaap:ParentCompanyMember 2010-01-01 2010-12-31 0000701221 us-gaap:ParentCompanyMember 2009-01-01 2009-12-31 0000701221 us-gaap:ParentCompanyMember 2011-12-31 0000701221 us-gaap:ParentCompanyMember 2010-12-31 0000701221 us-gaap:ParentCompanyMember 2008-12-31 0000701221 us-gaap:ParentCompanyMember 2009-12-31 0000701221 ci:TotalSegmentReportingMember 2009-01-01 2009-12-31 0000701221 ci:TotalSegmentReportingMember 2010-01-01 2010-12-31 0000701221 ci:TotalSegmentReportingMember 2011-01-01 2011-12-31 0000701221 us-gaap:RetainedEarningsMember 2011-01-01 2011-12-31 0000701221 us-gaap:RetainedEarningsMember 2010-01-01 2010-12-31 0000701221 ci:NotesDue2016275InterestMember us-gaap:ParentCompanyMember 2010-12-31 0000701221 ci:NotesDue2016275InterestMember us-gaap:ParentCompanyMember 2011-12-31 0000701221 ci:NotesDue20175375InterestMember us-gaap:ParentCompanyMember 2011-12-31 0000701221 ci:NotesDue20175375InterestMember us-gaap:ParentCompanyMember 2010-12-31 0000701221 ci:NotesDue2018635InterestMember us-gaap:ParentCompanyMember 2010-12-31 0000701221 ci:NotesDue2018635InterestMember us-gaap:ParentCompanyMember 2011-12-31 0000701221 ci:NotesDue201985InterestMember us-gaap:ParentCompanyMember 2010-12-31 0000701221 ci:NotesDue201985InterestMember us-gaap:ParentCompanyMember 2011-12-31 0000701221 ci:NotesDue20204375InterestMember us-gaap:ParentCompanyMember 2010-12-31 0000701221 ci:NotesDue20204375InterestMember us-gaap:ParentCompanyMember 2011-12-31 0000701221 ci:NotesDue20205125InterestMember us-gaap:ParentCompanyMember 2010-12-31 0000701221 ci:NotesDue20205125InterestMember us-gaap:ParentCompanyMember 2011-12-31 0000701221 ci:NotesDue202145InterestMember us-gaap:ParentCompanyMember 2011-12-31 0000701221 ci:NotesDue202145InterestMember us-gaap:ParentCompanyMember 2010-12-31 0000701221 ci:NotesDue20224InterestMember us-gaap:ParentCompanyMember 2010-12-31 0000701221 ci:NotesDue20224InterestMember us-gaap:ParentCompanyMember 2011-12-31 0000701221 ci:NotesDue2023765InterestMember us-gaap:ParentCompanyMember 2011-12-31 0000701221 ci:NotesDue2023765InterestMember us-gaap:ParentCompanyMember 2010-12-31 0000701221 ci:NotesDue202383InterestMember us-gaap:ParentCompanyMember 2010-12-31 0000701221 ci:NotesDue202383InterestMember us-gaap:ParentCompanyMember 2011-12-31 0000701221 ci:DebenturesDue20277875InterestMember us-gaap:ParentCompanyMember 2011-12-31 0000701221 ci:DebenturesDue20277875InterestMember us-gaap:ParentCompanyMember 2010-12-31 0000701221 us-gaap:ParentCompanyMember ci:StepDownNotesDue203383InterestMember 2010-12-31 0000701221 us-gaap:ParentCompanyMember ci:StepDownNotesDue203383InterestMember 2011-12-31 0000701221 ci:NotesDue2036615InterestMember us-gaap:ParentCompanyMember 2011-12-31 0000701221 ci:NotesDue2036615InterestMember us-gaap:ParentCompanyMember 2010-12-31 0000701221 ci:NotesDue20415875InterestMember us-gaap:ParentCompanyMember 2010-12-31 0000701221 ci:NotesDue20415875InterestMember us-gaap:ParentCompanyMember 2011-12-31 0000701221 ci:NotesDue20425375InterestMember us-gaap:ParentCompanyMember 2011-12-31 0000701221 ci:NotesDue20425375InterestMember us-gaap:ParentCompanyMember 2010-12-31 0000701221 ci:NotesDue2016275InterestMember us-gaap:ParentCompanyMember 2011-01-01 2011-12-31 0000701221 ci:NotesDue20224InterestMember us-gaap:ParentCompanyMember 2011-01-01 2011-12-31 0000701221 ci:NotesDue20425375InterestMember us-gaap:ParentCompanyMember 2011-01-01 2011-12-31 0000701221 ci:NotesDue202145InterestMember us-gaap:ParentCompanyMember 2011-01-01 2011-12-31 0000701221 ci:NotesDue20415875InterestMember us-gaap:ParentCompanyMember 2011-01-01 2011-12-31 0000701221 ci:NotesDue201985InterestMember us-gaap:ParentCompanyMember 2010-01-01 2010-12-31 0000701221 ci:NotesDue2018635InterestMember us-gaap:ParentCompanyMember 2010-01-01 2010-12-31 0000701221 us-gaap:BuildingAndBuildingImprovementsMember 2011-01-01 2011-12-31 0000701221 us-gaap:SoftwareMember 2011-01-01 2011-12-31 0000701221 us-gaap:SoftwareDevelopmentMember 2011-01-01 2011-12-31 0000701221 us-gaap:PropertyPlantAndEquipmentOtherTypesMember 2011-01-01 2011-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure 10-K 2011-12-31 false CIGNA Corporation 0000701221 --12-31 Large Accelerated Filer CI Yes Yes No 11992000000 2011 FY 286517042 19089000000 18393000000 16041000000 1146000000 1105000000 1014000000 1447000000 1420000000 1282000000 254000000 260000000 120000000 88000000 76000000 4000000 62000000 75000000 -43000000 21998000000 21253000000 18414000000 8182000000 8570000000 6927000000 4308000000 3663000000 3407000000 1203000000 1169000000 1036000000 234000000 55000000 -304000000 6103000000 5926000000 5450000000 20030000000 19383000000 16516000000 1968000000 1870000000 1898000000 398000000 331000000 275000000 242000000 190000000 319000000 1328000000 1349000000 1305000000 1000000 4000000 3000000 4.73 1327000000 1345000000 1301000000 4.90 4.93 4.75 0 0 0 4.90 4.93 4.75 4.84 4.89 0 0 0 4.84 4.89 4.73 0.04 0.04 0.04 -26000000 -1000000 -47000000 1304000000 1349000000 1328000000 640000000 521000000 594000000 1327000000 1345000000 1302000000 0 0 1000000 100000000 3301000000 1502000000 87000000 1058000000 225000000 22490000000 127000000 3486000000 1581000000 112000000 759000000 174000000 20948000000 4690000000 252000000 1358000000 6256000000 1312000000 1024000000 3164000000 1776000000 8093000000 51047000000 1605000000 235000000 1318000000 6495000000 1122000000 912000000 3119000000 1238000000 7908000000 45682000000 8553000000 8593000000 4146000000 1095000000 502000000 22889000000 6627000000 104000000 4990000000 0 8093000000 42703000000 8509000000 8147000000 4017000000 1246000000 416000000 22335000000 5936000000 552000000 2288000000 0 7908000000 39019000000 92000000 88000000 739000000 529000000 1000000 3000000 -23000000 -24000000 -3000000 25000000 1507000000 1147000000 -793000000 -614000000 11143000000 9879000000 5286000000 5242000000 8344000000 6645000000 0 18000000 8344000000 6663000000 51047000000 45682000000 29.22 24.44 14257000000 13445000000 124000000 144000000 0.25 0.25 366000000 351000000 3188000000 2534000000 632000000 782000000 0 0 16217000000 14709000000 600000000 600000000 88000000 88000000 88000000 2534000000 2514000000 2502000000 -614000000 9879000000 -5242000000 -5192000000 -5298000000 18000000 12000000 6000000 27000000 20000000 12000000 208000000 150000000 1000000 6000000 -17000000 -28000000 37000000 48000000 -360000000 -189000000 225000000 201000000 181000000 151000000 106000000 1000000 4000000 3000000 0 2000000 3000000 -618000000 -1074000000 8625000000 7374000000 92000000 3188000000 -793000000 11143000000 -5286000000 8344000000 6645000000 5417000000 0 5429000000 0 0 -18000000 0 0 18000000 -97000000 540000000 4000000 625000000 2000000 -19000000 1327000000 1345000000 1302000000 2000000 3000000 3000000 1302000000 474000000 543000000 -3000000 -1000000 151000000 210000000 -2000000 1327000000 1345000000 4000000 1000000 0 2000000 4000000 -179000000 210000000 151000000 543000000 -3000000 -1000000 -2000000 53000000 10000000 11000000 58000000 11000000 80000000 -17000000 48000000 -97000000 -28000000 -360000000 1000000 -189000000 6000000 37000000 830000000 822000000 927000000 46000000 4000000 22000000 253000000 63000000 61000000 1915000000 1102000000 910000000 1265000000 1084000000 1100000000 385000000 70000000 94000000 2877000000 2587000000 2916000000 20000000 12000000 14000000 487000000 239000000 175000000 2056000000 810000000 1187000000 422000000 300000000 307000000 102000000 539000000 0 -1270000000 -1342000000 -1485000000 1323000000 1295000000 1312000000 1178000000 1205000000 1223000000 -1000000 59000000 -451000000 -270000000 -200000000 2676000000 543000000 346000000 225000000 201000000 0 734000000 64000000 30000000 11000000 11000000 11000000 2867000000 274000000 307000000 -3000000 6000000 15000000 3085000000 681000000 -418000000 1342000000 924000000 633000000 326000000 220000000 185000000 180000000 158000000 345000000 268000000 292000000 62000000 75000000 -43000000 -242000000 -190000000 -319000000 25000000 13000000 32000000 50000000 -49000000 -19000000 -30000000 211000000 109000000 317000000 -452000000 154000000 -357000000 344000000 -1321000000 -246000000 55000000 30000000 -5000000 -44000000 1491000000 1743000000 745000000 53000000 -62000000 -37000000 156000000 3000000 325000000 -272000000 2000000 <p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;">Note </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">1</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"> &#8212; Description of Business</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">C</font><font style="font-family:Times New Roman;font-size:10pt;">igna</font><font style="font-family:Times New Roman;font-size:10pt;"> Corporation is a holding company and is not an insurance company. </font><font style="font-family:Times New Roman;font-size:10pt;">Its subsidiaries c</font><font style="font-family:Times New Roman;font-size:10pt;">onduct various businesses, that</font><font style="font-family:Times New Roman;font-size:10pt;"> are described in this Annual Report on Form 10-K for the fiscal year ended December 31, 2011 (&#8220;Form 10-K&#8221;).</font><font style="font-family:Times New Roman;font-size:10pt;"> As used in this document, &#8220;Cigna&#8221; and the &#8220;Company&#8221; may refer to </font><font style="font-family:Times New Roman;font-size:10pt;">C</font><font style="font-family:Times New Roman;font-size:10pt;">igna</font><font style="font-family:Times New Roman;font-size:10pt;"> Corporation itself, one or more of its subsidiaries, or </font><font style="font-family:Times New Roman;font-size:10pt;">C</font><font style="font-family:Times New Roman;font-size:10pt;">igna</font><font style="font-family:Times New Roman;font-size:10pt;"> Corporation and its consolidated subsidiaries. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company</font><font style="font-family:Times New Roman;font-size:10pt;"> is a global health services organization with </font><font style="font-family:Times New Roman;font-size:10pt;">insurance </font><font style="font-family:Times New Roman;font-size:10pt;">subsidiaries that are major providers of medical, dental, disability, life and accident insurance and related products and services. In the </font><font style="font-family:Times New Roman;font-size:10pt;">U.S.</font><font style="font-family:Times New Roman;font-size:10pt;">, the majority of these products and services are offered through employers and other groups (e.g. unions and associations) and</font><font style="font-family:Times New Roman;font-size:10pt;">,</font><font style="font-family:Times New Roman;font-size:10pt;"> in selected international markets, Cigna offers supplemental health, life and accident insurance products and international health care coverage and services to businesses, governmental and non-governmental organizations and individuals. In addition to its ongoing operations described above, the Company also has certain run-off operations, including a Run-off Reinsurance segment.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p> 45000000 49000000 5000000 10000000 0.01 0.1 0.01 0.038 0.0625 3200000000 3100000000 1 30 acclerated or straight-line 334000000 312000000 299000000 3 5 250000000 300000000 70000000 40 5 1 3 7 3 10 10 18000000 <p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;">Note </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">2</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"> &#8212; Summary of Significant Accounting Policies</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Basis of Presentation</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Consolidated F</font><font style="font-family:Times New Roman;font-size:10pt;">inancial </font><font style="font-family:Times New Roman;font-size:10pt;">S</font><font style="font-family:Times New Roman;font-size:10pt;">tatements include th</font><font style="font-family:Times New Roman;font-size:10pt;">e accounts of </font><font style="font-family:Times New Roman;font-size:10pt;">C</font><font style="font-family:Times New Roman;font-size:10pt;">igna</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">Corporation and</font><font style="font-family:Times New Roman;font-size:10pt;"> its significant subsidiaries</font><font style="font-family:Times New Roman;font-size:10pt;">. </font><font style="font-family:Times New Roman;font-size:10pt;">Intercompany transactions and accounts have been eliminated in consolidation.&#160;&#160;</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">These Consolidated Financial S</font><font style="font-family:Times New Roman;font-size:10pt;">tatements were prepared in conformity with accounting principles generally accepted in the </font><font style="font-family:Times New Roman;font-size:10pt;">United States of America</font><font style="font-family:Times New Roman;font-size:10pt;"> (</font><font style="font-family:Times New Roman;font-size:10pt;">&#8220;</font><font style="font-family:Times New Roman;font-size:10pt;">GAAP</font><font style="font-family:Times New Roman;font-size:10pt;">&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;">). Amounts recorded in the Consolidated F</font><font style="font-family:Times New Roman;font-size:10pt;">inancial </font><font style="font-family:Times New Roman;font-size:10pt;">S</font><font style="font-family:Times New Roman;font-size:10pt;">tatements </font><font style="font-family:Times New Roman;font-size:10pt;">necessarily </font><font style="font-family:Times New Roman;font-size:10pt;">reflect management's estimates and assumptions about medical costs, investment valuation, interest rates and </font><font style="font-family:Times New Roman;font-size:10pt;">other factors. Significant estimates are discussed throughout these Notes; however, actual results could differ from those estimates.</font><font style="font-family:Times New Roman;font-size:10pt;"> The impact of a change in estimate is generally included in earnings in the period of adjustment. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">In preparing these Consolidated Financial S</font><font style="font-family:Times New Roman;font-size:10pt;">tatements, the Company has evaluated events that occurred between the balance </font><font style="font-family:Times New Roman;font-size:10pt;">sheet date and February </font><font style="font-family:Times New Roman;font-size:10pt;">23</font><font style="font-family:Times New Roman;font-size:10pt;">, 201</font><font style="font-family:Times New Roman;font-size:10pt;">2</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">and determined</font><font style="font-family:Times New Roman;font-size:10pt;"> that, with the exception of the January 31, 2012 acquisition of HealthSpring, Inc., </font><font style="font-family:Times New Roman;font-size:10pt;">that </font><font style="font-family:Times New Roman;font-size:10pt;">is disclosed in Note 3, </font><font style="font-family:Times New Roman;font-size:10pt;"> there were no other items to disclose.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Certain reclassifications have been made to prior period amounts to conform to the current presentation. In addition, certain amounts have been restated as a result of the adoption of new accounting pronouncements.</font></p><p style='margin-top: 0pt; margin-bottom: 0pt;'></p><p style='margin-top:12pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Variable interest entities.</font><font style="font-family:Times New Roman;font-size:10pt;"> As of </font><font style="font-family:Times New Roman;font-size:10pt;">December 31, 2011</font><font style="font-family:Times New Roman;font-size:10pt;"> and 2010</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">the Company </font><font style="font-family:Times New Roman;font-size:10pt;">determined it </font><font style="font-family:Times New Roman;font-size:10pt;">was</font><font style="font-family:Times New Roman;font-size:10pt;"> no</font><font style="font-family:Times New Roman;font-size:10pt;">t</font><font style="font-family:Times New Roman;font-size:10pt;"> a primary beneficiary in any variable interest entities.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Changes in </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Accounting Pronouncements </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Deferred acquisition costs.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"> </font><font style="font-family:Times New Roman;font-size:10pt;">In October 2010, the Financial Accounting Standards Board (&#8220;FASB&#8221;) amended guidance (ASU 2010-26) for the accounting of costs to </font><font style="font-family:Times New Roman;font-size:10pt;">acquire or renew </font><font style="font-family:Times New Roman;font-size:10pt;">insurance contracts to require costs such as certain sales compensation or telemarketing costs that are related to unsuccessful efforts </font><font style="font-family:Times New Roman;font-size:10pt;">to acquire or retain business </font><font style="font-family:Times New Roman;font-size:10pt;">and any indirect costs to be expensed as incurred. This new guidance must be implemented on January 1, 2012 and any changes to the Company's Consolidated Financial Statements may be recognized prospectively for acquisition costs incurred beginning in 2012 or through retrospective adjustment of comparative prior periods. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company expects to implement the new requirements on January 1, 2012 through retrospective adjustment of prior periods. </font></p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company's deferred acquisition costs arise from sales and renewal activities primarily in its International segment. Because the new requirements further restrict the types of costs that are deferrable, more of the Company's acquisition costs will be expensed as incurred. The Company expects the cumulative effect of implementing this new guidance to decrease </font><font style="font-family:Times New Roman;font-size:10pt;">shareholders' equity</font><font style="font-family:Times New Roman;font-size:10pt;"> as of </font><font style="font-family:Times New Roman;font-size:10pt;">January </font><font style="font-family:Times New Roman;font-size:10pt;">1, 201</font><font style="font-family:Times New Roman;font-size:10pt;">1</font><font style="font-family:Times New Roman;font-size:10pt;"> by </font><font style="font-family:Times New Roman;font-size:10pt;">a range of</font><font style="font-family:Times New Roman;font-size:10pt;"> $</font><font style="font-family:Times New Roman;font-size:10pt;">250 </font><font style="font-family:Times New Roman;font-size:10pt;">million</font><font style="font-family:Times New Roman;font-size:10pt;"> to $300 million</font><font style="font-family:Times New Roman;font-size:10pt;">. In addition, </font><font style="font-family:Times New Roman;font-size:10pt;">as </font><font style="font-family:Times New Roman;font-size:10pt;">certain </font><font style="font-family:Times New Roman;font-size:10pt;">acquisition costs </font><font style="font-family:Times New Roman;font-size:10pt;">will </font><font style="font-family:Times New Roman;font-size:10pt;">no longer </font><font style="font-family:Times New Roman;font-size:10pt;">be </font><font style="font-family:Times New Roman;font-size:10pt;">eligible </font><font style="font-family:Times New Roman;font-size:10pt;">for</font><font style="font-family:Times New Roman;font-size:10pt;"> deferr</font><font style="font-family:Times New Roman;font-size:10pt;">al under the new guidance</font><font style="font-family:Times New Roman;font-size:10pt;">, the Company expects that full-year 2011 shareholders' net income on a retrospectively adjusted basis will decrease by a</font><font style="font-family:Times New Roman;font-size:10pt;">pproximately</font><font style="font-family:Times New Roman;font-size:10pt;"> $</font><font style="font-family:Times New Roman;font-size:10pt;">7</font><font style="font-family:Times New Roman;font-size:10pt;">0</font><font style="font-family:Times New Roman;font-size:10pt;"> million</font><font style="font-family:Times New Roman;font-size:10pt;"> primarily in its International segment. </font><font style="font-family:Times New Roman;font-size:10pt;">The Company expects t</font><font style="font-family:Times New Roman;font-size:10pt;">he effect</font><font style="font-family:Times New Roman;font-size:10pt;"> of the new guidance</font><font style="font-family:Times New Roman;font-size:10pt;"> on </font><font style="font-family:Times New Roman;font-size:10pt;">shareholders'</font><font style="font-family:Times New Roman;font-size:10pt;"> net income</font><font style="font-family:Times New Roman;font-size:10pt;"> in </font><font style="font-family:Times New Roman;font-size:10pt;">2012</font><font style="font-family:Times New Roman;font-size:10pt;"> to be generally comparable to that estimated for 2011. </font><font style="font-family:Times New Roman;font-size:10pt;">Implementation of this new guidance will have no impact on the underlying economic value, revenues or cash flows of the Company's businesses, nor will it impact the Company's liquidity or the statutory surplus of its insurance subsidiaries</font><font style="font-family:Times New Roman;font-size:10pt;">.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Troubled debt restructurings</font><font style="font-family:Times New Roman;font-size:10pt;">. Effective July 1, 2011, the Company adopted the FASB's updated guidance (ASU 2011-02) to clarify for lenders that a troubled debt restructuring occurs when a debt modification is a concession to the borrower and the borrower is experiencing financial difficulties. This guidance was required to be applied retrospectively for restructurings&#160;occurring on or after January&#160;1,&#160;2011. The amendment also required new disclosures to be provided&#160;</font><font style="font-family:Times New Roman;font-size:10pt;">beginning </font><font style="font-family:Times New Roman;font-size:10pt;">in the&#160;third quarter </font><font style="font-family:Times New Roman;font-size:10pt;">of </font><font style="font-family:Times New Roman;font-size:10pt;">2011 addressing certain troubled debt restructurings.&#160; Adoption of the new guidance did not have a material effect to the Company's results of operations or financial condition</font><font style="font-family:Times New Roman;font-size:10pt;">. </font><font style="font-family:Times New Roman;font-size:10pt;">See Note 11 for additional information related to commercial mortgage loans.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Fair value measurements.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">In May&#160;2011, the FASB amended guidance (ASU&#160;2011-04) to improve the comparability of fair value measurements presented and disclosed in financial statements prepared in accordance with U.S. GAAP and International Financial Reporting Standards. The amendments are effective January&#160;1,&#160;2012 and are to be applied prospectively.&#160;The Company expects no material effects at implementation. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company adopted the FASB's updated guidance on fair value measurements (ASU 2010-06) in the first quarter of 2010, which requires separate disclosures of significant transfers between levels in the fair value hierarchy. See Note </font><font style="font-family:Times New Roman;font-size:10pt;">10</font><font style="font-family:Times New Roman;font-size:10pt;"> for additional information. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">A</font><font style="font-family:Times New Roman;font-size:10pt;">mendments to th</font><font style="font-family:Times New Roman;font-size:10pt;">e FASB's fair value</font><font style="font-family:Times New Roman;font-size:10pt;"> guidance in 2009 had no effect on the Company's Consolidated Financial Statements. </font><font style="font-family:Times New Roman;font-size:10pt;">See Note </font><font style="font-family:Times New Roman;font-size:10pt;">10</font><font style="font-family:Times New Roman;font-size:10pt;"> for additional information.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Other-than-temporary impairments. </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;"> </font><font style="font-family:Times New Roman;font-size:10pt;">On April 1, 2009, the Company adopted the FASB's updated guidance for evaluating whether an impairment is other than temporary for fixed maturities with declines in fair value below amortized cost (ASC 320). A reclassification adjustment from retained earnings to accumulated other comprehensive income was required for previously impaired fixed maturities that had a non-credit loss as of the date of adoption, net of related tax effects. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The cumulative effect of adoption increased the Company's retained earnings in 2009 with an offsetting decrease to accumulated other comprehensive income of $18 million, with no overall change to shareholders' equity. </font><font style="font-family:Times New Roman;font-size:10pt;"> See </font><font style="font-family:Times New Roman;font-size:10pt;">Note 11 </font><font style="font-family:Times New Roman;font-size:10pt;">(A) </font><font style="font-family:Times New Roman;font-size:10pt;">for information on the Company's other-than-temporary impairments including additional required disclosures.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font></p><p style='margin-top: 0pt; margin-bottom: 0pt;'></p><p style='margin-top:12pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;">C</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">.&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Investments</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;">s accounting policies for investment assets are discussed below:</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Fixed maturities and equity securities. </font><font style="font-family:Times New Roman;font-size:10pt;">Fixed maturities primarily include bonds, mortgage and other asset-backed securities and preferred stocks redeemable by the investor. Equity securities include common stocks and preferred stocks that are non-redeemable or redeemable only at the option of the issuer. These investments are primarily classified as available for sale and are carried at fair value with changes in fair value</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">recorded in accumulated other comprehensive income (loss) within shareholders' equity. &#160;Beginning April 1, 2009, </font><font style="font-family:Times New Roman;font-size:10pt;">for </font><font style="font-family:Times New Roman;font-size:10pt;">fixed maturities with declines in fair value below a</font><font style="font-family:Times New Roman;font-size:10pt;">mortized cost, the Company </font><font style="font-family:Times New Roman;font-size:10pt;">assess</font><font style="font-family:Times New Roman;font-size:10pt;">es</font><font style="font-family:Times New Roman;font-size:10pt;"> its intent to sell or whether it is more likely than not to be required to sell such fixed maturities before their fair value</font><font style="font-family:Times New Roman;font-size:10pt;">s</font><font style="font-family:Times New Roman;font-size:10pt;"> recover. If so, an impairment loss is recognized in net income for the excess of the</font><font style="font-family:Times New Roman;font-size:10pt;">ir</font><font style="font-family:Times New Roman;font-size:10pt;"> amortized cost over fair value. In addition, </font><font style="font-family:Times New Roman;font-size:10pt;">when the Company determines it does not expect to recover the amortized cost basis of fixed maturities with declines in fair value (even if it does not intend to sell or will not be required to sell these fixed maturities), the credit portion of the impairment loss is recognized in net income and the non-credit portion, if any, is recognized in a separate component of shareholders' equity. The credit portion is the difference between the amortized cost basis of the fixed maturity and the net present value of its projected future cash flows. Projected future cash flows are based on qualitative and quantitative factors, including probability of default, and the estimated timing and amount of recovery. For mortgage and asset-backed securities, estimated future cash flows are based on assumptions about the collateral attributes including prepayment speeds, default rates and changes in value. Equity securities and, prior to April 1, 2009, fixed maturities were considered impaired, and their cost basis was written down to fair value through earnings, when management did not expect to recover the amortized cost, or if the Company could not demonstrate its intent or ability to hold the investment until full recovery. Fixed maturities and equity securities also include trading and </font><font style="font-family:Times New Roman;font-size:10pt;">certain </font><font style="font-family:Times New Roman;font-size:10pt;">hybrid securities</font><font style="font-family:Times New Roman;font-size:10pt;"> that are carried at fair value with changes in fair value reported in realized investment gains and losses.</font><font style="font-family:Stone Serif;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">The Company has irrevocably elected the fair value option for these securities to simplify accounting and mitigate volatility in results of operations and financial condition.</font><font style="font-family:Times New Roman;font-size:10pt;"> Hybrid securities include certain preferred stock and debt securities with call or conversion options. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Commercial mortgage loans.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">Mortgage loans held by the Company are made exclusively to commercial borrowers. Generally, commercial mortgage loans are carried at unpaid principal balances and are issued at a fixed rate of interest. Commercial mortgage loans are considered impaired when it is probable that the Company will not collect amounts due according to the terms of the original loan agreement.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">The Company </font><font style="font-family:Times New Roman;font-size:10pt;">monitors credit risk and </font><font style="font-family:Times New Roman;font-size:10pt;">assesses the impairment of loans individually </font><font style="font-family:Times New Roman;font-size:10pt;">and on a consistent basis </font><font style="font-family:Times New Roman;font-size:10pt;">for all loans in the portfolio</font><font style="font-family:Times New Roman;font-size:10pt;">. </font><font style="font-family:Times New Roman;font-size:10pt;">Impaired loans are carried at the lower of unpaid principal or fair value of the underlying </font><font style="font-family:Times New Roman;font-size:10pt;">real estate</font><font style="font-family:Times New Roman;font-size:10pt;">. Valuation reserves reflect any changes in fair value. The Company estimates the fair value of the underlying </font><font style="font-family:Times New Roman;font-size:10pt;">real estate</font><font style="font-family:Times New Roman;font-size:10pt;"> using internal valuations generally based on</font><font style="font-family:Times New Roman;font-size:10pt;"> discounted cash flow analyses. </font><font style="font-family:Times New Roman;font-size:10pt;">Certain commercial mortgage loans without valuation reserves are considered impaired because the Company will not collect all interest due according to the t</font><font style="font-family:Times New Roman;font-size:10pt;">erms of the original agreements,</font><font style="font-family:Times New Roman;font-size:10pt;"> however, the Company expects to recover their remaining carrying value primarily because it is less than the fair value of the underlying </font><font style="font-family:Times New Roman;font-size:10pt;">real estate.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Policy loans.</font><font style="font-family:Times New Roman;font-size:10pt;"> Policy loans are carried at unpaid principal balances</font><font style="font-family:Times New Roman;font-size:10pt;"> plus accumulated interest</font><font style="font-family:Times New Roman;font-size:10pt;">.</font><font style="font-family:Times New Roman;font-size:10pt;"> The loans are collateralized by insurance policy cash values and therefore have no exposure to credit loss.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Real estate.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"> </font><font style="font-family:Times New Roman;font-size:10pt;">Investment real estate can be &#8220;held and used&#8221; or &#8220;held for sale&#8221;. The Company accounts for real estate as follows: </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">Real estate "held and used" is expected to be held longer than one year and includes real estate acquired through the foreclosure of commercial mortgage loans. The Company carries real estate held and used at depreciated cost less any write-downs to fair value due to impairment and assesses impairment when cash flows indicate that the carrying value may not be recoverable. Depreciation is generally calculated using the straight-line method based on the estimated useful life of the particular real estate asset. </font></li><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">Real estate is "held for sale" when a buyer's investigation is completed, a deposit has been received and the sale is expected to be completed within the next year. Real estate held for sale is carried at the lower of carrying value or current fair value, less estimated costs to sell, and is not depreciated. Valuation reserves reflect any changes in fair value.</font></li><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">The Company uses several methods to determine the fair value of real estate, but relies primarily on discounted cash flow analyses and, in some cases, third</font><font style="font-family:Times New Roman;font-size:10pt;">-</font><font style="font-family:Times New Roman;font-size:10pt;">party appraisals.</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">At the time of foreclosure, properties are reclassified from commercial mortgage loans to real estate or other long-term investments depending on the ownership of the underlying assets. The Company rehabilitates, re-leases and sells foreclosed properties. Thi</font><font style="font-family:Times New Roman;font-size:10pt;">s process usually takes from three to five</font><font style="font-family:Times New Roman;font-size:10pt;"> years unless management considers a near-term sale preferable</font><font style="font-family:Stone Serif;font-size:10pt;">.</font><font style="font-family:Stone Serif;font-size:10pt;"> </font><font style="font-family:Stone Serif;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">When foreclosed real estate is recapitalized through a joint venture including a contribution of new equity from a third-party investor, the asset is accounted for as a</font><font style="font-family:Times New Roman;font-size:10pt;">n</font><font style="font-family:Times New Roman;font-size:10pt;"> investment </font><font style="font-family:Times New Roman;font-size:10pt;">in good standing </font><font style="font-family:Times New Roman;font-size:10pt;">reported in other long-term investments.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Other long-term investments. </font><font style="font-family:Times New Roman;font-size:10pt;">Other long-term investments include investments in unconsolidated entities. These entities include certain limited partnerships and limited liability companies holding real estate, securities or loans. These investments are carried at cost plus the Company's ownership percentage of reported income or loss in cases where the Co</font><font style="font-family:Times New Roman;font-size:10pt;">mpany has significant influence,</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">o</font><font style="font-family:Times New Roman;font-size:10pt;">therwise</font><font style="font-family:Times New Roman;font-size:10pt;"> the investment is carried at cost</font><font style="font-family:Times New Roman;font-size:10pt;">. </font><font style="font-family:Times New Roman;font-size:10pt;">I</font><font style="font-family:Times New Roman;font-size:10pt;">ncome from certain entities is reported on a one quarter lag</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">depending on when their financial information is received. </font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">Also included in other long-term investments are loans to unconsolidated real estate entities secured by the equity interests of these real estate entities, which are carried at unpaid principal balances (mezzanine loans).</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">These other long-term investments are considered impaired, and written down to their fair value, when cash flows indicate that the carrying value may not be recoverable. Fair value is generally determined based on a discounted cash flow analysis</font><font style="font-family:Times New Roman;font-size:10pt;">. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Additionally, other long-term investments include interest rate and foreign currency swaps carried at fair value. See Note 12 for information on the Company's accounting policies for these derivative financial instruments.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Short-term investments. </font><font style="font-family:Times New Roman;font-size:10pt;">Investments with maturities of greater than 90 days but less than one year from time of purchase are classified as short-term, available for sale and carried at fair value, which approximates cost.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Derivative financial instruments.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">The Company applies hedge accounting when derivatives are designated, qualify and are highly effective as hedges. Effectiveness is formally assessed and documented at inception and each period throughout the life of a hedge using various quantitative methods appropriate for each hedge, including regression analysis and dollar offset. Under hedge accounting, the changes in fair value of the derivative and the hedged risk are generally recognized together and offset each other when reported in shareholders' net income.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company accounts for derivative instruments as follows:</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li><font style="font-family:Times New Roman;font-size:10pt;">Derivatives are reported on the balance sheet at fair value with changes in fair values reported in shareholders</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;"> net income or accumulated other comprehensive income.</font></li><li><font style="font-family:Times New Roman;font-size:10pt;">Changes in the fair value of derivatives that hedge market risk related to future cash flows and that qualify for hedge accounting are reported in a separate caption in accumulated other comprehensive income. These hedges are referred to as cash flow hedges. </font></li><li><font style="font-family:Times New Roman;font-size:10pt;">A change in the fair value of a derivative instrument may not always equal the change in the fair value of the hedged item; this difference is referred to as hedge ineffectiveness. Where hedge accounting is used, the Company reflects hedge ineffectiveness in shareholders' net income (generally as part of realized investment gains and losses). </font></li><li><font style="font-family:Times New Roman;font-size:10pt;">On early termination, the fair value of derivatives that qualified</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">for hedge accounting are reported in shareholders' net income.</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Net investment income.</font><font style="font-family:Times New Roman;font-size:10pt;"> When interest and principal payments on investments are current, the Company recognizes interest income when it is earned. The Company stops recognizing interest income when interest payments are delinquent</font><font style="font-family:Times New Roman;font-size:10pt;"> based on contractual terms</font><font style="font-family:Times New Roman;font-size:10pt;"> or when certain terms (interest rate or maturity date) of the investment have been restructured. Net investment income on these investments is only recognized when interest payments are actually received. </font><font style="font-family:Times New Roman;font-size:10pt;"> Interest and dividends on trading and hybrid securities </font><font style="font-family:Times New Roman;font-size:10pt;">and prepayment penalties on mortgage loans </font><font style="font-family:Times New Roman;font-size:10pt;">are included in net investment income</font><font style="font-family:Times New Roman;font-size:10pt;"> when </font><font style="font-family:Times New Roman;font-size:10pt;">they are </font><font style="font-family:Times New Roman;font-size:10pt;">earned</font><font style="font-family:Times New Roman;font-size:10pt;">.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Investment gains and losses.</font><font style="font-family:Times New Roman;font-size:10pt;"> Realized investment gains and losses result from sales, investment asset write-downs, changes in the fair values of</font><font style="font-family:Times New Roman;font-size:10pt;"> trading and </font><font style="font-family:Times New Roman;font-size:10pt;">hybrid securities and certain derivatives</font><font style="font-family:Times New Roman;font-size:10pt;">,</font><font style="font-family:Times New Roman;font-size:10pt;"> changes in valuation reserves</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">and</font><font style="font-family:Times New Roman;font-size:10pt;"> prepayment penalties on fixed maturities</font><font style="font-family:Times New Roman;font-size:10pt;">,</font><font style="font-family:Times New Roman;font-size:10pt;"> based on specifically identified assets. Realized investment gains and losses on the disposition of certain directly owned real estate investments are eliminated from ongoing operations and reported in discontinued operations when the operations and cash flows of the underlying assets are clearly distinguishable and the Company has no significant continuing involvement in the</font><font style="font-family:Times New Roman;font-size:10pt;">ir</font><font style="font-family:Times New Roman;font-size:10pt;"> operations. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Unrealized gains and losses on fixed maturities and equity securities carried at fair value (excluding trading and hybrid securities) and certain derivatives are included in accumulated other comprehensive income (loss), net of: </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">amounts required to adjust future policy benefits</font><font style="font-family:Times New Roman;font-size:10pt;"> for</font><font style="font-family:Times New Roman;font-size:10pt;"> the</font><font style="font-family:Times New Roman;font-size:10pt;"> run-off settlement annuity business</font><font style="font-family:Times New Roman;font-size:10pt;">; and</font></li><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">deferred income taxes.</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:36px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Cash and Cash Equivalents</font><p>&#160;</p><p><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Cash equivalents consist of short-term investments w</font><font style="font-family:Times New Roman;font-size:10pt;">ith</font><font style="font-family:Times New Roman;font-size:10pt;"> matur</font><font style="font-family:Times New Roman;font-size:10pt;">ities</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">of</font><font style="font-family:Times New Roman;font-size:10pt;"> three months or less from the time of purchase</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">that are </font><font style="font-family:Times New Roman;font-size:10pt;">classified as held to maturity and carried at amortized cost</font><font style="font-family:Times New Roman;font-size:10pt;">. The Company reclassifi</font><font style="font-family:Times New Roman;font-size:10pt;">es cash overdraft positions to </font><font style="font-family:Times New Roman;font-size:10pt;">accounts payable, accrued </font><font style="font-family:Times New Roman;font-size:10pt;">expenses and other liabilities </font><font style="font-family:Times New Roman;font-size:10pt;">when the legal right of offset does not exist.</font></p><p>&#160;</p></li><li style="margin-left:36px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Premiums, Accounts and Notes Receivable and </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Reinsurance Recoverables</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Premiums, accounts and notes receivable are reported net of an allow</font><font style="font-family:Times New Roman;font-size:10pt;">a</font><font style="font-family:Times New Roman;font-size:10pt;">nce for doubtful accounts of $</font><font style="font-family:Times New Roman;font-size:10pt;">45</font><font style="font-family:Times New Roman;font-size:10pt;"> million as of December 31, 2011</font><font style="font-family:Times New Roman;font-size:10pt;"> and $4</font><font style="font-family:Times New Roman;font-size:10pt;">9</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">million as of December 31, 2010. </font><font style="font-family:Times New Roman;font-size:10pt;">Reinsurance recoverables are estimates of amounts that the Company will receive from reinsurers and are recorded net of </font><font style="font-family:Times New Roman;font-size:10pt;">an allowance for</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">unrecoverable reinsurance of $</font><font style="font-family:Times New Roman;font-size:10pt;">5</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">million as of December 31, 2011 and $</font><font style="font-family:Times New Roman;font-size:10pt;">10</font><font style="font-family:Times New Roman;font-size:10pt;"> million as of December 31, 2010</font><font style="font-family:Times New Roman;font-size:10pt;">.</font><font style="font-family:Times New Roman;font-size:10pt;"> The Company estimates these allowances for doubtful accounts for premiums, accounts and notes receivable, as well as for reinsurance recoverables, using management</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;">s best estimate of collectibility, taking into consideration the aging of </font><font style="font-family:Times New Roman;font-size:10pt;">these amounts</font><font style="font-family:Times New Roman;font-size:10pt;">, historical collection patterns and other economic factors</font><font style="font-family:Times New Roman;font-size:10pt;">.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman Bold;font-size:10pt;font-weight:bold;margin-left:0px;">F</font><font style="font-family:Stone Serif;font-size:10pt;">. </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Deferred Policy Acquisition Costs</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Acquisition costs include sales compensation, commissions,</font><font style="font-family:Times New Roman;font-size:10pt;"> direct response marketing, telemarketing,</font><font style="font-family:Times New Roman;font-size:10pt;"> premium taxes and other costs that the Company incurs in connection with new and renewal business. Depending on the product line they relate to, the Company records acquisition costs in different ways. Acquisition costs for:</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;">Universal life products</font><font style="font-family:Times New Roman;font-size:10pt;"> are deferred and amortized in proportion to the present value of total estimated gross profits over the expected lives of the contracts.</font></li><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;">Supplemental health</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;">, life and accident&#160;insurance (</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;">primarily&#160;individual international&#160;products) and group health&#160;and accident&#160;insurance products</font><font style="font-family:Arial;font-size:10pt;">&#160;</font><font style="font-family:Times New Roman;font-size:10pt;">are deferred and amortized, generally in proportion to the ratio of periodic revenue to the estimated total revenues over the contract periods.</font></li><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;">Other products</font><font style="font-family:Times New Roman;font-size:10pt;"> are expensed as incurred.</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">For universal life</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">and other individual products, management estimates the present value of future revenues less expected payments. For group health </font><font style="font-family:Times New Roman;font-size:10pt;">and accident insurance </font><font style="font-family:Times New Roman;font-size:10pt;">products, management estimates the sum of </font><font style="font-family:Times New Roman;font-size:10pt;">unearned premiums and anticipated net investment income </font><font style="font-family:Times New Roman;font-size:10pt;">less </font><font style="font-family:Times New Roman;font-size:10pt;">future expected claims and related costs. If management's estimates </font><font style="font-family:Times New Roman;font-size:10pt;">of these sums </font><font style="font-family:Times New Roman;font-size:10pt;">are less than the deferred costs, the Company reduces deferred policy acquisition</font><font style="font-family:Times New Roman;font-size:10pt;"> costs and records an expense. </font><font style="font-family:Times New Roman;font-size:10pt;">The Company recorded amortization for policy acquisition costs of $</font><font style="font-family:Times New Roman;font-size:10pt;">3</font><font style="font-family:Times New Roman;font-size:10pt;">3</font><font style="font-family:Times New Roman;font-size:10pt;">4</font><font style="font-family:Times New Roman;font-size:10pt;"> million in </font><font style="font-family:Times New Roman;font-size:10pt;">2011</font><font style="font-family:Times New Roman;font-size:10pt;">, $</font><font style="font-family:Times New Roman;font-size:10pt;">312 </font><font style="font-family:Times New Roman;font-size:10pt;">million in </font><font style="font-family:Times New Roman;font-size:10pt;">2010</font><font style="font-family:Times New Roman;font-size:10pt;"> and $</font><font style="font-family:Times New Roman;font-size:10pt;">299</font><font style="font-family:Times New Roman;font-size:10pt;"> million in </font><font style="font-family:Times New Roman;font-size:10pt;">2009</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">in other operating expenses</font><font style="font-family:Times New Roman;font-size:10pt;">. There are no deferred policy acquisition costs attributable to the </font><font style="font-family:Times New Roman;font-size:10pt;">sold </font><font style="font-family:Times New Roman;font-size:10pt;">individual life insurance and annuity</font><font style="font-family:Times New Roman;font-size:10pt;"> and</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">retirement </font><font style="font-family:Times New Roman;font-size:10pt;">businesses </font><font style="font-family:Times New Roman;font-size:10pt;">or </font><font style="font-family:Times New Roman;font-size:10pt;">the </font><font style="font-family:Times New Roman;font-size:10pt;">run-off reinsurance </font><font style="font-family:Times New Roman;font-size:10pt;">and settlement </font><font style="font-family:Times New Roman;font-size:10pt;">annuity</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">operations. </font><font style="font-family:Times New Roman;font-size:10pt;">The accounting for acquisition costs will change in 2012. See Recent Accounting Pronouncements for additional information.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Property and Equipment </font><p>&#160;</p><p><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Property and equipment is carried at cost less accumulated depreciation. When applicable, cost includes interest, real estate taxes and other costs incurred during construction. Also included in this category is internal-use software that is acquired, developed or modified solely to meet the Company's internal needs, with no plan to market externally. Costs directly related to acquiring, developing or modifying internal-use software are capitalized</font><font style="font-family:Times New Roman;font-size:10pt;">.</font></p><p>&#160;</p><p><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">T</font><font style="font-family:Times New Roman;font-size:10pt;">he Company calculates depreciation and amortization principally using the straight-line method </font><font style="font-family:Times New Roman;font-size:10pt;">generally </font><font style="font-family:Times New Roman;font-size:10pt;">based on the esti</font><font style="font-family:Times New Roman;font-size:10pt;">mated useful life of each asset</font><font style="font-family:Times New Roman;font-size:10pt;"> as follows: buildings and im</font><font style="font-family:Times New Roman;font-size:10pt;">provements, </font><font style="font-family:Times New Roman;font-size:10pt;">10</font><font style="font-family:Times New Roman;font-size:10pt;"> to 40 years; </font><font style="font-family:Times New Roman;font-size:10pt;">purchased </font><font style="font-family:Times New Roman;font-size:10pt;">software, </font><font style="font-family:Times New Roman;font-size:10pt;">one</font><font style="font-family:Times New Roman;font-size:10pt;"> to </font><font style="font-family:Times New Roman;font-size:10pt;">five</font><font style="font-family:Times New Roman;font-size:10pt;"> years</font><font style="font-family:Times New Roman;font-size:10pt;">; internally developed software</font><font style="font-family:Times New Roman;font-size:10pt;">,</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">three</font><font style="font-family:Times New Roman;font-size:10pt;"> to </font><font style="font-family:Times New Roman;font-size:10pt;">seven</font><font style="font-family:Times New Roman;font-size:10pt;"> years</font><font style="font-family:Times New Roman;font-size:10pt;">;</font><font style="font-family:Times New Roman;font-size:10pt;"> and</font><font style="font-family:Times New Roman;font-size:10pt;"> furniture and equipment (including computer equipment</font><font style="font-family:Times New Roman;font-size:10pt;">)</font><font style="font-family:Times New Roman;font-size:10pt;">,</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">three</font><font style="font-family:Times New Roman;font-size:10pt;"> to 10 years</font><font style="font-family:Times New Roman;font-size:10pt;">.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">Improvements to leased facilities are depreciated over the remaining lease term or the estimated life of the improvement. </font><font style="font-family:Times New Roman;font-size:10pt;">The Company considers events and circumstances that would indicate the carrying value of property, equipment or capitalized software might not be recoverable. </font><font style="font-family:Times New Roman;font-size:10pt;">If the Company determines the carrying value of a long-lived asset is not recoverable, an impairment charge is recorded.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">See Note 8 for additional information.</font></p><p>&#160;</p></li><li style="margin-left:18px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Goodwill </font><p>&#160;</p><p><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Goodwill represents the excess of the cost of businesses acquired over the fair value of their net assets. Goodwill primarily relates to the Health Care segment ($</font><font style="font-family:Times New Roman;font-size:10pt;">2.9</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">b</font><font style="font-family:Times New Roman;font-size:10pt;">illion) and, to a lesser extent, the International segment ($</font><font style="font-family:Times New Roman;font-size:10pt;">290</font><font style="font-family:Times New Roman;font-size:10pt;"> million). The Company evaluates goodwill for impairment </font><font style="font-family:Times New Roman;font-size:10pt;">at least </font><font style="font-family:Times New Roman;font-size:10pt;">annually during the third quarter at the reporting unit level, based on discounted cash flow analyses and writes it down through results of operations if impaired. Consistent with prior years, the Company's evaluations of goodwill associated with the Health Care </font><font style="font-family:Times New Roman;font-size:10pt;">and International </font><font style="font-family:Times New Roman;font-size:10pt;">segment</font><font style="font-family:Times New Roman;font-size:10pt;">s</font><font style="font-family:Times New Roman;font-size:10pt;"> used the best information available at the time, including reasonable assumptions and projections consistent with those used in its annual planning process. The discounted cash flow analyses used a range of discount rates that correspond wi</font><font style="font-family:Times New Roman;font-size:10pt;">th the Company's, or, in the case of International, the reporting unit's </font><font style="font-family:Times New Roman;font-size:10pt;">weighted average cost of capital, consistent with that used for investment decisions considering the specific and detailed operating plans and strategies within the segment</font><font style="font-family:Times New Roman;font-size:10pt;"> or reporting unit</font><font style="font-family:Times New Roman;font-size:10pt;">. The resulting discounted cash flow analysis indicated an estimated fair value for the Health Care segment&#160;</font><font style="font-family:Times New Roman;font-size:10pt;">and International's reporting unit </font><font style="font-family:Times New Roman;font-size:10pt;">exceeding </font><font style="font-family:Times New Roman;font-size:10pt;">their</font><font style="font-family:Times New Roman;font-size:10pt;"> carrying value</font><font style="font-family:Times New Roman;font-size:10pt;">s</font><font style="font-family:Times New Roman;font-size:10pt;">, including goodwill and other intangibles. Finally, the Company determined that no events or circumstances occurred subsequent to the annual evaluation of goodwill that would more likely than not reduce the fair value of </font><font style="font-family:Times New Roman;font-size:10pt;">the Health Care segment or International's</font><font style="font-family:Times New Roman;font-size:10pt;"> reporting unit</font><font style="font-family:Times New Roman;font-size:10pt;"> below </font><font style="font-family:Times New Roman;font-size:10pt;">their</font><font style="font-family:Times New Roman;font-size:10pt;"> carrying value</font><font style="font-family:Times New Roman;font-size:10pt;">s</font><font style="font-family:Times New Roman;font-size:10pt;">. </font><font style="font-family:Times New Roman;font-size:10pt;">See Note 8 for additional information.</font><font style="font-family:Times New Roman;font-size:10pt;">&#160;</font><font style="font-family:Times New Roman;font-size:10pt;">&#160;</font></p><p>&#160;</p><p>&#160;</p><p>&#160;</p><p>&#160;</p></li><li style="margin-left:18px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Other Assets, including Other Intangibles</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Other assets consist of various insurance-related assets</font><font style="font-family:Times New Roman;font-size:10pt;"> and the </font><font style="font-family:Times New Roman;font-size:10pt;">gain</font><font style="font-family:Times New Roman;font-size:10pt;"> position of certain derivatives, primarily GMIB assets</font><font style="font-family:Times New Roman;font-size:10pt;">. The Company's other intangible assets include purchased customer </font><font style="font-family:Times New Roman;font-size:10pt;">and producer </font><font style="font-family:Times New Roman;font-size:10pt;">relationships, provider networks, and trademarks. The Company amortizes other intangibles on a</font><font style="font-family:Times New Roman;font-size:10pt;">n accelerated or</font><font style="font-family:Times New Roman;font-size:10pt;"> straight-line</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">basis over periods from 1 to </font><font style="font-family:Times New Roman;font-size:10pt;">30</font><font style="font-family:Times New Roman;font-size:10pt;"> years. Management revises amortization periods if it believes there has been a change in the length of time that an intangible asset will continue to have value.</font><font style="font-family:Times New Roman;font-size:10pt;"> Costs incurred to renew or extend the terms of these intangible assets are g</font><font style="font-family:Times New Roman;font-size:10pt;">enerally expensed as incurred</font><font style="font-family:Times New Roman;font-size:10pt;">.</font><font style="font-family:Times New Roman;font-size:10pt;"> See Note 8 for additional information.</font></p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"> </font></p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;">J</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">.&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Separate Account Assets and Liabilities</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Separate account assets and liabilities are contractholder funds maintained in accounts with specific investment objectives. The assets of these accounts are legally segregated and are not subject to claims that arise out of any of the Company's other businesses. These separate account assets are carried at fair value with equal amounts for related separate account liabilities. The investment income, gains and losses of these accounts generally accrue to the contractholders and</font><font style="font-family:Times New Roman;font-size:10pt;">, together with their deposits and withdrawals, </font><font style="font-family:Times New Roman;font-size:10pt;">are </font><font style="font-family:Times New Roman;font-size:10pt;">ex</font><font style="font-family:Times New Roman;font-size:10pt;">cluded </font><font style="font-family:Times New Roman;font-size:10pt;">from</font><font style="font-family:Times New Roman;font-size:10pt;"> the Company's </font><font style="font-family:Times New Roman;font-size:10pt;">Consolidated Statements of Income and Cash Flows</font><font style="font-family:Times New Roman;font-size:10pt;">. </font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">Fees earned for asset management services are reported in premiums and fees.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;">K</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">.&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Contractholder Deposit Funds</font></p><p style='margin-top:5pt; margin-bottom:5pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Liabilities for contractholder deposit funds primarily include deposits received from customers for investment-related and universal life products and investment earnings on their fund balances. These liabilities are adjusted to reflect administrative charges and, for universal life fund balances, mortality charges. In addition, this caption includes premium stabilization reserves that are insurance experience refunds for group contracts that are left with the Company to pay future premiums, deposit administration funds that are used to fund nonpension retiree insurance programs, retained asset accounts and annuities or supplementary contracts without significant life contingencies. Interest credited on these funds is accrued ratably over the contract period. </font></p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Future Policy Benefits </font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Future policy benefits are liabilities for the present value of estimated future obligations under long-term life and supplemental health insurance policies and annuity products currently in force. These obligations are estimated using actuarial methods and primarily consist of reserves for annuity contracts, life insurance benefits, guaranteed minimum death benefit</font><font style="font-family:Times New Roman;font-size:10pt;"> (&#8220;GMDB&#8221;)</font><font style="font-family:Times New Roman;font-size:10pt;"> contracts and certain life, accident and health insurance products in our International operations.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Obligations for annuities represent specified periodic benefits to be paid to an individual or groups of individuals over their remaining lives. Obligations for life insurance policies represent benefits to be paid to policyholders, net of future premiums to be received. Management estimates these obligations based on assumptions as to premiums, interest rates, mortality and surrenders, allowing for adverse deviation. Mortality, morbidity, and surrender assumptions are based on either the Company's own experience or actuarial tables. Interest rate assumptions are based on management's judgment considering the Company's experience and future expectations, and range fro</font><font style="font-family:Times New Roman;font-size:10pt;">m </font><font style="font-family:Times New Roman;font-size:10pt;">1</font><font style="font-family:Times New Roman;font-size:10pt;">% to </font><font style="font-family:Times New Roman;font-size:10pt;">10</font><font style="font-family:Times New Roman;font-size:10pt;">%. Obligations for </font><font style="font-family:Times New Roman;font-size:10pt;">the run-off settlement </font><font style="font-family:Times New Roman;font-size:10pt;">annuit</font><font style="font-family:Times New Roman;font-size:10pt;">y business</font><font style="font-family:Times New Roman;font-size:10pt;"> include adjustments for investment</font><font style="font-family:Times New Roman;font-size:10pt;"> returns consistent with requirements of GAAP when a premium deficiency exists. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Certain reinsurance contracts</font><font style="font-family:Times New Roman;font-size:10pt;"> contain</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">GMDB</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">under variable annuities issued by other insurance companies. These obligations represent the guaranteed death benefit in excess of the contractholder's account values (based on underlying equity and bond mutual fund investments). These obligations are estimated based on assumptions regarding lapse, partial surrenders, mortality, interest rates (mean investment performance and discount rate), market volatility as well as investment returns and premiums, consistent with the requirements of </font><font style="font-family:Times New Roman;font-size:10pt;">GAAP</font><font style="font-family:Times New Roman;font-size:10pt;"> when a premium deficiency exists. Lapse, partial surrenders, mortality, interest rates and volatility are based on management's judgment considering the Company's experience and future expectations. The results of futures </font><font style="font-family:Times New Roman;font-size:10pt;">and swap </font><font style="font-family:Times New Roman;font-size:10pt;">contracts </font><font style="font-family:Times New Roman;font-size:10pt;">used in the GMDB equity </font><font style="font-family:Times New Roman;font-size:10pt;">and growth interest rate </font><font style="font-family:Times New Roman;font-size:10pt;">hedge program</font><font style="font-family:Times New Roman;font-size:10pt;">s</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">are reflected in the liability calculation as a component of investment returns. See also Note </font><font style="font-family:Times New Roman;font-size:10pt;">6</font><font style="font-family:Times New Roman;font-size:10pt;"> for additional information.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Unpaid Claims and Claims Expenses </font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Liabilities for unpaid claims and claim expenses are estimates of payments to be made under insurance coverages (primarily long-term disability, workers' compensation and life and health) for reported claims and for losses incurred but not yet reported. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company develops these estimates for losses incurred but not yet reported using actuarial principles and assumptions based on historical and projected claim incidence patterns, claim size</font><font style="font-family:Times New Roman;font-size:10pt;">, subrogation recoveries</font><font style="font-family:Times New Roman;font-size:10pt;"> and the length of time over which payments are expected to be made. The Company consistently applies these actuarial principles and assumptions each reporting period, with consideration given to the variability of these factors, and recognizes the actuarial best estimate of the ultimate liability within a level of confidence, as required by actuarial standards of practice, which require that the liabilities be adequate under moderately adverse conditions.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;">s estimate of the liability for disability claims reported but not yet paid is primarily calculated as the present value of expected benefit payments to be made over the estimated time period that a policyholder remains disabled. The Company estimates the expected time period that a policyholder may be disabled by analyzing the rate at which an open claim is expected to close (claim resolution rate). Claim resolution rates may vary based upon the length of time a policyholder is disabled, the covered benefit period, cause of disability, benefit design and the policyholder</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;">s age, gender and income level. The Company uses historical resolution rates combined with an analysis of current trends and operational factors to develop current estimates of resolution rates</font><font style="font-family:Times New Roman;font-size:10pt;">. </font><font style="font-family:Times New Roman;font-size:10pt;">The reserve for the gross monthly disability benefits due to a policyholder </font><font style="font-family:Times New Roman;font-size:10pt;">is</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">reduced</font><font style="font-family:Times New Roman;font-size:10pt;"> (</font><font style="font-family:Times New Roman;font-size:10pt;">offset</font><font style="font-family:Times New Roman;font-size:10pt;">)</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">by the income that the policyholder receives under other benefit programs, such as Social Security Disability Income, workers</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;"> compensation, statutory disability or other group disability benefit plans. For awards of such offsets that have not been finalized, the Company estimates the probability and amount of the offset based on the Company</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;">s experience over the past three to five years.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">T</font><font style="font-family:Times New Roman;font-size:10pt;">he Company discounts certain claim liabilities related to group long-term disability and workers' compensation</font><font style="font-family:Times New Roman;font-size:10pt;"> because b</font><font style="font-family:Times New Roman;font-size:10pt;">enefit payments may be made over</font><font style="font-family:Times New Roman;font-size:10pt;"> e</font><font style="font-family:Times New Roman;font-size:10pt;">xtended period</font><font style="font-family:Times New Roman;font-size:10pt;">s</font><font style="font-family:Times New Roman;font-size:10pt;">. Discount rate assumptions are based on projected investment returns for the asset portfolios that support these liabilities and range from </font><font style="font-family:Times New Roman;font-size:10pt;">3.80</font><font style="font-family:Times New Roman;font-size:10pt;">% to </font><font style="font-family:Times New Roman;font-size:10pt;">6</font><font style="font-family:Times New Roman;font-size:10pt;">.25</font><font style="font-family:Times New Roman;font-size:10pt;">%. When estimates change, the Company records the adjustment in benefits and expenses in the period in which the change in estimate is identified. Discounted liabilities associated with the long-term disability and certain workers' compensation businesses were $</font><font style="font-family:Times New Roman;font-size:10pt;">3.</font><font style="font-family:Times New Roman;font-size:10pt;">2</font><font style="font-family:Times New Roman;font-size:10pt;"> billion at </font><font style="font-family:Times New Roman;font-size:10pt;">December 31, 2011</font><font style="font-family:Times New Roman;font-size:10pt;"> and</font><font style="font-family:Times New Roman;font-size:10pt;"> $3.1 billion at</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">December 31, 2010</font><font style="font-family:Times New Roman;font-size:10pt;">.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;">N.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Health Care Medical Claims Payable</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Medical claims payable for the Health Care segment include both reported claims and estimates for losses incurred but not yet reported.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">The Company develops estimates for Health Care medical claims payable using actuarial principles and assumptions consistently applied each reporting period, and recognizes the actuarial best estimate of the ultimate liability within a level of confidence, as required by actuarial standards of practice, which require that the liabilities be adequate under moderately adverse conditions. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The liability </font><font style="font-family:Times New Roman;font-size:10pt;">is primarily calculated using &#8220;completion factors&#8221; (a measure of the time to process claims), which are developed by comparing the date claims were incurred, generally the date services were provided, </font><font style="font-family:Times New Roman;font-size:10pt;">to the date claims were paid. </font><font style="font-family:Times New Roman;font-size:10pt;">The Company uses historical completion factors combined with an analysis of current trends and operational factors to develop current estimates of completion factors. The Company estimates the liability for claims incurred in each month by applying the current estimates of completion factors to the current paid claims data. This approach implicitly assumes that historical completion rates will be a useful indicator for the current period. It is possible that the actual completion rates for the current period will develop differently from historical patterns, which could have a material impact on the Company</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;">s medical claims payable and </font><font style="font-family:Times New Roman;font-size:10pt;">shareholders' </font><font style="font-family:Times New Roman;font-size:10pt;">net income.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Completion factors are impacted by several key items including changes in: 1) electronic (auto-adjudication) versus manual claim processing, 2) provider claims submission rates, 3) membership and 4) the mix of products. As noted, the Company uses historical completion factors combined with an analysis of current trends and operational factors to develop current estimates of completion factors. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">In addition, for the more recent months, the Company also relies on medical cost trend analysis, which reflects expected claim payment patterns and other relevant operational considerations. Medical cost trend is primarily impacted by medical service utilization and unit costs, which are affected by changes in the level and mix of medical benefits offered, including inpatient, outpatient and pharmacy, the impact of copays and deductibles, changes in provider practices and changes in consumer demographics and consumption behavior. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Despite reflecting both historical and emerging trends in setting reserves, it is possible that the actual medical trend for the current period will develop differently from expect</font><font style="font-family:Times New Roman;font-size:10pt;">ations</font><font style="font-family:Times New Roman;font-size:10pt;">, which could have a material impact on the Company</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;">s medical claims payable and </font><font style="font-family:Times New Roman;font-size:10pt;">shareholders' </font><font style="font-family:Times New Roman;font-size:10pt;">net income.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">For each reporting period, the Company evaluates key assumptions by comparing the assumptions used in establishing the medical claims payable to actual experience. </font><font style="font-family:Times New Roman;font-size:10pt;">When actual experience differs from the assumptions used in establishing the liability, medical claims payable are increased or decreased through current period </font><font style="font-family:Times New Roman;font-size:10pt;">shareholders'</font><font style="font-family:Times New Roman;font-size:8pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">net income. </font><font style="font-family:Times New Roman;font-size:10pt;"> Additionally, the Company evaluates expected future developments and emerging trends which may impact key assumptions.</font><font style="font-family:Times New Roman;font-size:10pt;"> The estimation process involves considerable judgment, reflecting the variability inherent in forecasting future claim payments. These estimates are highly sensitive to changes in the Company</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;">s key assumptions, specifically completion factors, and medical cost trends.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Unearned Premiums and Fees</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Premiums for life, accident and health insurance are recognized as revenue on a pro rata basis over the contract period. Fees for mortality and contract administration of universal life products are recognized ratably over the coverage period. The unrecognized portion of these amounts</font><font style="font-family:Times New Roman;font-size:10pt;"> received</font><font style="font-family:Times New Roman;font-size:10pt;"> is recorded as unearned premiums and fees.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Accounts Payable, Accrued Expenses and Other Liabilities</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Accounts payable, accrued expenses and other liabilities consist principally of </font><font style="font-family:Times New Roman;font-size:10pt;">liabilities for </font><font style="font-family:Times New Roman;font-size:10pt;">pension, other postretirement and postemployment benefits</font><font style="font-family:Times New Roman;font-size:10pt;"> (see Note </font><font style="font-family:Times New Roman;font-size:10pt;">9</font><font style="font-family:Times New Roman;font-size:10pt;">)</font><font style="font-family:Times New Roman;font-size:10pt;">, self-insured </font><font style="font-family:Times New Roman;font-size:10pt;">exposures</font><font style="font-family:Times New Roman;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;">management</font><font style="font-family:Times New Roman;font-size:10pt;"> compensation</font><font style="font-family:Times New Roman;font-size:10pt;"> and various insurance-related </font><font style="font-family:Times New Roman;font-size:10pt;">items</font><font style="font-family:Times New Roman;font-size:10pt;">, including </font><font style="font-family:Times New Roman;font-size:10pt;">experience rated refunds, the minimum </font><font style="font-family:Times New Roman;font-size:10pt;">medical </font><font style="font-family:Times New Roman;font-size:10pt;">loss ratio rebate accrual under Health Care Reform, </font><font style="font-family:Times New Roman;font-size:10pt;">amounts related to reinsurance contracts and insurance-related assessments that management can reasonably estimate. Accounts payable, accrued expenses and other liabilities also include certain overdraft positions and the loss position of certain derivatives</font><font style="font-family:Times New Roman;font-size:10pt;">, primarily </font><font style="font-family:Times New Roman;font-size:10pt;">for </font><font style="font-family:Times New Roman;font-size:10pt;">GMIB </font><font style="font-family:Times New Roman;font-size:10pt;">contracts</font><font style="font-family:Times New Roman;font-size:10pt;"> (see Note </font><font style="font-family:Times New Roman;font-size:10pt;">12</font><font style="font-family:Times New Roman;font-size:10pt;">). Legal costs to defend the Company's litigation and arbitration matters are expensed when incurred</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">in</font><font style="font-family:Times New Roman;font-size:10pt;"> cases </font><font style="font-family:Times New Roman;font-size:10pt;">that</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">the Company cannot reasonably estimate the ultimate cost to defend</font><font style="font-family:Times New Roman;font-size:10pt;">.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">In</font><font style="font-family:Times New Roman;font-size:10pt;"> cases</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">that </font><font style="font-family:Times New Roman;font-size:10pt;">the Company can reasonably estimate the cost to defend, </font><font style="font-family:Times New Roman;font-size:10pt;">these </font><font style="font-family:Times New Roman;font-size:10pt;">costs </font><font style="font-family:Times New Roman;font-size:10pt;">are</font><font style="font-family:Times New Roman;font-size:10pt;"> recognized when the claim is reported.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Translation of Foreign Currencies</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company generally conducts its international business through foreign operating entities that maintain assets and liabilities in local currencies, which are generally their functional currencies. The Company uses exchange rates as of the balance sheet date to translate assets and liabilities into U.S. dollars. Translation gains or losses on functional currencies, net of applicable taxes, are recorded in accumulated other </font><font style="font-family:Times New Roman;font-size:10pt;">comprehensive</font><font style="font-family:Times New Roman;font-size:10pt;"> income (loss). The Company uses average </font><font style="font-family:Times New Roman;font-size:10pt;">monthly </font><font style="font-family:Times New Roman;font-size:10pt;">exchange rates during the year to translate revenues and expenses into U.S. dollars. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Premiums and Fees, Revenues and Related Expenses</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Premiums for </font><font style="font-family:Times New Roman;font-size:10pt;">group</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">life, accident and health insurance and managed care coverages are recognized as revenue on a pro rata basis over the contract period. Benefits and expenses are recognized when incurred.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">Premiums and fees include revenue from experience-rated contracts </font><font style="font-family:Times New Roman;font-size:10pt;">that</font><font style="font-family:Times New Roman;font-size:10pt;"> is based on the estimated ultimate claim, and in some cases, administrative cost experience of the contract. For these contracts, premium revenue includes an adjustment for experience-rated refunds which is calculated </font><font style="font-family:Times New Roman;font-size:10pt;">according to contract terms </font><font style="font-family:Times New Roman;font-size:10pt;">and </font><font style="font-family:Times New Roman;font-size:10pt;">using the customer's experience (including estimates of incurred but not reported claims)</font><font style="font-family:Times New Roman;font-size:10pt;">.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;"> Beginning in 2011, premium revenue also includes an adjustment to reflect the estimated effect of rebates due to customers under the minimum </font><font style="font-family:Times New Roman;font-size:10pt;">medical </font><font style="font-family:Times New Roman;font-size:10pt;">loss ratio provisions of Health Care Reform. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Premiums for</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">individual life</font><font style="font-family:Times New Roman;font-size:10pt;">, accident and health</font><font style="font-family:Times New Roman;font-size:10pt;"> insurance and annuity products, excluding universal life and investment-related products,</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">are recognized as revenue when due. Benefits and expenses are matched with premiums.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Premiums and fees received for</font><font style="font-family:Times New Roman;font-size:10pt;"> the Company's</font><font style="font-family:Times New Roman;font-size:10pt;"> Medicare Advantage Plans and Medicare Part D products from customers and the Centers for Medicare and Medicaid Services (CMS) are recognized as revenue ratably over the contract period. CMS provides risk adjusted premium payments for the Medicare Advantage Plans and Medicare Part D products, based on the demographics and health severity of enrollees. The Company recognizes periodic changes to risk adjusted premiums as revenue when the amounts are determinable and collection is reasonably assured. Additionally, Medicare Part D includes payments from CMS for risk sharing adjustments. The risk sharing adjustments, </font><font style="font-family:Times New Roman;font-size:10pt;">that</font><font style="font-family:Times New Roman;font-size:10pt;"> are estimated quarterly based on claim experience, compare actual incurred drug benefit costs to estimated costs submitted in original contracts and may result in more or less revenue from CMS. Final revenue adjustments are determined through an annual settlement with CMS that occurs after the contract year.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Revenue for investment-related products is recognized as follows:</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">Net investment income on assets supporting investment-related products is recognized as earned. </font></li><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">Contract fees, which are based upon related administrative expenses, are recognized in premiums and fees as they are earned ratably over the contract period.</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Benefits and expenses for investment-related products consist primarily of income credited to policyholders in accordance with contract provisions.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Revenue for universal life products is recognized as follows:</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">Net investment income on assets supporting universal life products is recognized as earned.</font></li><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">Fees for mortality</font><font style="font-family:Times New Roman;font-size:10pt;"> and surrender charges</font><font style="font-family:Times New Roman;font-size:10pt;"> are recognized as assessed, which is as earned.</font></li><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">Administration fees are recognized as services are provided.</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Benefits and expenses for universal life products consist of benefit claims in excess of policyholder account balances. Expenses are recognized when claims are submitted, and income is credited</font><font style="font-family:Times New Roman;font-size:10pt;"> to policyholders</font><font style="font-family:Times New Roman;font-size:10pt;"> in accordance with contract provisions. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Contract fees and expenses for administrative services only programs and pharmacy programs and services are recognized as services are provided. Mail order pharmacy revenues and cost of goods sold are recognized as each prescription is shipped.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Stock Compensation</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company records compensation expense for stock awards and options over their vesting periods </font><font style="font-family:Times New Roman;font-size:10pt;">primarily </font><font style="font-family:Times New Roman;font-size:10pt;">based on the estimated fair value </font><font style="font-family:Times New Roman;font-size:10pt;">at the grant date. Compensation expense is recorded for</font><font style="font-family:Times New Roman;font-size:10pt;"> stock options</font><font style="font-family:Times New Roman;font-size:10pt;"> over their vesting period based on fair value at the grant date</font><font style="font-family:Times New Roman;font-size:10pt;"> which is calculated using an option-pricing model. Compensation expense is recorded for restricted stock grants and units over their vesting periods based on fair value, which is equal to the market price of the Company's common stock on the date of grant.</font><font style="font-family:Times New Roman;font-size:10pt;"> Compensation expense for str</font><font style="font-family:Times New Roman;font-size:10pt;">ategic performance shares </font><font style="font-family:Times New Roman;font-size:10pt;">is recorded over the performance period. For</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">strategic performance shares </font><font style="font-family:Times New Roman;font-size:10pt;">with</font><font style="font-family:Times New Roman;font-size:10pt;"> payment</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">dependent</font><font style="font-family:Times New Roman;font-size:10pt;"> on </font><font style="font-family:Times New Roman;font-size:10pt;">market condition, fair value is determined at the grant date using a </font><font style="font-family:Times New Roman;font-size:10pt;">Monte Carlo</font><font style="font-family:Times New Roman;font-size:10pt;"> simulation model and not subsequently adjusted regardless of the final outcome. For </font><font style="font-family:Times New Roman;font-size:10pt;">strategic performance shares</font><font style="font-family:Times New Roman;font-size:10pt;"> with </font><font style="font-family:Times New Roman;font-size:10pt;">payment dependent</font><font style="font-family:Times New Roman;font-size:10pt;"> on </font><font style="font-family:Times New Roman;font-size:10pt;">performance conditions, expense is initially accrued based on the most likely outcome, but evaluated for adjustment each period for updates in the expected outcome. At the end of the performance period, expense is </font><font style="font-family:Times New Roman;font-size:10pt;">adjusted</font><font style="font-family:Times New Roman;font-size:10pt;"> to the actual outcome (number of shares awarded times the share price at the grant date).</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Participating Business</font><p>&#160;</p><p><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company's participating life insurance policies entitle policyholders to earn dividends that represent a portion of the earnings of the Company's life insurance subsidiaries. Participating insuran</font><font style="font-family:Times New Roman;font-size:10pt;">ce accoun</font><font style="font-family:Times New Roman;font-size:10pt;">ted for approximately 1</font><font style="font-family:Times New Roman;font-size:10pt;">% </font><font style="font-family:Times New Roman;font-size:10pt;">of the Company's total life insurance in force at the end of </font><font style="font-family:Times New Roman;font-size:10pt;">2011</font><font style="font-family:Times New Roman;font-size:10pt;">,</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">2010</font><font style="font-family:Times New Roman;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;">2009</font><font style="font-family:Times New Roman;font-size:10pt;">. </font></p><p>&#160;</p></li><li style="margin-left:18px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Income Taxes</font><p>&#160;</p><p><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company and its domestic subsidiaries file a consolidated </font><font style="font-family:Times New Roman;font-size:10pt;">United States</font><font style="font-family:Times New Roman;font-size:10pt;"> federal income tax return. The Company</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;">s foreign subsidiaries file tax returns in accordance with foreign law. </font><font style="font-family:Times New Roman;font-size:10pt;">U.S.</font><font style="font-family:Times New Roman;font-size:10pt;"> taxation of </font><font style="font-family:Times New Roman;font-size:10pt;">these </font><font style="font-family:Times New Roman;font-size:10pt;">foreign </font><font style="font-family:Times New Roman;font-size:10pt;">subsidiaries</font><font style="font-family:Times New Roman;font-size:10pt;"> may differ in timing and amount from taxation under foreign laws. Reportable amounts, including credits for foreign tax paid by th</font><font style="font-family:Times New Roman;font-size:10pt;">ese subsidiaries</font><font style="font-family:Times New Roman;font-size:10pt;">, are reflected in the </font><font style="font-family:Times New Roman;font-size:10pt;">U.S.</font><font style="font-family:Times New Roman;font-size:10pt;"> tax return of the affiliates</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;"> domestic parent. </font></p><p>&#160;</p><p><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company recognizes deferred income taxes when </font><font style="font-family:Times New Roman;font-size:10pt;">the financial statement and tax-</font><font style="font-family:Times New Roman;font-size:10pt;">based carrying values of assets and liabilities are different and recognizes deferred income tax liabilities on the unremitted earnings of foreign subsidiaries</font><font style="font-family:Times New Roman;font-size:10pt;"> that are not permanently invested overseas</font><font style="font-family:Times New Roman;font-size:10pt;">. </font><font style="font-family:Times New Roman;font-size:10pt;">For subsidiaries whose earnings are considered permanently invested overseas, income taxes are accrued at the local foreign tax rate. </font><font style="font-family:Times New Roman;font-size:10pt;"> The Company establishes valuation allowances against deferred tax assets if it is more likely than not that the deferred tax asset will not be realized. The need for a valuation allowance is determined based on the evaluation of various factors, including expectations of future earnings and management's judgment. Note </font><font style="font-family:Times New Roman;font-size:10pt;">19</font><font style="font-family:Times New Roman;font-size:10pt;"> contains detailed information about the Company</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;">s income taxes. </font></p><p>&#160;</p><p>&#160;</p><p>&#160;</p><p><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company recognizes interim period income taxes by estimating an annual effective tax rate and applying it to year-to-date results. The estimated annual effective tax rate is periodically updated throughout the year based on actual results to date and an updated projection of full year income. Although the effective tax rate approach is generally used for interim periods, taxes on significant, unusual and infrequent items are recognized at the statutory tax rate entirely in the period the amounts are realized. </font></p><p>&#160;</p></li><li style="margin-left:18px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Earnings Per Share</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company computes basic earnings per share using the weighted-average number of unrestricted common and deferred shares outstanding. Diluted earnings per share also includes the dilutive effect of outstanding employee stock options and unvested restricted stock granted after 2009 using the treasury stock method and the effect of strategic performance shares.</font></p> <p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Variable interest entities.</font><font style="font-family:Times New Roman;font-size:10pt;"> As of </font><font style="font-family:Times New Roman;font-size:10pt;">December 31, 2011</font><font style="font-family:Times New Roman;font-size:10pt;"> and 2010</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">the Company </font><font style="font-family:Times New Roman;font-size:10pt;">determined it </font><font style="font-family:Times New Roman;font-size:10pt;">was</font><font style="font-family:Times New Roman;font-size:10pt;"> no</font><font style="font-family:Times New Roman;font-size:10pt;">t</font><font style="font-family:Times New Roman;font-size:10pt;"> a primary beneficiary in any variable interest entities.</font></p> <p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Deferred acquisition costs.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"> </font><font style="font-family:Times New Roman;font-size:10pt;">In October 2010, the Financial Accounting Standards Board (&#8220;FASB&#8221;) amended guidance (ASU 2010-26) for the accounting of costs to </font><font style="font-family:Times New Roman;font-size:10pt;">acquire or renew </font><font style="font-family:Times New Roman;font-size:10pt;">insurance contracts to require costs such as certain sales compensation or telemarketing costs that are related to unsuccessful efforts </font><font style="font-family:Times New Roman;font-size:10pt;">to acquire or retain business </font><font style="font-family:Times New Roman;font-size:10pt;">and any indirect costs to be expensed as incurred. This new guidance must be implemented on January 1, 2012 and any changes to the Company's Consolidated Financial Statements may be recognized prospectively for acquisition costs incurred beginning in 2012 or through retrospective adjustment of comparative prior periods. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company expects to implement the new requirements on January 1, 2012 through retrospective adjustment of prior periods. </font></p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company's deferred acquisition costs arise from sales and renewal activities primarily in its International segment. Because the new requirements further restrict the types of costs that are deferrable, more of the Company's acquisition costs will be expensed as incurred. The Company expects the cumulative effect of implementing this new guidance to decrease </font><font style="font-family:Times New Roman;font-size:10pt;">shareholders' equity</font><font style="font-family:Times New Roman;font-size:10pt;"> as of </font><font style="font-family:Times New Roman;font-size:10pt;">January </font><font style="font-family:Times New Roman;font-size:10pt;">1, 201</font><font style="font-family:Times New Roman;font-size:10pt;">1</font><font style="font-family:Times New Roman;font-size:10pt;"> by </font><font style="font-family:Times New Roman;font-size:10pt;">a range of</font><font style="font-family:Times New Roman;font-size:10pt;"> $</font><font style="font-family:Times New Roman;font-size:10pt;">250 </font><font style="font-family:Times New Roman;font-size:10pt;">million</font><font style="font-family:Times New Roman;font-size:10pt;"> to $300 million</font><font style="font-family:Times New Roman;font-size:10pt;">. In addition, </font><font style="font-family:Times New Roman;font-size:10pt;">as </font><font style="font-family:Times New Roman;font-size:10pt;">certain </font><font style="font-family:Times New Roman;font-size:10pt;">acquisition costs </font><font style="font-family:Times New Roman;font-size:10pt;">will </font><font style="font-family:Times New Roman;font-size:10pt;">no longer </font><font style="font-family:Times New Roman;font-size:10pt;">be </font><font style="font-family:Times New Roman;font-size:10pt;">eligible </font><font style="font-family:Times New Roman;font-size:10pt;">for</font><font style="font-family:Times New Roman;font-size:10pt;"> deferr</font><font style="font-family:Times New Roman;font-size:10pt;">al under the new guidance</font><font style="font-family:Times New Roman;font-size:10pt;">, the Company expects that full-year 2011 shareholders' net income on a retrospectively adjusted basis will decrease by a</font><font style="font-family:Times New Roman;font-size:10pt;">pproximately</font><font style="font-family:Times New Roman;font-size:10pt;"> $</font><font style="font-family:Times New Roman;font-size:10pt;">7</font><font style="font-family:Times New Roman;font-size:10pt;">0</font><font style="font-family:Times New Roman;font-size:10pt;"> million</font><font style="font-family:Times New Roman;font-size:10pt;"> primarily in its International segment. </font><font style="font-family:Times New Roman;font-size:10pt;">The Company expects t</font><font style="font-family:Times New Roman;font-size:10pt;">he effect</font><font style="font-family:Times New Roman;font-size:10pt;"> of the new guidance</font><font style="font-family:Times New Roman;font-size:10pt;"> on </font><font style="font-family:Times New Roman;font-size:10pt;">shareholders'</font><font style="font-family:Times New Roman;font-size:10pt;"> net income</font><font style="font-family:Times New Roman;font-size:10pt;"> in </font><font style="font-family:Times New Roman;font-size:10pt;">2012</font><font style="font-family:Times New Roman;font-size:10pt;"> to be generally comparable to that estimated for 2011. </font><font style="font-family:Times New Roman;font-size:10pt;">Implementation of this new guidance will have no impact on the underlying economic value, revenues or cash flows of the Company's businesses, nor will it impact the Company's liquidity or the statutory surplus of its insurance subsidiaries</font><font style="font-family:Times New Roman;font-size:10pt;">.</font></p> <p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Fair value measurements.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">In May&#160;2011, the FASB amended guidance (ASU&#160;2011-04) to improve the comparability of fair value measurements presented and disclosed in financial statements prepared in accordance with U.S. GAAP and International Financial Reporting Standards. The amendments are effective January&#160;1,&#160;2012 and are to be applied prospectively.&#160;The Company expects no material effects at implementation. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company adopted the FASB's updated guidance on fair value measurements (ASU 2010-06) in the first quarter of 2010, which requires separate disclosures of significant transfers between levels in the fair value hierarchy. See Note </font><font style="font-family:Times New Roman;font-size:10pt;">10</font><font style="font-family:Times New Roman;font-size:10pt;"> for additional information. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">A</font><font style="font-family:Times New Roman;font-size:10pt;">mendments to th</font><font style="font-family:Times New Roman;font-size:10pt;">e FASB's fair value</font><font style="font-family:Times New Roman;font-size:10pt;"> guidance in 2009 had no effect on the Company's Consolidated Financial Statements. </font><font style="font-family:Times New Roman;font-size:10pt;">See Note </font><font style="font-family:Times New Roman;font-size:10pt;">10</font><font style="font-family:Times New Roman;font-size:10pt;"> for additional information.</font></p> <p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Other-than-temporary impairments. </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;"> </font><font style="font-family:Times New Roman;font-size:10pt;">On April 1, 2009, the Company adopted the FASB's updated guidance for evaluating whether an impairment is other than temporary for fixed maturities with declines in fair value below amortized cost (ASC 320). A reclassification adjustment from retained earnings to accumulated other comprehensive income was required for previously impaired fixed maturities that had a non-credit loss as of the date of adoption, net of related tax effects. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The cumulative effect of adoption increased the Company's retained earnings in 2009 with an offsetting decrease to accumulated other comprehensive income of $18 million, with no overall change to shareholders' equity. </font><font style="font-family:Times New Roman;font-size:10pt;"> See </font><font style="font-family:Times New Roman;font-size:10pt;">Note 11 </font><font style="font-family:Times New Roman;font-size:10pt;">(A) </font><font style="font-family:Times New Roman;font-size:10pt;">for information on the Company's other-than-temporary impairments including additional required disclosures.</font></p> <p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Troubled debt restructurings</font><font style="font-family:Times New Roman;font-size:10pt;">. Effective July 1, 2011, the Company adopted the FASB's updated guidance (ASU 2011-02) to clarify for lenders that a troubled debt restructuring occurs when a debt modification is a concession to the borrower and the borrower is experiencing financial difficulties. This guidance was required to be applied retrospectively for restructurings&#160;occurring on or after January&#160;1,&#160;2011. The amendment also required new disclosures to be provided&#160;</font><font style="font-family:Times New Roman;font-size:10pt;">beginning </font><font style="font-family:Times New Roman;font-size:10pt;">in the&#160;third quarter </font><font style="font-family:Times New Roman;font-size:10pt;">of </font><font style="font-family:Times New Roman;font-size:10pt;">2011 addressing certain troubled debt restructurings.&#160; Adoption of the new guidance did not have a material effect to the Company's results of operations or financial condition</font><font style="font-family:Times New Roman;font-size:10pt;">. </font><font style="font-family:Times New Roman;font-size:10pt;">See Note 11 for additional information related to commercial mortgage loans.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p> Fixed maturities and equity securities. Fixed maturities primarily include bonds, mortgage and other asset-backed securities and preferred stocks redeemable by the investor. Equity securities include common stocks and preferred stocks that are non-redeemable or redeemable only at the option of the issuer. These investments are primarily classified as available for sale and are carried at fair value with changes in fair value recorded in accumulated other comprehensive income (loss) within shareholders&#8217; equity. &#160;Beginning April 1, 2009, for fixed maturities with declines in fair value below amortized cost, the Company assesses its intent to sell or whether it is more likely than not to be required to sell such fixed maturities before their fair values recover. If so, an impairment loss is recognized in net income for the excess of their amortized cost over fair value. In addition, when the Company determines it does not expect to recover the amortized cost basis of fixed maturities with declines in fair value (even if it does not intend to sell or will not be required to sell these fixed maturities), the credit portion of the impairment loss is recognized in net income and the non-credit portion, if any, is recognized in a separate component of shareholders&#8217; equity. The credit portion is the difference between the amortized cost basis of the fixed maturity and the net present value of its projected future cash flows. Projected future cash flows are based on qualitative and quantitative factors, including probability of default, and the estimated timing and amount of recovery. For mortgage and asset-backed securities, estimated future cash flows are based on assumptions about the collateral attributes including prepayment speeds, default rates and changes in value. Equity securities and, prior to April 1, 2009, fixed maturities were considered impaired, and their cost basis was written down to fair value through earnings, when management did not expect to recover the amortized cost, or if the Company could not demonstrate its intent or ability to hold the investment until full recovery. Fixed maturities and equity securities also include trading and certain hybrid securities that are carried at fair value with changes in fair value reported in realized investment gains and losses. The Company has irrevocably elected the fair value option for these securities to simplify accounting and mitigate volatility in results of operations and financial condition. Hybrid securities include certain preferred stock and debt securities with call or conversion options. <p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Commercial mortgage loans.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">Mortgage loans held by the Company are made exclusively to commercial borrowers. Generally, commercial mortgage loans are carried at unpaid principal balances and are issued at a fixed rate of interest. Commercial mortgage loans are considered impaired when it is probable that the Company will not collect amounts due according to the terms of the original loan agreement.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">The Company </font><font style="font-family:Times New Roman;font-size:10pt;">monitors credit risk and </font><font style="font-family:Times New Roman;font-size:10pt;">assesses the impairment of loans individually </font><font style="font-family:Times New Roman;font-size:10pt;">and on a consistent basis </font><font style="font-family:Times New Roman;font-size:10pt;">for all loans in the portfolio</font><font style="font-family:Times New Roman;font-size:10pt;">. </font><font style="font-family:Times New Roman;font-size:10pt;">Impaired loans are carried at the lower of unpaid principal or fair value of the underlying </font><font style="font-family:Times New Roman;font-size:10pt;">real estate</font><font style="font-family:Times New Roman;font-size:10pt;">. Valuation reserves reflect any changes in fair value. The Company estimates the fair value of the underlying </font><font style="font-family:Times New Roman;font-size:10pt;">real estate</font><font style="font-family:Times New Roman;font-size:10pt;"> using internal valuations generally based on</font><font style="font-family:Times New Roman;font-size:10pt;"> discounted cash flow analyses. </font><font style="font-family:Times New Roman;font-size:10pt;">Certain commercial mortgage loans without valuation reserves are considered impaired because the Company will not collect all interest due according to the t</font><font style="font-family:Times New Roman;font-size:10pt;">erms of the original agreements,</font><font style="font-family:Times New Roman;font-size:10pt;"> however, the Company expects to recover their remaining carrying value primarily because it is less than the fair value of the underlying </font><font style="font-family:Times New Roman;font-size:10pt;">real estate.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p> <p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Policy loans.</font><font style="font-family:Times New Roman;font-size:10pt;"> Policy loans are carried at unpaid principal balances</font><font style="font-family:Times New Roman;font-size:10pt;"> plus accumulated interest</font><font style="font-family:Times New Roman;font-size:10pt;">.</font><font style="font-family:Times New Roman;font-size:10pt;"> The loans are collateralized by insurance policy cash values and therefore have no exposure to credit loss.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p> <p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Real estate.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"> </font><font style="font-family:Times New Roman;font-size:10pt;">Investment real estate can be &#8220;held and used&#8221; or &#8220;held for sale&#8221;. The Company accounts for real estate as follows: </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">Real estate "held and used" is expected to be held longer than one year and includes real estate acquired through the foreclosure of commercial mortgage loans. The Company carries real estate held and used at depreciated cost less any write-downs to fair value due to impairment and assesses impairment when cash flows indicate that the carrying value may not be recoverable. Depreciation is generally calculated using the straight-line method based on the estimated useful life of the particular real estate asset. </font></li><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">Real estate is "held for sale" when a buyer's investigation is completed, a deposit has been received and the sale is expected to be completed within the next year. Real estate held for sale is carried at the lower of carrying value or current fair value, less estimated costs to sell, and is not depreciated. Valuation reserves reflect any changes in fair value.</font></li><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">The Company uses several methods to determine the fair value of real estate, but relies primarily on discounted cash flow analyses and, in some cases, third</font><font style="font-family:Times New Roman;font-size:10pt;">-</font><font style="font-family:Times New Roman;font-size:10pt;">party appraisals.</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">At the time of foreclosure, properties are reclassified from commercial mortgage loans to real estate or other long-term investments depending on the ownership of the underlying assets. The Company rehabilitates, re-leases and sells foreclosed properties. Thi</font><font style="font-family:Times New Roman;font-size:10pt;">s process usually takes from three to five</font><font style="font-family:Times New Roman;font-size:10pt;"> years unless management considers a near-term sale preferable</font><font style="font-family:Stone Serif;font-size:10pt;">.</font><font style="font-family:Stone Serif;font-size:10pt;"> </font><font style="font-family:Stone Serif;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">When foreclosed real estate is recapitalized through a joint venture including a contribution of new equity from a third-party investor, the asset is accounted for as a</font><font style="font-family:Times New Roman;font-size:10pt;">n</font><font style="font-family:Times New Roman;font-size:10pt;"> investment </font><font style="font-family:Times New Roman;font-size:10pt;">in good standing </font><font style="font-family:Times New Roman;font-size:10pt;">reported in other long-term investments.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p> <p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Other long-term investments. </font><font style="font-family:Times New Roman;font-size:10pt;">Other long-term investments include investments in unconsolidated entities. These entities include certain limited partnerships and limited liability companies holding real estate, securities or loans. These investments are carried at cost plus the Company's ownership percentage of reported income or loss in cases where the Co</font><font style="font-family:Times New Roman;font-size:10pt;">mpany has significant influence,</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">o</font><font style="font-family:Times New Roman;font-size:10pt;">therwise</font><font style="font-family:Times New Roman;font-size:10pt;"> the investment is carried at cost</font><font style="font-family:Times New Roman;font-size:10pt;">. </font><font style="font-family:Times New Roman;font-size:10pt;">I</font><font style="font-family:Times New Roman;font-size:10pt;">ncome from certain entities is reported on a one quarter lag</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">depending on when their financial information is received. </font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">Also included in other long-term investments are loans to unconsolidated real estate entities secured by the equity interests of these real estate entities, which are carried at unpaid principal balances (mezzanine loans).</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">These other long-term investments are considered impaired, and written down to their fair value, when cash flows indicate that the carrying value may not be recoverable. Fair value is generally determined based on a discounted cash flow analysis</font><font style="font-family:Times New Roman;font-size:10pt;">. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Additionally, other long-term investments include interest rate and foreign currency swaps carried at fair value. See Note 12 for information on the Company's accounting policies for these derivative financial instruments.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p> <p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Accounts Payable, Accrued Expenses and Other Liabilities</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Accounts payable, accrued expenses and other liabilities consist principally of </font><font style="font-family:Times New Roman;font-size:10pt;">liabilities for </font><font style="font-family:Times New Roman;font-size:10pt;">pension, other postretirement and postemployment benefits</font><font style="font-family:Times New Roman;font-size:10pt;"> (see Note </font><font style="font-family:Times New Roman;font-size:10pt;">9</font><font style="font-family:Times New Roman;font-size:10pt;">)</font><font style="font-family:Times New Roman;font-size:10pt;">, self-insured </font><font style="font-family:Times New Roman;font-size:10pt;">exposures</font><font style="font-family:Times New Roman;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;">management</font><font style="font-family:Times New Roman;font-size:10pt;"> compensation</font><font style="font-family:Times New Roman;font-size:10pt;"> and various insurance-related </font><font style="font-family:Times New Roman;font-size:10pt;">items</font><font style="font-family:Times New Roman;font-size:10pt;">, including </font><font style="font-family:Times New Roman;font-size:10pt;">experience rated refunds, the minimum </font><font style="font-family:Times New Roman;font-size:10pt;">medical </font><font style="font-family:Times New Roman;font-size:10pt;">loss ratio rebate accrual under Health Care Reform, </font><font style="font-family:Times New Roman;font-size:10pt;">amounts related to reinsurance contracts and insurance-related assessments that management can reasonably estimate. Accounts payable, accrued expenses and other liabilities also include certain overdraft positions and the loss position of certain derivatives</font><font style="font-family:Times New Roman;font-size:10pt;">, primarily </font><font style="font-family:Times New Roman;font-size:10pt;">for </font><font style="font-family:Times New Roman;font-size:10pt;">GMIB </font><font style="font-family:Times New Roman;font-size:10pt;">contracts</font><font style="font-family:Times New Roman;font-size:10pt;"> (see Note </font><font style="font-family:Times New Roman;font-size:10pt;">12</font><font style="font-family:Times New Roman;font-size:10pt;">). Legal costs to defend the Company's litigation and arbitration matters are expensed when incurred</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">in</font><font style="font-family:Times New Roman;font-size:10pt;"> cases </font><font style="font-family:Times New Roman;font-size:10pt;">that</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">the Company cannot reasonably estimate the ultimate cost to defend</font><font style="font-family:Times New Roman;font-size:10pt;">.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">In</font><font style="font-family:Times New Roman;font-size:10pt;"> cases</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">that </font><font style="font-family:Times New Roman;font-size:10pt;">the Company can reasonably estimate the cost to defend, </font><font style="font-family:Times New Roman;font-size:10pt;">these </font><font style="font-family:Times New Roman;font-size:10pt;">costs </font><font style="font-family:Times New Roman;font-size:10pt;">are</font><font style="font-family:Times New Roman;font-size:10pt;"> recognized when the claim is reported.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p> <p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Translation of Foreign Currencies</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company generally conducts its international business through foreign operating entities that maintain assets and liabilities in local currencies, which are generally their functional currencies. The Company uses exchange rates as of the balance sheet date to translate assets and liabilities into U.S. dollars. Translation gains or losses on functional currencies, net of applicable taxes, are recorded in accumulated other </font><font style="font-family:Times New Roman;font-size:10pt;">comprehensive</font><font style="font-family:Times New Roman;font-size:10pt;"> income (loss). The Company uses average </font><font style="font-family:Times New Roman;font-size:10pt;">monthly </font><font style="font-family:Times New Roman;font-size:10pt;">exchange rates during the year to translate revenues and expenses into U.S. dollars. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p> <p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Stock Compensation</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company records compensation expense for stock awards and options over their vesting periods </font><font style="font-family:Times New Roman;font-size:10pt;">primarily </font><font style="font-family:Times New Roman;font-size:10pt;">based on the estimated fair value </font><font style="font-family:Times New Roman;font-size:10pt;">at the grant date. Compensation expense is recorded for</font><font style="font-family:Times New Roman;font-size:10pt;"> stock options</font><font style="font-family:Times New Roman;font-size:10pt;"> over their vesting period based on fair value at the grant date</font><font style="font-family:Times New Roman;font-size:10pt;"> which is calculated using an option-pricing model. Compensation expense is recorded for restricted stock grants and units over their vesting periods based on fair value, which is equal to the market price of the Company's common stock on the date of grant.</font><font style="font-family:Times New Roman;font-size:10pt;"> Compensation expense for str</font><font style="font-family:Times New Roman;font-size:10pt;">ategic performance shares </font><font style="font-family:Times New Roman;font-size:10pt;">is recorded over the performance period. For</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">strategic performance shares </font><font style="font-family:Times New Roman;font-size:10pt;">with</font><font style="font-family:Times New Roman;font-size:10pt;"> payment</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">dependent</font><font style="font-family:Times New Roman;font-size:10pt;"> on </font><font style="font-family:Times New Roman;font-size:10pt;">market condition, fair value is determined at the grant date using a </font><font style="font-family:Times New Roman;font-size:10pt;">Monte Carlo</font><font style="font-family:Times New Roman;font-size:10pt;"> simulation model and not subsequently adjusted regardless of the final outcome. For </font><font style="font-family:Times New Roman;font-size:10pt;">strategic performance shares</font><font style="font-family:Times New Roman;font-size:10pt;"> with </font><font style="font-family:Times New Roman;font-size:10pt;">payment dependent</font><font style="font-family:Times New Roman;font-size:10pt;"> on </font><font style="font-family:Times New Roman;font-size:10pt;">performance conditions, expense is initially accrued based on the most likely outcome, but evaluated for adjustment each period for updates in the expected outcome. At the end of the performance period, expense is </font><font style="font-family:Times New Roman;font-size:10pt;">adjusted</font><font style="font-family:Times New Roman;font-size:10pt;"> to the actual outcome (number of shares awarded times the share price at the grant date).</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p> <p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Income Taxes</font><p>&#160;</p><p><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company and its domestic subsidiaries file a consolidated </font><font style="font-family:Times New Roman;font-size:10pt;">United States</font><font style="font-family:Times New Roman;font-size:10pt;"> federal income tax return. The Company</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;">s foreign subsidiaries file tax returns in accordance with foreign law. </font><font style="font-family:Times New Roman;font-size:10pt;">U.S.</font><font style="font-family:Times New Roman;font-size:10pt;"> taxation of </font><font style="font-family:Times New Roman;font-size:10pt;">these </font><font style="font-family:Times New Roman;font-size:10pt;">foreign </font><font style="font-family:Times New Roman;font-size:10pt;">subsidiaries</font><font style="font-family:Times New Roman;font-size:10pt;"> may differ in timing and amount from taxation under foreign laws. Reportable amounts, including credits for foreign tax paid by th</font><font style="font-family:Times New Roman;font-size:10pt;">ese subsidiaries</font><font style="font-family:Times New Roman;font-size:10pt;">, are reflected in the </font><font style="font-family:Times New Roman;font-size:10pt;">U.S.</font><font style="font-family:Times New Roman;font-size:10pt;"> tax return of the affiliates</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;"> domestic parent. </font></p><p>&#160;</p><p><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company recognizes deferred income taxes when </font><font style="font-family:Times New Roman;font-size:10pt;">the financial statement and tax-</font><font style="font-family:Times New Roman;font-size:10pt;">based carrying values of assets and liabilities are different and recognizes deferred income tax liabilities on the unremitted earnings of foreign subsidiaries</font><font style="font-family:Times New Roman;font-size:10pt;"> that are not permanently invested overseas</font><font style="font-family:Times New Roman;font-size:10pt;">. </font><font style="font-family:Times New Roman;font-size:10pt;">For subsidiaries whose earnings are considered permanently invested overseas, income taxes are accrued at the local foreign tax rate. </font><font style="font-family:Times New Roman;font-size:10pt;"> The Company establishes valuation allowances against deferred tax assets if it is more likely than not that the deferred tax asset will not be realized. The need for a valuation allowance is determined based on the evaluation of various factors, including expectations of future earnings and management's judgment. Note </font><font style="font-family:Times New Roman;font-size:10pt;">19</font><font style="font-family:Times New Roman;font-size:10pt;"> contains detailed information about the Company</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;">s income taxes. </font></p><p>&#160;</p><p>&#160;</p><p>&#160;</p></li></ul><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company recognizes interim period income taxes by estimating an annual effective tax rate and applying it to year-to-date results. The estimated annual effective tax rate is periodically updated throughout the year based on actual results to date and an updated projection of full year income. Although the effective tax rate approach is generally used for interim periods, taxes on significant, unusual and infrequent items are recognized at the statutory tax rate entirely in the period the amounts are realized. </font></p> <p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Other Assets, including Other Intangibles</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Other assets consist of various insurance-related assets</font><font style="font-family:Times New Roman;font-size:10pt;"> and the </font><font style="font-family:Times New Roman;font-size:10pt;">gain</font><font style="font-family:Times New Roman;font-size:10pt;"> position of certain derivatives, primarily GMIB assets</font><font style="font-family:Times New Roman;font-size:10pt;">. The Company's other intangible assets include purchased customer </font><font style="font-family:Times New Roman;font-size:10pt;">and producer </font><font style="font-family:Times New Roman;font-size:10pt;">relationships, provider networks, and trademarks. The Company amortizes other intangibles on a</font><font style="font-family:Times New Roman;font-size:10pt;">n accelerated or</font><font style="font-family:Times New Roman;font-size:10pt;"> straight-line</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">basis over periods from 1 to </font><font style="font-family:Times New Roman;font-size:10pt;">30</font><font style="font-family:Times New Roman;font-size:10pt;"> years. Management revises amortization periods if it believes there has been a change in the length of time that an intangible asset will continue to have value.</font><font style="font-family:Times New Roman;font-size:10pt;"> Costs incurred to renew or extend the terms of these intangible assets are g</font><font style="font-family:Times New Roman;font-size:10pt;">enerally expensed as incurred</font><font style="font-family:Times New Roman;font-size:10pt;">.</font><font style="font-family:Times New Roman;font-size:10pt;"> See Note 8 for additional information.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p> <p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Derivative financial instruments.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">The Company applies hedge accounting when derivatives are designated, qualify and are highly effective as hedges. Effectiveness is formally assessed and documented at inception and each period throughout the life of a hedge using various quantitative methods appropriate for each hedge, including regression analysis and dollar offset. Under hedge accounting, the changes in fair value of the derivative and the hedged risk are generally recognized together and offset each other when reported in shareholders' net income.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company accounts for derivative instruments as follows:</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li><font style="font-family:Times New Roman;font-size:10pt;">Derivatives are reported on the balance sheet at fair value with changes in fair values reported in shareholders</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;"> net income or accumulated other comprehensive income.</font></li><li><font style="font-family:Times New Roman;font-size:10pt;">Changes in the fair value of derivatives that hedge market risk related to future cash flows and that qualify for hedge accounting are reported in a separate caption in accumulated other comprehensive income. These hedges are referred to as cash flow hedges. </font></li><li><font style="font-family:Times New Roman;font-size:10pt;">A change in the fair value of a derivative instrument may not always equal the change in the fair value of the hedged item; this difference is referred to as hedge ineffectiveness. Where hedge accounting is used, the Company reflects hedge ineffectiveness in shareholders' net income (generally as part of realized investment gains and losses). </font></li><li><font style="font-family:Times New Roman;font-size:10pt;">On early termination, the fair value of derivatives that qualified</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">for hedge accounting are reported in shareholders' net income.</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p> <p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Investment gains and losses.</font><font style="font-family:Times New Roman;font-size:10pt;"> Realized investment gains and losses result from sales, investment asset write-downs, changes in the fair values of</font><font style="font-family:Times New Roman;font-size:10pt;"> trading and </font><font style="font-family:Times New Roman;font-size:10pt;">hybrid securities and certain derivatives</font><font style="font-family:Times New Roman;font-size:10pt;">,</font><font style="font-family:Times New Roman;font-size:10pt;"> changes in valuation reserves</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">and</font><font style="font-family:Times New Roman;font-size:10pt;"> prepayment penalties on fixed maturities</font><font style="font-family:Times New Roman;font-size:10pt;">,</font><font style="font-family:Times New Roman;font-size:10pt;"> based on specifically identified assets. Realized investment gains and losses on the disposition of certain directly owned real estate investments are eliminated from ongoing operations and reported in discontinued operations when the operations and cash flows of the underlying assets are clearly distinguishable and the Company has no significant continuing involvement in the</font><font style="font-family:Times New Roman;font-size:10pt;">ir</font><font style="font-family:Times New Roman;font-size:10pt;"> operations. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Unrealized gains and losses on fixed maturities and equity securities carried at fair value (excluding trading and hybrid securities) and certain derivatives are included in accumulated other comprehensive income (loss), net of: </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">amounts required to adjust future policy benefits</font><font style="font-family:Times New Roman;font-size:10pt;"> for</font><font style="font-family:Times New Roman;font-size:10pt;"> the</font><font style="font-family:Times New Roman;font-size:10pt;"> run-off settlement annuity business</font><font style="font-family:Times New Roman;font-size:10pt;">; and</font></li><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">deferred income taxes.</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p> <p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Net investment income.</font><font style="font-family:Times New Roman;font-size:10pt;"> When interest and principal payments on investments are current, the Company recognizes interest income when it is earned. The Company stops recognizing interest income when interest payments are delinquent</font><font style="font-family:Times New Roman;font-size:10pt;"> based on contractual terms</font><font style="font-family:Times New Roman;font-size:10pt;"> or when certain terms (interest rate or maturity date) of the investment have been restructured. Net investment income on these investments is only recognized when interest payments are actually received. </font><font style="font-family:Times New Roman;font-size:10pt;"> Interest and dividends on trading and hybrid securities </font><font style="font-family:Times New Roman;font-size:10pt;">and prepayment penalties on mortgage loans </font><font style="font-family:Times New Roman;font-size:10pt;">are included in net investment income</font><font style="font-family:Times New Roman;font-size:10pt;"> when </font><font style="font-family:Times New Roman;font-size:10pt;">they are </font><font style="font-family:Times New Roman;font-size:10pt;">earned</font><font style="font-family:Times New Roman;font-size:10pt;">.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p> <p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Short-term investments. </font><font style="font-family:Times New Roman;font-size:10pt;">Investments with maturities of greater than 90 days but less than one year from time of purchase are classified as short-term, available for sale and carried at fair value, which approximates cost.</font></p> <p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:36px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Cash and Cash Equivalents</font><p>&#160;</p><p><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Cash equivalents consist of short-term investments w</font><font style="font-family:Times New Roman;font-size:10pt;">ith</font><font style="font-family:Times New Roman;font-size:10pt;"> matur</font><font style="font-family:Times New Roman;font-size:10pt;">ities</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">of</font><font style="font-family:Times New Roman;font-size:10pt;"> three months or less from the time of purchase</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">that are </font><font style="font-family:Times New Roman;font-size:10pt;">classified as held to maturity and carried at amortized cost</font><font style="font-family:Times New Roman;font-size:10pt;">. The Company reclassifi</font><font style="font-family:Times New Roman;font-size:10pt;">es cash overdraft positions to </font><font style="font-family:Times New Roman;font-size:10pt;">accounts payable, accrued </font><font style="font-family:Times New Roman;font-size:10pt;">expenses and other liabilities </font><font style="font-family:Times New Roman;font-size:10pt;">when the legal right of offset does not exist.</font></p></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p> <p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;margin-left:0px;">Deferred Policy Acquisition Costs</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Acquisition costs include sales compensation, commissions,</font><font style="font-family:Times New Roman;font-size:10pt;"> direct response marketing, telemarketing,</font><font style="font-family:Times New Roman;font-size:10pt;"> premium taxes and other costs that the Company incurs in connection with new and renewal business. Depending on the product line they relate to, the Company records acquisition costs in different ways. Acquisition costs for:</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;">Universal life products</font><font style="font-family:Times New Roman;font-size:10pt;"> are deferred and amortized in proportion to the present value of total estimated gross profits over the expected lives of the contracts.</font></li><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;">Supplemental health</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;">, life and accident&#160;insurance (</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;">primarily&#160;individual international&#160;products) and group health&#160;and accident&#160;insurance products</font><font style="font-family:Arial;font-size:10pt;">&#160;</font><font style="font-family:Times New Roman;font-size:10pt;">are deferred and amortized, generally in proportion to the ratio of periodic revenue to the estimated total revenues over the contract periods.</font></li><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;">Other products</font><font style="font-family:Times New Roman;font-size:10pt;"> are expensed as incurred.</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">For universal life</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">and other individual products, management estimates the present value of future revenues less expected payments. For group health </font><font style="font-family:Times New Roman;font-size:10pt;">and accident insurance </font><font style="font-family:Times New Roman;font-size:10pt;">products, management estimates the sum of </font><font style="font-family:Times New Roman;font-size:10pt;">unearned premiums and anticipated net investment income </font><font style="font-family:Times New Roman;font-size:10pt;">less </font><font style="font-family:Times New Roman;font-size:10pt;">future expected claims and related costs. If management's estimates </font><font style="font-family:Times New Roman;font-size:10pt;">of these sums </font><font style="font-family:Times New Roman;font-size:10pt;">are less than the deferred costs, the Company reduces deferred policy acquisition</font><font style="font-family:Times New Roman;font-size:10pt;"> costs and records an expense. </font><font style="font-family:Times New Roman;font-size:10pt;">The Company recorded amortization for policy acquisition costs of $</font><font style="font-family:Times New Roman;font-size:10pt;">3</font><font style="font-family:Times New Roman;font-size:10pt;">3</font><font style="font-family:Times New Roman;font-size:10pt;">4</font><font style="font-family:Times New Roman;font-size:10pt;"> million in </font><font style="font-family:Times New Roman;font-size:10pt;">2011</font><font style="font-family:Times New Roman;font-size:10pt;">, $</font><font style="font-family:Times New Roman;font-size:10pt;">312 </font><font style="font-family:Times New Roman;font-size:10pt;">million in </font><font style="font-family:Times New Roman;font-size:10pt;">2010</font><font style="font-family:Times New Roman;font-size:10pt;"> and $</font><font style="font-family:Times New Roman;font-size:10pt;">299</font><font style="font-family:Times New Roman;font-size:10pt;"> million in </font><font style="font-family:Times New Roman;font-size:10pt;">2009</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">in other operating expenses</font><font style="font-family:Times New Roman;font-size:10pt;">. There are no deferred policy acquisition costs attributable to the </font><font style="font-family:Times New Roman;font-size:10pt;">sold </font><font style="font-family:Times New Roman;font-size:10pt;">individual life insurance and annuity</font><font style="font-family:Times New Roman;font-size:10pt;"> and</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">retirement </font><font style="font-family:Times New Roman;font-size:10pt;">businesses </font><font style="font-family:Times New Roman;font-size:10pt;">or </font><font style="font-family:Times New Roman;font-size:10pt;">the </font><font style="font-family:Times New Roman;font-size:10pt;">run-off reinsurance </font><font style="font-family:Times New Roman;font-size:10pt;">and settlement </font><font style="font-family:Times New Roman;font-size:10pt;">annuity</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">operations. </font><font style="font-family:Times New Roman;font-size:10pt;">The accounting for acquisition costs will change in 2012. See Recent Accounting Pronouncements for additional information.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p> <p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Property and Equipment </font><p>&#160;</p><p><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Property and equipment is carried at cost less accumulated depreciation. When applicable, cost includes interest, real estate taxes and other costs incurred during construction. Also included in this category is internal-use software that is acquired, developed or modified solely to meet the Company's internal needs, with no plan to market externally. Costs directly related to acquiring, developing or modifying internal-use software are capitalized</font><font style="font-family:Times New Roman;font-size:10pt;">.</font></p><p>&#160;</p><p><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">T</font><font style="font-family:Times New Roman;font-size:10pt;">he Company calculates depreciation and amortization principally using the straight-line method </font><font style="font-family:Times New Roman;font-size:10pt;">generally </font><font style="font-family:Times New Roman;font-size:10pt;">based on the esti</font><font style="font-family:Times New Roman;font-size:10pt;">mated useful life of each asset</font><font style="font-family:Times New Roman;font-size:10pt;"> as follows: buildings and im</font><font style="font-family:Times New Roman;font-size:10pt;">provements, </font><font style="font-family:Times New Roman;font-size:10pt;">10</font><font style="font-family:Times New Roman;font-size:10pt;"> to 40 years; </font><font style="font-family:Times New Roman;font-size:10pt;">purchased </font><font style="font-family:Times New Roman;font-size:10pt;">software, </font><font style="font-family:Times New Roman;font-size:10pt;">one</font><font style="font-family:Times New Roman;font-size:10pt;"> to </font><font style="font-family:Times New Roman;font-size:10pt;">five</font><font style="font-family:Times New Roman;font-size:10pt;"> years</font><font style="font-family:Times New Roman;font-size:10pt;">; internally developed software</font><font style="font-family:Times New Roman;font-size:10pt;">,</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">three</font><font style="font-family:Times New Roman;font-size:10pt;"> to </font><font style="font-family:Times New Roman;font-size:10pt;">seven</font><font style="font-family:Times New Roman;font-size:10pt;"> years</font><font style="font-family:Times New Roman;font-size:10pt;">;</font><font style="font-family:Times New Roman;font-size:10pt;"> and</font><font style="font-family:Times New Roman;font-size:10pt;"> furniture and equipment (including computer equipment</font><font style="font-family:Times New Roman;font-size:10pt;">)</font><font style="font-family:Times New Roman;font-size:10pt;">,</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">three</font><font style="font-family:Times New Roman;font-size:10pt;"> to 10 years</font><font style="font-family:Times New Roman;font-size:10pt;">.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">Improvements to leased facilities are depreciated over the remaining lease term or the estimated life of the improvement. </font><font style="font-family:Times New Roman;font-size:10pt;">The Company considers events and circumstances that would indicate the carrying value of property, equipment or capitalized software might not be recoverable. </font><font style="font-family:Times New Roman;font-size:10pt;">If the Company determines the carrying value of a long-lived asset is not recoverable, an impairment charge is recorded.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">See Note 8 for additional information.</font></p></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p> <p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Goodwill </font><p>&#160;</p></li></ul><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Goodwill represents the excess of the cost of businesses acquired over the fair value of their net assets. Goodwill primarily relates to the Health Care segment ($</font><font style="font-family:Times New Roman;font-size:10pt;">2.9</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">b</font><font style="font-family:Times New Roman;font-size:10pt;">illion) and, to a lesser extent, the International segment ($</font><font style="font-family:Times New Roman;font-size:10pt;">290</font><font style="font-family:Times New Roman;font-size:10pt;"> million). The Company evaluates goodwill for impairment </font><font style="font-family:Times New Roman;font-size:10pt;">at least </font><font style="font-family:Times New Roman;font-size:10pt;">annually during the third quarter at the reporting unit level, based on discounted cash flow analyses and writes it down through results of operations if impaired. Consistent with prior years, the Company's evaluations of goodwill associated with the Health Care </font><font style="font-family:Times New Roman;font-size:10pt;">and International </font><font style="font-family:Times New Roman;font-size:10pt;">segment</font><font style="font-family:Times New Roman;font-size:10pt;">s</font><font style="font-family:Times New Roman;font-size:10pt;"> used the best information available at the time, including reasonable assumptions and projections consistent with those used in its annual planning process. The discounted cash flow analyses used a range of discount rates that correspond wi</font><font style="font-family:Times New Roman;font-size:10pt;">th the Company's, or, in the case of International, the reporting unit's </font><font style="font-family:Times New Roman;font-size:10pt;">weighted average cost of capital, consistent with that used for investment decisions considering the specific and detailed operating plans and strategies within the segment</font><font style="font-family:Times New Roman;font-size:10pt;"> or reporting unit</font><font style="font-family:Times New Roman;font-size:10pt;">. The resulting discounted cash flow analysis indicated an estimated fair value for the Health Care segment&#160;</font><font style="font-family:Times New Roman;font-size:10pt;">and International's reporting unit </font><font style="font-family:Times New Roman;font-size:10pt;">exceeding </font><font style="font-family:Times New Roman;font-size:10pt;">their</font><font style="font-family:Times New Roman;font-size:10pt;"> carrying value</font><font style="font-family:Times New Roman;font-size:10pt;">s</font><font style="font-family:Times New Roman;font-size:10pt;">, including goodwill and other intangibles. Finally, the Company determined that no events or circumstances occurred subsequent to the annual evaluation of goodwill that would more likely than not reduce the fair value of </font><font style="font-family:Times New Roman;font-size:10pt;">the Health Care segment or International's</font><font style="font-family:Times New Roman;font-size:10pt;"> reporting unit</font><font style="font-family:Times New Roman;font-size:10pt;"> below </font><font style="font-family:Times New Roman;font-size:10pt;">their</font><font style="font-family:Times New Roman;font-size:10pt;"> carrying value</font><font style="font-family:Times New Roman;font-size:10pt;">s</font><font style="font-family:Times New Roman;font-size:10pt;">. </font><font style="font-family:Times New Roman;font-size:10pt;">See Note 8 for additional information.</font><font style="font-family:Times New Roman;font-size:10pt;">&#160;</font></p> <p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;margin-left:0px;">Separate Account Assets and Liabilities</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Separate account assets and liabilities are contractholder funds maintained in accounts with specific investment objectives. The assets of these accounts are legally segregated and are not subject to claims that arise out of any of the Company's other businesses. These separate account assets are carried at fair value with equal amounts for related separate account liabilities. The investment income, gains and losses of these accounts generally accrue to the contractholders and</font><font style="font-family:Times New Roman;font-size:10pt;">, together with their deposits and withdrawals, </font><font style="font-family:Times New Roman;font-size:10pt;">are </font><font style="font-family:Times New Roman;font-size:10pt;">ex</font><font style="font-family:Times New Roman;font-size:10pt;">cluded </font><font style="font-family:Times New Roman;font-size:10pt;">from</font><font style="font-family:Times New Roman;font-size:10pt;"> the Company's </font><font style="font-family:Times New Roman;font-size:10pt;">Consolidated Statements of Income and Cash Flows</font><font style="font-family:Times New Roman;font-size:10pt;">. </font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">Fees earned for asset management services are reported in premiums and fees.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p> <p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;margin-left:0px;">Contractholder Deposit Funds</font></p><p style='margin-top:5pt; margin-bottom:5pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Liabilities for contractholder deposit funds primarily include deposits received from customers for investment-related and universal life products and investment earnings on their fund balances. These liabilities are adjusted to reflect administrative charges and, for universal life fund balances, mortality charges. In addition, this caption includes premium stabilization reserves that are insurance experience refunds for group contracts that are left with the Company to pay future premiums, deposit administration funds that are used to fund nonpension retiree insurance programs, retained asset accounts and annuities or supplementary contracts without significant life contingencies. Interest credited on these funds is accrued ratably over the contract period. </font></p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;">&#160;</li></ul> <p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Future Policy Benefits </font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Future policy benefits are liabilities for the present value of estimated future obligations under long-term life and supplemental health insurance policies and annuity products currently in force. These obligations are estimated using actuarial methods and primarily consist of reserves for annuity contracts, life insurance benefits, guaranteed minimum death benefit</font><font style="font-family:Times New Roman;font-size:10pt;"> (&#8220;GMDB&#8221;)</font><font style="font-family:Times New Roman;font-size:10pt;"> contracts and certain life, accident and health insurance products in our International operations.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Obligations for annuities represent specified periodic benefits to be paid to an individual or groups of individuals over their remaining lives. Obligations for life insurance policies represent benefits to be paid to policyholders, net of future premiums to be received. Management estimates these obligations based on assumptions as to premiums, interest rates, mortality and surrenders, allowing for adverse deviation. Mortality, morbidity, and surrender assumptions are based on either the Company's own experience or actuarial tables. Interest rate assumptions are based on management's judgment considering the Company's experience and future expectations, and range fro</font><font style="font-family:Times New Roman;font-size:10pt;">m </font><font style="font-family:Times New Roman;font-size:10pt;">1</font><font style="font-family:Times New Roman;font-size:10pt;">% to </font><font style="font-family:Times New Roman;font-size:10pt;">10</font><font style="font-family:Times New Roman;font-size:10pt;">%. Obligations for </font><font style="font-family:Times New Roman;font-size:10pt;">the run-off settlement </font><font style="font-family:Times New Roman;font-size:10pt;">annuit</font><font style="font-family:Times New Roman;font-size:10pt;">y business</font><font style="font-family:Times New Roman;font-size:10pt;"> include adjustments for investment</font><font style="font-family:Times New Roman;font-size:10pt;"> returns consistent with requirements of GAAP when a premium deficiency exists. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Certain reinsurance contracts</font><font style="font-family:Times New Roman;font-size:10pt;"> contain</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">GMDB</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">under variable annuities issued by other insurance companies. These obligations represent the guaranteed death benefit in excess of the contractholder's account values (based on underlying equity and bond mutual fund investments). These obligations are estimated based on assumptions regarding lapse, partial surrenders, mortality, interest rates (mean investment performance and discount rate), market volatility as well as investment returns and premiums, consistent with the requirements of </font><font style="font-family:Times New Roman;font-size:10pt;">GAAP</font><font style="font-family:Times New Roman;font-size:10pt;"> when a premium deficiency exists. Lapse, partial surrenders, mortality, interest rates and volatility are based on management's judgment considering the Company's experience and future expectations. The results of futures </font><font style="font-family:Times New Roman;font-size:10pt;">and swap </font><font style="font-family:Times New Roman;font-size:10pt;">contracts </font><font style="font-family:Times New Roman;font-size:10pt;">used in the GMDB equity </font><font style="font-family:Times New Roman;font-size:10pt;">and growth interest rate </font><font style="font-family:Times New Roman;font-size:10pt;">hedge program</font><font style="font-family:Times New Roman;font-size:10pt;">s</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">are reflected in the liability calculation as a component of investment returns. See also Note </font><font style="font-family:Times New Roman;font-size:10pt;">6</font><font style="font-family:Times New Roman;font-size:10pt;"> for additional information.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p> <p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Unpaid Claims and Claims Expenses </font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Liabilities for unpaid claims and claim expenses are estimates of payments to be made under insurance coverages (primarily long-term disability, workers' compensation and life and health) for reported claims and for losses incurred but not yet reported. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company develops these estimates for losses incurred but not yet reported using actuarial principles and assumptions based on historical and projected claim incidence patterns, claim size</font><font style="font-family:Times New Roman;font-size:10pt;">, subrogation recoveries</font><font style="font-family:Times New Roman;font-size:10pt;"> and the length of time over which payments are expected to be made. The Company consistently applies these actuarial principles and assumptions each reporting period, with consideration given to the variability of these factors, and recognizes the actuarial best estimate of the ultimate liability within a level of confidence, as required by actuarial standards of practice, which require that the liabilities be adequate under moderately adverse conditions.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;">s estimate of the liability for disability claims reported but not yet paid is primarily calculated as the present value of expected benefit payments to be made over the estimated time period that a policyholder remains disabled. The Company estimates the expected time period that a policyholder may be disabled by analyzing the rate at which an open claim is expected to close (claim resolution rate). Claim resolution rates may vary based upon the length of time a policyholder is disabled, the covered benefit period, cause of disability, benefit design and the policyholder</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;">s age, gender and income level. The Company uses historical resolution rates combined with an analysis of current trends and operational factors to develop current estimates of resolution rates</font><font style="font-family:Times New Roman;font-size:10pt;">. </font><font style="font-family:Times New Roman;font-size:10pt;">The reserve for the gross monthly disability benefits due to a policyholder </font><font style="font-family:Times New Roman;font-size:10pt;">is</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">reduced</font><font style="font-family:Times New Roman;font-size:10pt;"> (</font><font style="font-family:Times New Roman;font-size:10pt;">offset</font><font style="font-family:Times New Roman;font-size:10pt;">)</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">by the income that the policyholder receives under other benefit programs, such as Social Security Disability Income, workers</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;"> compensation, statutory disability or other group disability benefit plans. For awards of such offsets that have not been finalized, the Company estimates the probability and amount of the offset based on the Company</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;">s experience over the past three to five years.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">T</font><font style="font-family:Times New Roman;font-size:10pt;">he Company discounts certain claim liabilities related to group long-term disability and workers' compensation</font><font style="font-family:Times New Roman;font-size:10pt;"> because b</font><font style="font-family:Times New Roman;font-size:10pt;">enefit payments may be made over</font><font style="font-family:Times New Roman;font-size:10pt;"> e</font><font style="font-family:Times New Roman;font-size:10pt;">xtended period</font><font style="font-family:Times New Roman;font-size:10pt;">s</font><font style="font-family:Times New Roman;font-size:10pt;">. Discount rate assumptions are based on projected investment returns for the asset portfolios that support these liabilities and range from </font><font style="font-family:Times New Roman;font-size:10pt;">3.80</font><font style="font-family:Times New Roman;font-size:10pt;">% to </font><font style="font-family:Times New Roman;font-size:10pt;">6</font><font style="font-family:Times New Roman;font-size:10pt;">.25</font><font style="font-family:Times New Roman;font-size:10pt;">%. When estimates change, the Company records the adjustment in benefits and expenses in the period in which the change in estimate is identified. Discounted liabilities associated with the long-term disability and certain workers' compensation businesses were $</font><font style="font-family:Times New Roman;font-size:10pt;">3.</font><font style="font-family:Times New Roman;font-size:10pt;">2</font><font style="font-family:Times New Roman;font-size:10pt;"> billion at </font><font style="font-family:Times New Roman;font-size:10pt;">December 31, 2011</font><font style="font-family:Times New Roman;font-size:10pt;"> and</font><font style="font-family:Times New Roman;font-size:10pt;"> $3.1 billion at</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">December 31, 2010</font><font style="font-family:Times New Roman;font-size:10pt;">.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p> <p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;margin-left:0px;">Health Care Medical Claims Payable</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Medical claims payable for the Health Care segment include both reported claims and estimates for losses incurred but not yet reported.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">The Company develops estimates for Health Care medical claims payable using actuarial principles and assumptions consistently applied each reporting period, and recognizes the actuarial best estimate of the ultimate liability within a level of confidence, as required by actuarial standards of practice, which require that the liabilities be adequate under moderately adverse conditions. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The liability </font><font style="font-family:Times New Roman;font-size:10pt;">is primarily calculated using &#8220;completion factors&#8221; (a measure of the time to process claims), which are developed by comparing the date claims were incurred, generally the date services were provided, </font><font style="font-family:Times New Roman;font-size:10pt;">to the date claims were paid. </font><font style="font-family:Times New Roman;font-size:10pt;">The Company uses historical completion factors combined with an analysis of current trends and operational factors to develop current estimates of completion factors. The Company estimates the liability for claims incurred in each month by applying the current estimates of completion factors to the current paid claims data. This approach implicitly assumes that historical completion rates will be a useful indicator for the current period. It is possible that the actual completion rates for the current period will develop differently from historical patterns, which could have a material impact on the Company</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;">s medical claims payable and </font><font style="font-family:Times New Roman;font-size:10pt;">shareholders' </font><font style="font-family:Times New Roman;font-size:10pt;">net income.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Completion factors are impacted by several key items including changes in: 1) electronic (auto-adjudication) versus manual claim processing, 2) provider claims submission rates, 3) membership and 4) the mix of products. As noted, the Company uses historical completion factors combined with an analysis of current trends and operational factors to develop current estimates of completion factors. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">In addition, for the more recent months, the Company also relies on medical cost trend analysis, which reflects expected claim payment patterns and other relevant operational considerations. Medical cost trend is primarily impacted by medical service utilization and unit costs, which are affected by changes in the level and mix of medical benefits offered, including inpatient, outpatient and pharmacy, the impact of copays and deductibles, changes in provider practices and changes in consumer demographics and consumption behavior. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Despite reflecting both historical and emerging trends in setting reserves, it is possible that the actual medical trend for the current period will develop differently from expect</font><font style="font-family:Times New Roman;font-size:10pt;">ations</font><font style="font-family:Times New Roman;font-size:10pt;">, which could have a material impact on the Company</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;">s medical claims payable and </font><font style="font-family:Times New Roman;font-size:10pt;">shareholders' </font><font style="font-family:Times New Roman;font-size:10pt;">net income.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">For each reporting period, the Company evaluates key assumptions by comparing the assumptions used in establishing the medical claims payable to actual experience. </font><font style="font-family:Times New Roman;font-size:10pt;">When actual experience differs from the assumptions used in establishing the liability, medical claims payable are increased or decreased through current period </font><font style="font-family:Times New Roman;font-size:10pt;">shareholders'</font><font style="font-family:Times New Roman;font-size:8pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">net income. </font><font style="font-family:Times New Roman;font-size:10pt;"> Additionally, the Company evaluates expected future developments and emerging trends which may impact key assumptions.</font><font style="font-family:Times New Roman;font-size:10pt;"> The estimation process involves considerable judgment, reflecting the variability inherent in forecasting future claim payments. These estimates are highly sensitive to changes in the Company</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;">s key assumptions, specifically completion factors, and medical cost trends.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p> <p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Participating Business</font><p>&#160;</p><p><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company's participating life insurance policies entitle policyholders to earn dividends that represent a portion of the earnings of the Company's life insurance subsidiaries. Participating insuran</font><font style="font-family:Times New Roman;font-size:10pt;">ce accoun</font><font style="font-family:Times New Roman;font-size:10pt;">ted for approximately 1</font><font style="font-family:Times New Roman;font-size:10pt;">% </font><font style="font-family:Times New Roman;font-size:10pt;">of the Company's total life insurance in force at the end of </font><font style="font-family:Times New Roman;font-size:10pt;">2011</font><font style="font-family:Times New Roman;font-size:10pt;">,</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">2010</font><font style="font-family:Times New Roman;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;">2009</font><font style="font-family:Times New Roman;font-size:10pt;">. </font></p><p>&#160;</p></li><li style="margin-left:18px;">&#160;</li></ul> <p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Earnings Per Share</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company computes basic earnings per share using the weighted-average number of unrestricted common and deferred shares outstanding. Diluted earnings per share also includes the dilutive effect of outstanding employee stock options and unvested restricted stock granted after 2009 using the treasury stock method and the effect of strategic performance shares.</font></p> <p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Premiums and Fees, Revenues and Related Expenses</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Premiums for </font><font style="font-family:Times New Roman;font-size:10pt;">group</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">life, accident and health insurance and managed care coverages are recognized as revenue on a pro rata basis over the contract period. Benefits and expenses are recognized when incurred.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">Premiums and fees include revenue from experience-rated contracts </font><font style="font-family:Times New Roman;font-size:10pt;">that</font><font style="font-family:Times New Roman;font-size:10pt;"> is based on the estimated ultimate claim, and in some cases, administrative cost experience of the contract. For these contracts, premium revenue includes an adjustment for experience-rated refunds which is calculated </font><font style="font-family:Times New Roman;font-size:10pt;">according to contract terms </font><font style="font-family:Times New Roman;font-size:10pt;">and </font><font style="font-family:Times New Roman;font-size:10pt;">using the customer's experience (including estimates of incurred but not reported claims)</font><font style="font-family:Times New Roman;font-size:10pt;">.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;"> Beginning in 2011, premium revenue also includes an adjustment to reflect the estimated effect of rebates due to customers under the minimum </font><font style="font-family:Times New Roman;font-size:10pt;">medical </font><font style="font-family:Times New Roman;font-size:10pt;">loss ratio provisions of Health Care Reform. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Premiums for</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">individual life</font><font style="font-family:Times New Roman;font-size:10pt;">, accident and health</font><font style="font-family:Times New Roman;font-size:10pt;"> insurance and annuity products, excluding universal life and investment-related products,</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">are recognized as revenue when due. Benefits and expenses are matched with premiums.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Premiums and fees received for</font><font style="font-family:Times New Roman;font-size:10pt;"> the Company's</font><font style="font-family:Times New Roman;font-size:10pt;"> Medicare Advantage Plans and Medicare Part D products from customers and the Centers for Medicare and Medicaid Services (CMS) are recognized as revenue ratably over the contract period. CMS provides risk adjusted premium payments for the Medicare Advantage Plans and Medicare Part D products, based on the demographics and health severity of enrollees. The Company recognizes periodic changes to risk adjusted premiums as revenue when the amounts are determinable and collection is reasonably assured. Additionally, Medicare Part D includes payments from CMS for risk sharing adjustments. The risk sharing adjustments, </font><font style="font-family:Times New Roman;font-size:10pt;">that</font><font style="font-family:Times New Roman;font-size:10pt;"> are estimated quarterly based on claim experience, compare actual incurred drug benefit costs to estimated costs submitted in original contracts and may result in more or less revenue from CMS. Final revenue adjustments are determined through an annual settlement with CMS that occurs after the contract year.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Revenue for investment-related products is recognized as follows:</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">Net investment income on assets supporting investment-related products is recognized as earned. </font></li><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">Contract fees, which are based upon related administrative expenses, are recognized in premiums and fees as they are earned ratably over the contract period.</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Benefits and expenses for investment-related products consist primarily of income credited to policyholders in accordance with contract provisions.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Revenue for universal life products is recognized as follows:</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">Net investment income on assets supporting universal life products is recognized as earned.</font></li><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">Fees for mortality</font><font style="font-family:Times New Roman;font-size:10pt;"> and surrender charges</font><font style="font-family:Times New Roman;font-size:10pt;"> are recognized as assessed, which is as earned.</font></li><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">Administration fees are recognized as services are provided.</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Benefits and expenses for universal life products consist of benefit claims in excess of policyholder account balances. Expenses are recognized when claims are submitted, and income is credited</font><font style="font-family:Times New Roman;font-size:10pt;"> to policyholders</font><font style="font-family:Times New Roman;font-size:10pt;"> in accordance with contract provisions. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Contract fees and expenses for administrative services only programs and pharmacy programs and services are recognized as services are provided. Mail order pharmacy revenues and cost of goods sold are recognized as each prescription is shipped.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p> January 31, 2012 HealthSpring, Inc. December 2011 FristAssist Group Holdings Limited 2010-12-01 sale -20000000 -31000000 18000000 essentially exited 190000000 August 31, 2010 412000000 15 210000000 Vanbreda International NV 55 3800000000 115000000 58000000 not material 56000000 International segment Run-off Reinsurance segment Disability and Life segment 11000000 International segment not material 1.9 <p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;">Note 3 &#8212; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">A</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">cquisitions</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">and Dispositions</font><font style="font-family:Times New Roman;font-size:12pt;"> </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company may from time to time acquire or dispose of assets, subsidiaries or lines of business.&#160;&#160;Significant transactions are described below.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:37.8px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Acqui</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">sition of</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"> HealthSpring, Inc.</font><p>&#160;</p><p><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">On </font><font style="font-family:Times New Roman;font-size:10pt;">January 31</font><font style="font-family:Times New Roman;font-size:10pt;">, 2012</font><font style="font-family:Times New Roman;font-size:10pt;"> the Company </font><font style="font-family:Times New Roman;font-size:10pt;">acquired </font><font style="font-family:Times New Roman;font-size:10pt;">all of the outstanding shares of HealthSpring, Inc. (&#8220;HealthSpring&#8221;) for $55 per share in cash</font><font style="font-family:Times New Roman;font-size:10pt;"> and Cigna stock awards</font><font style="font-family:Times New Roman;font-size:10pt;">, representing an estimated cost of approximately $</font><font style="font-family:Times New Roman;font-size:10pt;">3.</font><font style="font-family:Times New Roman;font-size:10pt;">8</font><font style="font-family:Times New Roman;font-size:10pt;"> billion. HealthSpring provides Medicare Advantage coverage in 11 states and </font><font style="font-family:Times New Roman;font-size:10pt;">the </font><font style="font-family:Times New Roman;font-size:10pt;">District of Columbia</font><font style="font-family:Times New Roman;font-size:10pt;">,</font><font style="font-family:Times New Roman;font-size:10pt;"> as well as a large, national stand-alone Medicare prescription drug business. </font><font style="font-family:Times New Roman;font-size:10pt;">The Company </font><font style="font-family:Times New Roman;font-size:10pt;">funded</font><font style="font-family:Times New Roman;font-size:10pt;"> the acquisition with internal cash resources</font><font style="font-family:Times New Roman;font-size:10pt;">, including cash generated from the issuance of commercial paper in 2012,</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">as well as </font><font style="font-family:Times New Roman;font-size:10pt;">$2.1 billion of additional debt and $</font><font style="font-family:Times New Roman;font-size:10pt;">650</font><font style="font-family:Times New Roman;font-size:10pt;"> million of new equity issued during the fourth quarter of 2011</font><font style="font-family:Times New Roman;font-size:10pt;"> ($629 million net of underwriting discount and fees)</font><font style="font-family:Times New Roman;font-size:10pt;">.</font></p><p><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"> </font></p></li><li style="margin-left:37.8px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Acquisition of FirstAssist</font><p>&#160;</p><p><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">In </font><font style="font-family:Times New Roman;font-size:10pt;">Nov</font><font style="font-family:Times New Roman;font-size:10pt;">e</font><font style="font-family:Times New Roman;font-size:10pt;">mber 2011</font><font style="font-family:Times New Roman;font-size:10pt;">, the Company acquired FirstAssist Group Holdings Limited (&#8220;FirstAssist&#8221;) for approximately $</font><font style="font-family:Times New Roman;font-size:10pt;">11</font><font style="font-family:Times New Roman;font-size:10pt;">5</font><font style="font-family:Times New Roman;font-size:10pt;"> million,</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">using available cash on hand. FirstAssist is based in the </font><font style="font-family:Times New Roman;font-size:10pt;">United Kingdom</font><font style="font-family:Times New Roman;font-size:10pt;"> and provides travel and protection insurance services that </font><font style="font-family:Times New Roman;font-size:10pt;">the Company expects will enhance its individual business in the </font><font style="font-family:Times New Roman;font-size:10pt;">U.K.</font><font style="font-family:Times New Roman;font-size:10pt;"> and around the world.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font></p><p>&#160;</p><p><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">In accordance with GAAP, the total purchase price has been allocated</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">to the tangible and intangible net assets acquired based on management's </font><font style="font-family:Times New Roman;font-size:10pt;">preliminary </font><font style="font-family:Times New Roman;font-size:10pt;">estimates of their fair values</font><font style="font-family:Times New Roman;font-size:10pt;"> and may change when appraisals are finalized and as additional information becomes available over the next several months.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">Accordingly, approximately $</font><font style="font-family:Times New Roman;font-size:10pt;">5</font><font style="font-family:Times New Roman;font-size:10pt;">8</font><font style="font-family:Times New Roman;font-size:10pt;"> million was allocated to intangible assets, </font><font style="font-family:Times New Roman;font-size:10pt;">while</font><font style="font-family:Times New Roman;font-size:10pt;"> $</font><font style="font-family:Times New Roman;font-size:10pt;">5</font><font style="font-family:Times New Roman;font-size:10pt;">6 </font><font style="font-family:Times New Roman;font-size:10pt;">million </font><font style="font-family:Times New Roman;font-size:10pt;">has been allocated to</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">g</font><font style="font-family:Times New Roman;font-size:10pt;">oodwill</font><font style="font-family:Times New Roman;font-size:10pt;"> and is reported in</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">the International segment.</font></p><p>&#160;</p><p><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The results of FirstAssist are included in the Company's Consolidated Financial Statements from the date of acquisition. The pro forma effect on total revenues and net income assuming the acquisition had occurred as of January 1, 2010 were not material to the Company's total revenues and shareholders' net income for the years ended December 3</font><font style="font-family:Times New Roman;font-size:10pt;">1</font><font style="font-family:Times New Roman;font-size:10pt;">, 2011 and 2010.</font></p><p>&#160;</p></li><li style="margin-left:37.8px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Reinsurance </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">of Run-off Workers' Compensation and Personal Accident Business</font><p>&#160;</p><p><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">On December 31, 2010, the Company e</font><font style="font-family:Times New Roman;font-size:10pt;">ssentially</font><font style="font-family:Times New Roman;font-size:10pt;"> exited from its workers' compensation and personal accident reinsurance business by purchasing retrocessional coverage from a </font><font style="font-family:Times New Roman;font-size:10pt;">Bermuda</font><font style="font-family:Times New Roman;font-size:10pt;"> subsidiary of Enstar Group Limited and transferring administration of this business to the reinsurer. </font><font style="font-family:Times New Roman;font-size:10pt;">Under the reinsurance agreement, </font><font style="font-family:Times New Roman;font-size:10pt;">C</font><font style="font-family:Times New Roman;font-size:10pt;">igna</font><font style="font-family:Times New Roman;font-size:10pt;"> is indemnified for l</font><font style="font-family:Times New Roman;font-size:10pt;">iabilities with respect to its </font><font style="font-family:Times New Roman;font-size:10pt;">workers</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;"> compensation and personal accident reinsurance business to the extent that </font><font style="font-family:Times New Roman;font-size:10pt;">these </font><font style="font-family:Times New Roman;font-size:10pt;">liabilities do not exceed 190% of the December 31</font><font style="font-family:Times New Roman;font-size:10pt;">, 2010 </font><font style="font-family:Times New Roman;font-size:10pt;">net reserves.</font><font style="font-family:Times New Roman;font-size:12pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">The Company believes that the risk of loss beyond this maximum aggregate is remote. The reinsurance arrangement is secured by assets held in trust. </font><font style="font-family:Times New Roman;font-size:10pt;">Cash consideration paid to the reinsurer was $190 million. The net effect of this transaction was an af</font><font style="font-family:Times New Roman;font-size:10pt;">ter-tax loss of $20 million ($31</font><font style="font-family:Times New Roman;font-size:10pt;"> million pre-</font><font style="font-family:Times New Roman;font-size:10pt;">tax), primarily reported in other operating expenses in the Run-off Reinsurance segment. </font></p><p>&#160;</p></li><li style="margin-left:37.8px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Sale</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"> of Workers' Compensation and Case Management Business</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">On December 1, 2010 the Company completed the sale of its </font><font style="font-family:Times New Roman;font-size:10pt;">w</font><font style="font-family:Times New Roman;font-size:10pt;">orkers' </font><font style="font-family:Times New Roman;font-size:10pt;">c</font><font style="font-family:Times New Roman;font-size:10pt;">ompensation and </font><font style="font-family:Times New Roman;font-size:10pt;">c</font><font style="font-family:Times New Roman;font-size:10pt;">ase </font><font style="font-family:Times New Roman;font-size:10pt;">m</font><font style="font-family:Times New Roman;font-size:10pt;">anagement business to GENEX Holdings, Inc. </font><font style="font-family:Times New Roman;font-size:10pt;"> The Company recognized an after-tax gain on sale of $</font><font style="font-family:Times New Roman;font-size:10pt;">11</font><font style="font-family:Times New Roman;font-size:10pt;"> million ($</font><font style="font-family:Times New Roman;font-size:10pt;">18</font><font style="font-family:Times New Roman;font-size:10pt;"> million pre-</font><font style="font-family:Times New Roman;font-size:10pt;">tax) which was reported in other revenues in the Disability and Life segment. </font><font style="font-family:Times New Roman;font-size:10pt;">Proceeds of the sale were received in preferred stock of GENEX Holdings, Inc., resulting in the Company becoming a minority shareholder in GENEX Holdings, Inc. </font><font style="font-family:Times New Roman;font-size:10pt;">This investment is classified in other long-term investments and accounted for using the equity method of accounting.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top: 0pt; margin-bottom: 0pt;'></p><p style='margin-top:12pt; margin-bottom:0pt'></p><ul><li style="margin-left:36px;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;">Acquisition of Vanbreda International</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"> On August 31, 2010, the Company acquired 100% of the voting stock of Vanbreda International NV (Vanbreda International), based in </font><font style="font-family:Times New Roman;font-size:10pt;">Antwerp</font><font style="font-family:Times New Roman;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;">Belgium</font><font style="font-family:Times New Roman;font-size:10pt;"> for a cash purchase price of $41</font><font style="font-family:Times New Roman;font-size:10pt;">2</font><font style="font-family:Times New Roman;font-size:10pt;"> million. Vanbreda International specializes in providing worldwide medical insurance and employee benefits to intergovernmental and non-governmental organizations, including international humanitarian operations, as well as corporate clients. Vanbreda International's </font><font style="font-family:Times New Roman;font-size:10pt;">market leadership i</font><font style="font-family:Times New Roman;font-size:10pt;">n the intergovernmental</font><font style="font-family:Times New Roman;font-size:10pt;"> segment</font><font style="font-family:Times New Roman;font-size:10pt;"> complements the Company's position in providing </font><font style="font-family:Times New Roman;font-size:10pt;">global health</font><font style="font-family:Times New Roman;font-size:10pt;"> benefits primarily to </font><font style="font-family:Times New Roman;font-size:10pt;">multinational companies and organizations and their globally mobile employees in North America, </font><font style="font-family:Times New Roman;font-size:10pt;">Europe</font><font style="font-family:Times New Roman;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;">the </font><font style="font-family:Times New Roman;font-size:10pt;">Middle East </font><font style="font-family:Times New Roman;font-size:10pt;">and </font><font style="font-family:Times New Roman;font-size:10pt;">Asia</font><font style="font-family:Times New Roman;font-size:10pt;">.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">In accordance with GAAP, the total </font><font style="font-family:Times New Roman;font-size:10pt;">p</font><font style="font-family:Times New Roman;font-size:10pt;">urchase price has been allocated to the tangible and intangible net assets acquired based on management's estimates of their fair values</font><font style="font-family:Times New Roman;font-size:10pt;">.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">Accordingly, approximately $</font><font style="font-family:Times New Roman;font-size:10pt;">210 </font><font style="font-family:Times New Roman;font-size:10pt;">million was allocated to intangible assets, primarily customer relationships. The weighted average amortization period is </font><font style="font-family:Times New Roman;font-size:10pt;">1</font><font style="font-family:Times New Roman;font-size:10pt;">5</font><font style="font-family:Times New Roman;font-size:10pt;"> years. </font><font style="font-family:Times New Roman;font-size:10pt;">The condensed balance sheet at the acquisition date was as follows: </font></p><p style='margin-top: 0pt; margin-bottom: 0pt;'></p><div><table style="border-collapse:collapse;margin-top:20px;"><tr style="height: 15px"><td style="width: 614px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"><font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">(In millions)</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 15px"><td style="width: 614px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Investments</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> 39</font></td></tr><tr style="height: 15px"><td style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Cash and cash equivalents</font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> 73</font></td></tr><tr style="height: 15px"><td style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Premiums, accounts and notes receivable</font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> 22</font></td></tr><tr style="height: 15px"><td style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Property and equipment </font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> 1</font></td></tr><tr style="height: 15px"><td style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Deferred income taxes</font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> (71)</font></td></tr><tr style="height: 15px"><td style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Goodwill</font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> 229</font></td></tr><tr style="height: 15px"><td style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Other assets, including other intangibles</font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> 220</font></td></tr><tr style="height: 15px"><td style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> Total assets acquired</font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> 513</font></td></tr><tr style="height: 15px"><td style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;">&#160;</td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 15px"><td style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Accounts payable, accrued expenses and other liabilities</font><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> </font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> 101</font></td></tr><tr style="height: 15px"><td style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> Total liabilities acquired</font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> 101</font></td></tr><tr style="height: 15px"><td style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;">&#160;</td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 16px"><td style="width: 614px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Net assets acquired</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> 412</font></td></tr></table></div><p style='margin-top: 0pt; margin-bottom: 0pt;'></p><p style='margin-top:12pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Goodwill </font><font style="font-family:Times New Roman;font-size:10pt;">was </font><font style="font-family:Times New Roman;font-size:10pt;">allocated to </font><font style="font-family:Times New Roman;font-size:10pt;">the </font><font style="font-family:Times New Roman;font-size:10pt;">International segment. For foreign tax purposes, the acquisition of Vanbreda International </font><font style="font-family:Times New Roman;font-size:10pt;">was</font><font style="font-family:Times New Roman;font-size:10pt;"> treated as a stock purchase. Accordingly, goodwill and other intangible assets will not be amortized for foreign tax purposes but may reduce the taxability of earnings repatriated to the </font><font style="font-family:Times New Roman;font-size:10pt;">U.S.</font><font style="font-family:Times New Roman;font-size:10pt;"> by Vanbreda International. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The results of Vanbreda International are included in the Company's Consolidated Financial Statements from the date of acquisition. The pro forma effect on total revenues and net income assuming the acquisition had occurred as of January 1, 2009 was not material to the Company's total revenues and shareholders' net income for the years ended December 31, 2010 or 2009. </font></p> On December 31, 2010, the Company essentially exited from its workers' compensation and personal accident reinsurance business by purchasing retrocessional coverage from a Bermuda subsidiary of Enstar Group Limited and transferring administration of this business to the reinsurer. Under the reinsurance agreement, Cigna is indemnified for liabilities with respect to its workers&#8217; compensation and personal accident reinsurance business to the extent that these liabilities do not exceed 190% of the December 31, 2010 net reserves. The Company believes that the risk of loss beyond this maximum aggregate is remote. The reinsurance arrangement is secured by assets held in trust. Proceeds of the sale were received in preferred stock of GENEX Holdings, Inc., resulting in the Company becoming a minority shareholder in GENEX Holdings, Inc. On December 1, 2010 the Company completed the sale of its workers&#8217; compensation and case management business to GENEX Holdings, Inc. <div><table style="border-collapse:collapse;margin-top:20px;"><tr style="height: 15px"><td style="width: 614px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"><font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">(In millions)</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 15px"><td style="width: 614px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Investments</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> 39</font></td></tr><tr style="height: 15px"><td style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Cash and cash equivalents</font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> 73</font></td></tr><tr style="height: 15px"><td style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Premiums, accounts and notes receivable</font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> 22</font></td></tr><tr style="height: 15px"><td style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Property and equipment </font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> 1</font></td></tr><tr style="height: 15px"><td style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Deferred income taxes</font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> (71)</font></td></tr><tr style="height: 15px"><td style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Goodwill</font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> 229</font></td></tr><tr style="height: 15px"><td style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Other assets, including other intangibles</font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> 220</font></td></tr><tr style="height: 15px"><td style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> Total assets acquired</font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> 513</font></td></tr><tr style="height: 15px"><td style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;">&#160;</td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 15px"><td style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Accounts payable, accrued expenses and other liabilities</font><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> </font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> 101</font></td></tr><tr style="height: 15px"><td style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> Total liabilities acquired</font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> 101</font></td></tr><tr style="height: 15px"><td style="width: 614px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;">&#160;</td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 16px"><td style="width: 614px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:614px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Net assets acquired</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> 412</font></td></tr></table></div> 39000000 73000000 22000000 1000000 -71000000 229000000 220000000 412000000 101000000 101000000 513000000 <p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;">Note 4 &#8212; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">E</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">arnings</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"> P</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">er</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"> S</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">hare</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Basic and diluted earnings per share were computed as follows:</font></p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></p><p style='margin-top: 0pt; margin-bottom: 0pt;'></p><div><table style="border-collapse:collapse;margin-top:20px;"><tr style="height: 17px"><td style="width: 42px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;">&#160;</td><td style="width: 403px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:403px;">&#160;</td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;">&#160;</td><td colspan="2" style="width: 95px; border-top-style:solid;border-top-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:95px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">Effect of </font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 17px"><td colspan="2" style="width: 445px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">(Dollars in millions, except per share amounts)</font></td><td colspan="2" style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">Basic</font></td><td colspan="2" style="width: 95px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:95px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">Dilution</font></td><td colspan="2" style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">Diluted</font></td></tr><tr style="height: 17px"><td style="width: 42px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;">2011</font></td><td style="width: 403px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:403px;">&#160;</td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 18px"><td colspan="2" style="width: 445px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Shareholders' income from continuing operations</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,327</font></td><td style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> -</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,327</font></td></tr><tr style="height: 16px"><td style="width: 42px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Shares</font></td><td style="width: 403px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:403px;"><font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;">(in thousands):</font></td><td style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 20px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 17px"><td colspan="2" style="width: 445px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Weighted average</font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 270,691</font></td><td style="width: 20px; text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> -</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 270,691</font></td></tr><tr style="height: 17px"><td colspan="2" style="width: 445px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Common stock equivalents </font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 20px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 3,558</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 3,558</font></td></tr><tr style="height: 18px"><td colspan="2" style="width: 445px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Total shares</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 270,691</font></td><td style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 3,558</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 274,249</font></td></tr><tr style="height: 18px"><td colspan="2" style="width: 445px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">EPS</font></td><td style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 4.90</font></td><td style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> (0.06)</font></td><td style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 4.84</font></td></tr><tr style="height: 17px"><td style="width: 42px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;">2010</font></td><td style="width: 403px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:403px;">&#160;</td><td style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 18px"><td colspan="2" style="width: 445px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Shareholders' income from continuing operations</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,345</font></td><td style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> -</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,345</font></td></tr><tr style="height: 17px"><td style="width: 42px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Shares</font></td><td style="width: 403px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:403px;"><font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;">(in thousands):</font></td><td style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 20px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 17px"><td colspan="2" style="width: 445px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Weighted average</font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 272,866</font></td><td style="width: 20px; text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> -</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 272,866</font></td></tr><tr style="height: 17px"><td colspan="2" style="width: 445px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Common stock equivalents </font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 20px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 2,421</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 2,421</font></td></tr><tr style="height: 16px"><td colspan="2" style="width: 445px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Total shares</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 272,866</font></td><td style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 2,421</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 275,287</font></td></tr><tr style="height: 18px"><td colspan="2" style="width: 445px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">EPS</font></td><td style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 4.93</font></td><td style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> (0.04)</font></td><td style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 4.89</font></td></tr><tr style="height: 18px"><td style="width: 42px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;">2009</font></td><td style="width: 403px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:403px;">&#160;</td><td style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 17px"><td colspan="2" style="width: 445px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Shareholders' income from continuing operations</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,301</font></td><td style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> -</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,301</font></td></tr><tr style="height: 17px"><td style="width: 42px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Shares</font></td><td style="width: 403px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:403px;"><font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;">(in thousands):</font></td><td style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 20px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 18px"><td colspan="2" style="width: 445px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Weighted average</font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 274,058</font></td><td style="width: 20px; text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> -</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 274,058</font></td></tr><tr style="height: 17px"><td colspan="2" style="width: 445px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Common stock equivalents </font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 20px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,299</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,299</font></td></tr><tr style="height: 17px"><td colspan="2" style="width: 445px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Total shares</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 274,058</font></td><td style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,299</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 275,357</font></td></tr><tr style="height: 18px"><td colspan="2" style="width: 445px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">EPS</font></td><td style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 4.75</font></td><td style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> (0.02)</font></td><td style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 4.73</font></td></tr></table></div><p style='margin-top: 0pt; margin-bottom: 0pt;'></p><p style='margin-top:12pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The following outstanding employee stock options were not included in the computation of diluted earnings per share because their effect would have increased diluted earnings per share (antidilutive) as their exercise price was greater than the average sha</font><font style="font-family:Times New Roman;font-size:10pt;">re price of the Company'</font><font style="font-family:Times New Roman;font-size:10pt;">s common stock for the period.</font></p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></p><p style='margin-top: 0pt; margin-bottom: 0pt;'></p><div><table style="border-collapse:collapse;margin-top:20px;"><tr style="height: 17px"><td style="width: 496px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:496px;"><font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">(In millions)</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">2011</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">2010</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">2009</font></td></tr><tr style="height: 17px"><td style="width: 496px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:496px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Antidilutive options</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">3.7</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">6.3</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">8.8</font></td></tr></table></div> <div><table style="border-collapse:collapse;margin-top:20px;"><tr style="height: 17px"><td style="width: 42px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;">&#160;</td><td style="width: 403px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:403px;">&#160;</td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;">&#160;</td><td colspan="2" style="width: 95px; border-top-style:solid;border-top-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:95px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">Effect of </font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 17px"><td colspan="2" style="width: 445px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">(Dollars in millions, except per share amounts)</font></td><td colspan="2" style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">Basic</font></td><td colspan="2" style="width: 95px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:95px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">Dilution</font></td><td colspan="2" style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">Diluted</font></td></tr><tr style="height: 17px"><td style="width: 42px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;">2011</font></td><td style="width: 403px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:403px;">&#160;</td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 18px"><td colspan="2" style="width: 445px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Shareholders' income from continuing operations</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,327</font></td><td style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> -</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,327</font></td></tr><tr style="height: 16px"><td style="width: 42px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Shares</font></td><td style="width: 403px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:403px;"><font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;">(in thousands):</font></td><td style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 20px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 17px"><td colspan="2" style="width: 445px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Weighted average</font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 270,691</font></td><td style="width: 20px; text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> -</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 270,691</font></td></tr><tr style="height: 17px"><td colspan="2" style="width: 445px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Common stock equivalents </font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 20px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 3,558</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 3,558</font></td></tr><tr style="height: 18px"><td colspan="2" style="width: 445px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Total shares</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 270,691</font></td><td style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 3,558</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 274,249</font></td></tr><tr style="height: 18px"><td colspan="2" style="width: 445px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">EPS</font></td><td style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 4.90</font></td><td style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> (0.06)</font></td><td style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 4.84</font></td></tr><tr style="height: 17px"><td style="width: 42px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;">2010</font></td><td style="width: 403px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:403px;">&#160;</td><td style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 18px"><td colspan="2" style="width: 445px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Shareholders' income from continuing operations</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,345</font></td><td style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> -</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,345</font></td></tr><tr style="height: 17px"><td style="width: 42px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Shares</font></td><td style="width: 403px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:403px;"><font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;">(in thousands):</font></td><td style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 20px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 17px"><td colspan="2" style="width: 445px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Weighted average</font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 272,866</font></td><td style="width: 20px; text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> -</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 272,866</font></td></tr><tr style="height: 17px"><td colspan="2" style="width: 445px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Common stock equivalents </font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 20px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 2,421</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 2,421</font></td></tr><tr style="height: 16px"><td colspan="2" style="width: 445px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Total shares</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 272,866</font></td><td style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 2,421</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 275,287</font></td></tr><tr style="height: 18px"><td colspan="2" style="width: 445px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">EPS</font></td><td style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 4.93</font></td><td style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> (0.04)</font></td><td style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 4.89</font></td></tr><tr style="height: 18px"><td style="width: 42px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;">2009</font></td><td style="width: 403px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:403px;">&#160;</td><td style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 17px"><td colspan="2" style="width: 445px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Shareholders' income from continuing operations</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,301</font></td><td style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> -</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,301</font></td></tr><tr style="height: 17px"><td style="width: 42px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:42px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Shares</font></td><td style="width: 403px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:403px;"><font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;">(in thousands):</font></td><td style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 20px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 18px"><td colspan="2" style="width: 445px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Weighted average</font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 274,058</font></td><td style="width: 20px; text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> -</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 274,058</font></td></tr><tr style="height: 17px"><td colspan="2" style="width: 445px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Common stock equivalents </font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 20px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,299</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,299</font></td></tr><tr style="height: 17px"><td colspan="2" style="width: 445px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Total shares</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 274,058</font></td><td style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,299</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 275,357</font></td></tr><tr style="height: 18px"><td colspan="2" style="width: 445px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:445px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">EPS</font></td><td style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 4.75</font></td><td style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> (0.02)</font></td><td style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 4.73</font></td></tr></table></div> 270691000 274249000 3558000 272866000 274058000 4.84 272866000 2421000 275287000 4.89 274058000 1299000 275357000 4.73 1299000 1299000 -0.02 2421000 2421000 -0.04 3558000 3558000 -0.06 272866000 274058000 4.90 4.93 4.75 270691000 270691000 <div><table style="border-collapse:collapse;margin-top:20px;"><tr style="height: 17px"><td style="width: 496px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:496px;"><font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">(In millions)</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">2011</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">2010</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">2009</font></td></tr><tr style="height: 17px"><td style="width: 496px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:496px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Antidilutive options</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">3.7</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">6.3</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">8.8</font></td></tr></table></div> 3700000 6300000 8800000 126000000 87000000 0.015 0.010 0.005 0.006 0.007 0.013 93000000 51000000 26000000 53000000 42000000 39000000 <p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;">N</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">ote</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">5</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">&#8212; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">H</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">ealth</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"> C</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">are</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"> M</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">edical</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"> C</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">laims </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">P</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">ayable</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Medical claims payable for the Health Care segment reflects estimates of the ultimate cost of claims that have been incurred but not yet reported, those which have been reported but not yet paid (reported claims in process) and other medical expense payable, which primarily comprises accruals for provider incentives and other amounts payable to providers. Incurred but not yet reported comprises the majority of the reserve balance as follows:</font></p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></p><p style='margin-top: 0pt; margin-bottom: 0pt;'></p><div><table style="border-collapse:collapse;margin-top:20px;"><tr style="height: 17px"><td style="width: 530px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"><font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">(In millions)</font></td><td colspan="2" style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">2011</font></td><td colspan="2" style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">2010</font></td></tr><tr style="height: 17px"><td style="width: 530px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Incurred but not yet reported</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 952</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,067</font></td></tr><tr style="height: 17px"><td style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Reported claims in process</font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 129</font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 164</font></td></tr><tr style="height: 16px"><td style="width: 530px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Other medical expense payable</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 14</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 15</font></td></tr><tr style="height: 18px"><td style="width: 530px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;">Medical claims payable</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,095</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,246</font></td></tr></table></div><p style='margin-top: 0pt; margin-bottom: 0pt;'></p><p style='margin-top:12pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Activity in medical claims payable was as follows:</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top: 0pt; margin-bottom: 0pt;'></p><div><table style="border-collapse:collapse;margin-top:20px;"><tr style="height: 17px"><td style="width: 446px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">(In millions)</font></td><td colspan="2" style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:94px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">2011</font></td><td colspan="2" style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:94px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">2010</font></td><td colspan="2" style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:94px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">2009</font></td></tr><tr style="height: 17px"><td style="width: 446px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Balance at January 1,</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,246</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 921</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 924</font></td></tr><tr style="height: 17px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Less: Reinsurance and other amounts recoverable</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 236</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 206</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 211</font></td></tr><tr style="height: 17px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Balance at January 1, net</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,010</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 715</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 713</font></td></tr><tr style="height: 3px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;">&#160;</td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 5px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;">&#160;</td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 16px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Incurred claims related to:</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 17px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> Current year</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 8,308</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 8,663</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 6,970</font></td></tr><tr style="height: 17px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> Prior years</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> (126)</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> (93)</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> (43)</font></td></tr><tr style="height: 17px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> Total incurred</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 8,182</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 8,570</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 6,927</font></td></tr><tr style="height: 17px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Paid claims related to:</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 17px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> Current year</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 7,450</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 7,682</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 6,278</font></td></tr><tr style="height: 17px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> Prior years</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 841</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 593</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 647</font></td></tr><tr style="height: 17px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> Total paid</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 8,291</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 8,275</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 6,925</font></td></tr><tr style="height: 17px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Balance at December 31, net</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 901</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,010</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 715</font></td></tr><tr style="height: 17px"><td style="width: 446px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Add: Reinsurance and other amounts recoverable</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 194</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 236</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 206</font></td></tr><tr style="height: 16px"><td style="width: 446px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Balance at December 31, </font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,095</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,246</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 921</font></td></tr></table></div><p style='margin-top: 0pt; margin-bottom: 0pt;'></p><p style='margin-top:12pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Reinsurance and other amounts recoverable reflect amounts due from reinsurers and policyholders to cover incurred but not reported and pending claims for minimum premium products and certain administrative services only business where the right of offset does not exist.&#160;See Note 7 for additional information on reinsurance. For the </font><font style="font-family:Times New Roman;font-size:10pt;">year ended</font><font style="font-family:Times New Roman;font-size:10pt;"> December 31, 2011, actual experience differed from the Company's key assumptions resulting in favorable incurred claims related to prior years' medical claims payable of $126 million, or 1.5% of the current year incurred claims as reported for the year ended December 31, 2010. Actual completion factors resulted in </font><font style="font-family:Times New Roman;font-size:10pt;">a reduction</font><font style="font-family:Times New Roman;font-size:10pt;"> in medical claims payable of $</font><font style="font-family:Times New Roman;font-size:10pt;">87</font><font style="font-family:Times New Roman;font-size:10pt;"> million, or </font><font style="font-family:Times New Roman;font-size:10pt;">1.0%</font><font style="font-family:Times New Roman;font-size:10pt;"> of the current year incurred claims as reported for the year ended December 31, 2010 for the insured book of business. Actual medical cost trend resulted in </font><font style="font-family:Times New Roman;font-size:10pt;">a reduction</font><font style="font-family:Times New Roman;font-size:10pt;"> in medical claims payable of $</font><font style="font-family:Times New Roman;font-size:10pt;">39</font><font style="font-family:Times New Roman;font-size:10pt;"> million, or </font><font style="font-family:Times New Roman;font-size:10pt;">0.5%</font><font style="font-family:Times New Roman;font-size:10pt;"> of the current year incurred claims as reported for the year ended December 31, 2010 for the insured book of business.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">For the year ended December 31, 2010, actual experience differed from the Company</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;">s key assumptions, resulting in favorable incurred claims related to prior year</font><font style="font-family:Times New Roman;font-size:10pt;">s' medical claims payable of $93</font><font style="font-family:Times New Roman;font-size:10pt;"> million, or </font><font style="font-family:Times New Roman;font-size:10pt;">1.3</font><font style="font-family:Times New Roman;font-size:10pt;">% of the current year incurred claims as reported for the year ended December 31, 2009.&#160;Actual completion factors resulted in a reduction of the medical claims payabl</font><font style="font-family:Times New Roman;font-size:10pt;">e of $</font><font style="font-family:Times New Roman;font-size:10pt;">51</font><font style="font-family:Times New Roman;font-size:10pt;"> million, or 0.</font><font style="font-family:Times New Roman;font-size:10pt;">7</font><font style="font-family:Times New Roman;font-size:10pt;">% of the current year incurred claims as reported for the year ended December 31, 2009 for the insured book of business.&#160;Actual medical cost trend resulted in a reduction of t</font><font style="font-family:Times New Roman;font-size:10pt;">he medical claims payable of $42 million, or 0.6</font><font style="font-family:Times New Roman;font-size:10pt;">% of the current year incurred claims as reported for the year ended December 31, 2009 for the insured book of business.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The corresponding impact of prior year development on shareholders' net income was $53 million </font><font style="font-family:Times New Roman;font-size:10pt;">for the year ended December 31</font><font style="font-family:Times New Roman;font-size:10pt;">, 2011 compared with $26 million for the year ended December 31, 2010. The favorable effects of prior year development on net income in 2011 and 2010 primarily reflect low medical services utilization trend. The change in the amount of the incurred claims related to prior years in the medical claims payable liability does not directly correspond to an increase or decrease in the Company</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;">s shareholders' net income recognized for the following reasons</font><font style="font-family:Times New Roman;font-size:10pt;">:</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">First</font><font style="font-family:Times New Roman;font-size:10pt;">, the Company consistently recognizes the actuarial best estimate of the ultimate liability within a level of confidence, as required by actuarial standards of practice, which require that the liabilities be adequate under moderately adverse conditions.&#160;As the Company establishes the liability for each incurral year, the Company ensures that its assumptions appropriately consider moderately adverse conditions. When a portion of the development related to the prior year incurred claims is of</font><font style="font-family:Times New Roman;font-size:10pt;">fset by an increase determined</font><font style="font-family:Times New Roman;font-size:10pt;"> appropriate to address moderately adverse conditions for the current year incurred claims, the Company does not consider that offset amount as having any impact on </font><font style="font-family:Times New Roman;font-size:10pt;">shareholders' </font><font style="font-family:Times New Roman;font-size:10pt;">net income</font><font style="font-family:Times New Roman;font-size:10pt;">.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Second</font><font style="font-family:Times New Roman;font-size:10pt;">, while changes</font><font style="font-family:Times New Roman;font-size:10pt;"> in reserves for the Company's guaranteed c</font><font style="font-family:Times New Roman;font-size:10pt;">ost products do directly affect shareholders' net income, changes in reserves for the Company</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;">s retrospectively experience-rated business do not always impact shareholders' net income. For the Company's retrospectively experience-rate</font><font style="font-family:Times New Roman;font-size:10pt;">d</font><font style="font-family:Times New Roman;font-size:10pt;"> business only adjustments to medical claims payable on accounts in deficit affect shareholders' net income. An increase or decrease to medical claims payable on accounts in deficit, in effect, accrues to the Company and directly impacts shareholders' net income. An account is in deficit when the accumulated medical costs and administrative charges, including profit charges, exceed the accumulated premium received. Adjustments to medical claims payable on accounts in surplus accrue directly to the policyholder with no impact on the Company's shareholders' net income. An account is in surplus when the accumulated premium received exceeds the accumulated medical costs and administrative charges, including profit charges.</font></p> 952000000 129000000 14000000 1067000000 164000000 15000000 <div><table style="border-collapse:collapse;margin-top:20px;"><tr style="height: 17px"><td style="width: 530px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"><font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">(In millions)</font></td><td colspan="2" style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">2011</font></td><td colspan="2" style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">2010</font></td></tr><tr style="height: 17px"><td style="width: 530px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Incurred but not yet reported</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 952</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,067</font></td></tr><tr style="height: 17px"><td style="width: 530px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Reported claims in process</font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 129</font></td><td style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 164</font></td></tr><tr style="height: 16px"><td style="width: 530px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Other medical expense payable</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 14</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 15</font></td></tr><tr style="height: 18px"><td style="width: 530px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:530px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;">Medical claims payable</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,095</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,246</font></td></tr></table></div> 211000000 0 8308000000 8663000000 6970000000 -126000000 7450000000 7682000000 6278000000 841000000 593000000 647000000 8291000000 8275000000 6925000000 901000000 1010000000 715000000 194000000 921000000 206000000 -43000000 0 713000000 924000000 0 -93000000 236000000 <div><table style="border-collapse:collapse;margin-top:20px;"><tr style="height: 17px"><td style="width: 446px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">(In millions)</font></td><td colspan="2" style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:94px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">2011</font></td><td colspan="2" style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:94px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">2010</font></td><td colspan="2" style="width: 94px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:94px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;">2009</font></td></tr><tr style="height: 17px"><td style="width: 446px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Balance at January 1,</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,246</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 921</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 924</font></td></tr><tr style="height: 17px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Less: Reinsurance and other amounts recoverable</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 236</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 206</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 211</font></td></tr><tr style="height: 17px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Balance at January 1, net</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,010</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 715</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 713</font></td></tr><tr style="height: 3px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;">&#160;</td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 5px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;">&#160;</td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 16px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Incurred claims related to:</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 17px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> Current year</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 8,308</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 8,663</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 6,970</font></td></tr><tr style="height: 17px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> Prior years</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> (126)</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> (93)</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> (43)</font></td></tr><tr style="height: 17px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> Total incurred</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 8,182</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 8,570</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 6,927</font></td></tr><tr style="height: 17px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Paid claims related to:</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;">&#160;</td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;">&#160;</td></tr><tr style="height: 17px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> Current year</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 7,450</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 7,682</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 6,278</font></td></tr><tr style="height: 17px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> Prior years</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 841</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 593</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 647</font></td></tr><tr style="height: 17px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"> Total paid</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 8,291</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 8,275</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 6,925</font></td></tr><tr style="height: 17px"><td style="width: 446px; text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Balance at December 31, net</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 901</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,010</font></td><td style="width: 19px; text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 715</font></td></tr><tr style="height: 17px"><td style="width: 446px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Add: Reinsurance and other amounts recoverable</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 194</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 236</font></td><td style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;">&#160;</td><td style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 206</font></td></tr><tr style="height: 16px"><td style="width: 446px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:446px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;">Balance at December 31, </font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,095</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 1,246</font></td><td style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;">$</font></td><td style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"><font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"> 921</font></td></tr></table></div> 0 0.15 0.0475 0.01 0.16 0.25 0.04 0.1 0.02 0.0575 0.65 0.89 0.01 0 0.24 70000000 45000000 34000000 22000000 23000000 15000000 13000000 8000000 52000000 34000000 73000000 47000000 0.05 0.05 0.0475 0.03 <p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;">N</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">ote</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">6</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">&#8213;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">Guaranteed Minimum Death Benefit Contracts</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company's reinsurance operations, which were discontinued in 2000 and are now an inactive business in run-off mode, reinsured a guaranteed minimum death benefit</font><font style="font-family:Times New Roman;font-size:10pt;"> (</font><font style="font-family:Times New Roman;font-size:10pt;">&#8220;</font><font style="font-family:Times New Roman;font-size:10pt;">GMDB</font><font style="font-family:Times New Roman;font-size:10pt;">&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;">)</font><font style="font-family:Times New Roman;font-size:10pt;">, also known as variable annuity death benefits</font><font style="font-family:Times New Roman;font-size:10pt;"> (</font><font style="font-family:Times New Roman;font-size:10pt;">&#8220;</font><font style="font-family:Times New Roman;font-size:10pt;">VADBe</font><font style="font-family:Times New Roman;font-size:10pt;">&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;">)</font><font style="font-family:Times New Roman;font-size:10pt;">, under certain variable annuities issued by other insurance companies.&#160;&#160;These variable annuities are essentially investments in mutual funds combined with a death benefit.&#160;&#160;The Company has equity and other market exposures as a result of this product.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">In periods of declining equity markets and in periods of flat equity markets following a decline, the Company's liabilities for these guaranteed minimum death benefits increase. Conversely, in periods of rising equity markets, the Company's liabilities for these guaranteed minimum death benefits decrease. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">In 2000, the Company determined that t</font><font style="font-family:Times New Roman;font-size:10pt;">he GMDB reinsurance business </font><font style="font-family:Times New Roman;font-size:10pt;">wa</font><font style="font-family:Times New Roman;font-size:10pt;">s premium deficient</font><font style="font-family:Times New Roman;font-size:10pt;"> because the </font><font style="font-family:Times New Roman;font-size:10pt;">recorded future policy benefit reserve was less than the </font><font style="font-family:Times New Roman;font-size:10pt;">expected present value of future claims and expenses </font><font style="font-family:Times New Roman;font-size:10pt;">less</font><font style="font-family:Times New Roman;font-size:10pt;"> the expected present value of future premiums and investment income using revised assumptions based on actual and expected experience. </font><font style="font-family:Times New Roman;font-size:10pt;">T</font><font style="font-family:Times New Roman;font-size:10pt;">he Company </font><font style="font-family:Times New Roman;font-size:10pt;">test</font><font style="font-family:Times New Roman;font-size:10pt;">s</font><font style="font-family:Times New Roman;font-size:10pt;"> for premium deficiency by </font><font style="font-family:Times New Roman;font-size:10pt;">review</font><font style="font-family:Times New Roman;font-size:10pt;">ing its reserve each quarter</font><font style="font-family:Times New Roman;font-size:10pt;"> using current market conditions and </font><font style="font-family:Times New Roman;font-size:10pt;">its long-term </font><font style="font-family:Times New Roman;font-size:10pt;">assumptions. Under premium deficiency accounting</font><font style="font-family:Times New Roman;font-size:10pt;">,</font><font style="font-family:Times New Roman;font-size:10pt;"> if the recorded reserve is determined insufficient, an increase to the reserve is reflected as a charge to current period income. Consistent with GAAP, the Company does not recognize gains on premium deficient long duration products. </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">See Note 12 for further information on the Company's dynamic hedge programs that are used to reduce certain equity and interest rate exposures associated with this business.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The Company had future policy benefit reserves for </font><font style="font-family:Times New Roman;font-size:10pt;">GMDB</font><font style="font-family:Times New Roman;font-size:10pt;"> contracts of $</font><font style="font-family:Times New Roman;font-size:10pt;">1.2</font><font style="font-family:Times New Roman;font-size:10pt;"> billion as of </font><font style="font-family:Times New Roman;font-size:10pt;">December 31, 2011</font><font style="font-family:Times New Roman;font-size:10pt;">, and $1.1 b</font><font style="font-family:Times New Roman;font-size:10pt;">illion as of </font><font style="font-family:Times New Roman;font-size:10pt;">December 31, 2010</font><font style="font-family:Times New Roman;font-size:10pt;">.&#160;&#160;</font><font style="font-family:Times New Roman;font-size:10pt;">The determination of liabilities for GMDB requires the Company to make critical accounting estimates.&#160;&#160;The Company estimates its liabilities for GMDB exposures using a</font><font style="font-family:Times New Roman;font-size:10pt;">n</font><font style="font-family:Times New Roman;font-size:10pt;"> internal model run using many scenarios and based on assumptions regarding lapse, future partial surrenders, </font><font style="font-family:Times New Roman;font-size:10pt;">claim </font><font style="font-family:Times New Roman;font-size:10pt;">mortality</font><font style="font-family:Times New Roman;font-size:10pt;"> (deaths that result in claims)</font><font style="font-family:Times New Roman;font-size:10pt;">, interest rates (mean investment performance and discount rate) and volatility. Lapse refers to the full surrender of an annuity prior to a contractholder's death. Future partial surrender refers to the fact that most contractholders have the ability to withdraw substantially all of their mutual fund investments while retaining the death benefit coverage in effect at the time of the withdrawal. Mean investment performance </font><font style="font-family:Times New Roman;font-size:10pt;">for underlying equity mutual funds </font><font style="font-family:Times New Roman;font-size:10pt;">refers to market rates </font><font style="font-family:Times New Roman;font-size:10pt;">expected </font><font style="font-family:Times New Roman;font-size:10pt;">to be earned </font><font style="font-family:Times New Roman;font-size:10pt;">on the hedging instruments </font><font style="font-family:Times New Roman;font-size:10pt;">over the life of the GMDB equity hedge program, and </font><font style="font-family:Times New Roman;font-size:10pt;">for underlying fixed income mutual funds refers to the expected market return over the life of the contracts. M</font><font style="font-family:Times New Roman;font-size:10pt;">arket volatility refers to market fluctuation. These assumptions are based on the Company's experience and future expectations over the long-term period, consistent with the long-term nature of this product. The Company regularly evaluates these assumptions and changes its estimates if actual experience or other evidence suggests that assumptions should be revised.&#160;&#160;If actual experience differs from the assumptions (including lapse, future partial surrenders, </font><font style="font-family:Times New Roman;font-size:10pt;">claim </font><font style="font-family:Times New Roman;font-size:10pt;">mortality, interest rates and volatility) used in estimating these liabilities, the result could have a material adverse effect on the Company's consolidated results of operations, and in certain situations, could have a material adverse effect on the Company's</font><font style="font-family:Times New Roman;font-size:10pt;"> financial condition.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">The following provides information about the Company's reserving methodology and assumptions for </font><font style="font-family:Times New Roman;font-size:10pt;">GMDB</font><font style="font-family:Times New Roman;font-size:10pt;"> as of </font><font style="font-family:Times New Roman;font-size:10pt;">December 31, 2011</font><font style="font-family:Times New Roman;font-size:10pt;">:</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">The reserves represent estimates of the present value of net amounts expected to be paid, less the present value of net future premiums.&#160;&#160;Included in net amounts expected to be paid is the excess of the guaranteed death benefits over the values of the contractholders' accounts (based on underlying equity and bond mutual fund investments).</font></li><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">The reserves include an estimate for partial surrenders that essentially lock in the death benefit for a particular policy based on annual </font><font style="font-family:Times New Roman;font-size:10pt;">election rates that vary from 0</font><font style="font-family:Times New Roman;font-size:10pt;">%</font><font style="font-family:Times New Roman;font-size:10pt;"> to </font><font style="font-family:Times New Roman;font-size:10pt;">15</font><font style="font-family:Times New Roman;font-size:10pt;">%</font><font style="font-family:Times New Roman;font-size:10pt;"> depending on the net amount at risk for each policy and whether surrender charges apply.</font></li><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">The </font><font style="font-family:Times New Roman;font-size:10pt;">assumed </font><font style="font-family:Times New Roman;font-size:10pt;">mean investment performance</font><font style="font-family:Times New Roman;font-size:10pt;"> (&#8220;growth interest rate&#8221;)</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">for the underlying equity mutual funds</font><font style="font-family:Times New Roman;font-size:10pt;"> for the portion of the liability that is covered by the Company's growth interest rate hedge program is based on the market-obs</font><font style="font-family:Times New Roman;font-size:10pt;">ervable LIBOR swap curve. The a</font><font style="font-family:Times New Roman;font-size:10pt;">ssumed mean investment performance for the remainder of the underlying equity mutual funds</font><font style="font-family:Times New Roman;font-size:10pt;"> considers </font><font style="font-family:Times New Roman;font-size:10pt;">the Company's GMDB equity hedge program using futures contracts</font><font style="font-family:Times New Roman;font-size:10pt;">, and</font><font style="font-family:Times New Roman;font-size:10pt;"> is based on </font><font style="font-family:Times New Roman;font-size:10pt;">the Company's view that short-te</font><font style="font-family:Times New Roman;font-size:10pt;">rm interest rates will average </font><font style="font-family:Times New Roman;font-size:10pt;">4.75%</font><font style="font-family:Times New Roman;font-size:10pt;"> over future periods</font><font style="font-family:Times New Roman;font-size:10pt;">, but considers that current short-term rates are less tha</font><font style="font-family:Times New Roman;font-size:10pt;">n </font><font style="font-family:Times New Roman;font-size:10pt;">4.75</font><font style="font-family:Times New Roman;font-size:10pt;">%.</font><font style="font-family:Times New Roman;font-size:10pt;">&#160;&#160;</font><font style="font-family:Times New Roman;font-size:10pt;">The mean investment performance assumption for the underlying fixed income mutual fun</font><font style="font-family:Times New Roman;font-size:10pt;">ds (bonds and money market) is </font><font style="font-family:Times New Roman;font-size:10pt;">5% </font><font style="font-family:Times New Roman;font-size:10pt;">based on a review of historical returns. </font><font style="font-family:Times New Roman;font-size:10pt;">Th</font><font style="font-family:Times New Roman;font-size:10pt;">e investment performance for underlying equity and fixed income mutual funds</font><font style="font-family:Times New Roman;font-size:10pt;"> is reduce</font><font style="font-family:Times New Roman;font-size:10pt;">d by fund fees ranging from </font><font style="font-family:Times New Roman;font-size:10pt;">1%</font><font style="font-family:Times New Roman;font-size:10pt;"> to </font><font style="font-family:Times New Roman;font-size:10pt;">3</font><font style="font-family:Times New Roman;font-size:10pt;">% across all funds.&#160;&#160;</font></li><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">The volatility assumption </font><font style="font-family:Times New Roman;font-size:10pt;">is </font><font style="font-family:Times New Roman;font-size:10pt;">based on a review of historical monthly returns for each key index (e.g. S&amp;P 500) over a period of at least ten years. Volatility represents the dispersion of historical returns compared to the average historical return (standard deviation) for </font><font style="font-family:Times New Roman;font-size:10pt;">each index. The assumption is </font><font style="font-family:Times New Roman;font-size:10pt;">16</font><font style="font-family:Times New Roman;font-size:10pt;">% to </font><font style="font-family:Times New Roman;font-size:10pt;">25</font><font style="font-family:Times New Roman;font-size:10pt;">%, varying by equity fund type; </font><font style="font-family:Times New Roman;font-size:10pt;">4% to 10</font><font style="font-family:Times New Roman;font-size:10pt;">%, </font><font style="font-family:Times New Roman;font-size:10pt;">varying by bond fund type; and </font><font style="font-family:Times New Roman;font-size:10pt;">2</font><font style="font-family:Times New Roman;font-size:10pt;">% for money market funds. These volatility assumptions are used along with the mean investment performance assumption to project future return scenarios.</font><p>&#160;</p></li><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">The discount rate is </font><font style="font-family:Times New Roman;font-size:10pt;">5.75</font><font style="font-family:Times New Roman;font-size:10pt;">%, which is determined based on the underlying</font><font style="font-family:Times New Roman;font-size:10pt;"> and projected </font><font style="font-family:Times New Roman;font-size:10pt;">yield of the portfolio of assets supporting the GMDB liability.</font></li><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">The </font><font style="font-family:Times New Roman;font-size:10pt;">claim </font><font style="font-family:Times New Roman;font-size:10pt;">mortality assumption is </font><font style="font-family:Times New Roman;font-size:10pt;">65</font><font style="font-family:Times New Roman;font-size:10pt;">% to </font><font style="font-family:Times New Roman;font-size:10pt;">89</font><font style="font-family:Times New Roman;font-size:10pt;">% of the 1994 Group</font><font style="font-family:Times New Roman;font-size:10pt;"> Annuity Mortality table, with 1</font><font style="font-family:Times New Roman;font-size:10pt;">% annual improvement beginning January 1, 2000.</font><font style="font-family:Times New Roman;font-size:10pt;"> The assumption reflects that for certain contracts, a spousal beneficiary is allowed to elect to continue a contract by becoming its new owner, thereby postponing the death claim rather than receiving the death benefit currently. For certain issuers of these contracts, the claim mortality assumption depends on age, gender, and net amount at risk for the policy. </font></li><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">The lapse rate assump</font><font style="font-family:Times New Roman;font-size:10pt;">tion is 0% to 24</font><font style="font-family:Times New Roman;font-size:10pt;">%, depending on contract type, policy duration and the ratio of the net amount at risk to account value.</font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">During 2011, the Company completed its normal review of reserves (including assumptions) and recorded additional other benefit expenses of $</font><font style="font-family:Times New Roman;font-size:10pt;">70 million ($45</font><font style="font-family:Times New Roman;font-size:10pt;"> million after-tax) to strengthen GMDB reserves. The reserve strengthening was driven primarily by:</font></p><p style='margin-top:0pt; margin-bottom:0pt'></p><ul><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">adverse </font><font style="font-family:Times New Roman;font-size:10pt;">impacts of $34</font><font style="font-family:Times New Roman;font-size:10pt;"> mi</font><font style="font-family:Times New Roman;font-size:10pt;">llion ($</font><font style="font-family:Times New Roman;font-size:10pt;">22</font><font style="font-family:Times New Roman;font-size:10pt;"> million after-tax) due to </font><font style="font-family:Times New Roman;font-size:10pt;">volatile</font><font style="font-family:Times New Roman;font-size:10pt;"> equity market conditions. Volatility risk is not covered by the hedging programs. Also, the equity market volatility reduced the effectiveness of the hedging program for equity market exposures, in part because the market does not offer futures contracts that exactly match the diverse mix of equity fund investments held by contractholders.</font></li><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">adverse interest rate impacts of $</font><font style="font-family:Times New Roman;font-size:10pt;">23 million ($15</font><font style="font-family:Times New Roman;font-size:10pt;"> million after-tax) reflecting management's consideration of the anticipated impact of continuing low current short-term interest rates. This evaluation also led management to lower the mean investment performance as</font><font style="font-family:Times New Roman;font-size:10pt;">sumption for equity funds from 5% to 4.75</font><font style="font-family:Times New Roman;font-size:10pt;">% for those funds not subject to the growth interest rate hedge program. </font></li><li style="margin-left:18px;list-style:disc;"><font style="font-family:Times New Roman;font-size:10pt;">adverse impacts o</font><font style="font-family:Times New Roman;font-size:10pt;">f overall market declines </font><font style="font-family:Times New Roman;font-size:10pt;">in the third quarter </font><font style="font-family:Times New Roman;font-size:10pt;">of $13</font><font style="font-family:Times New Roman;font-size:10pt;"> million ($</font><font style="font-family:Times New Roman;font-size:10pt;">8</font><font style="font-family:Times New Roman;font-size:10pt;"> million after-tax), that include an increase in the provision for expected future partial surrenders and declines in the value of contractholders' non-equity investments such as bond funds, neither of which are included in the hedge programs. </font></li></ul><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">During 2010, the Company performed its periodic review of assumptions resulting in a charge